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Introduction and outline of the thesis
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1The World Health Organization (WHO) estimated that the world population aged 65 years 
and older will increase by 88% over the next 25 years. (1) In this aging population, the 
incidence of osteoporosis has increased over the last decades as well. (2–4) As advanced 
age and osteoporosis lead to enhanced bone fragility and increased fracture risk, the 
amount of osteoporosis-related fractures has also increased in the past decennia. 
Lifetime risk for developing an osteoporotic fracture is 30 % with an estimated amount of 
nine million fractures worldwide in the year 2000. (5,6) 
Fractures of the proximal femur, distal radius, proximal humerus and vertebrae are 
the most frequently seen types of osteoporosis-related fractures. For the individual 
patient the impact is huge; loss of independency, mobility and quality of life is very often 
observed after a hip fracture. (7–11) These fractures are also related with increased 
morbidity and mortality. For that matter, hip fractures can have a 1-year mortality rate 
between 18 to 32 %, compared to a mortality rate of 15 % after a vertebral fracture. 
(4,12–14) Half of all hip fracture patients will never recover their pre-fracture functional 
capacity and 25 % of these patients reside in a long-term care institution one year after 
sustaining a hip fracture. (15–17) It has been estimated that by 2050 the worldwide 
number of hip fracture patients aged 50 years and older will grow to around 6.3 million. 
(18,19) In contrast to this, a recent evaluation in The Netherlands shows a slight decrease 
in hip-fracture related hospital admissions. (20)
Reports from Sweden, Belgium and the UK have demonstrated the level and impact 
on society of costs associated with hip fracture care, both for acute care and subsequent 
dependency. (7,21–23) For example, these costs are almost two billion pounds (2.5 
billion euro) per year in the UK, as presented in the National Report from the National 
Hip Fracture Database in 2011. (7)
Current issues
The focus of hip fracture research was initially on the technical aspects (type and technique 
of implants) of hip fracture treatment. However, since the surgical technique of fracture 
treatment has been more or less established, researchers have started addressing clinical 
and functional outcome of these fractures in these often-frail elderly. The latter has been 
seldom addressed in the past, despite the fact that overall patient outcome should be the 





































with a hip fracture will probably be the major determinant for this overall outcome. Are 
elderly patients with a hip fracture different than their peers without a hip fracture, i.e. 
the background population? Which patients will survive and which will not? Who will 
regain their pre-fracture level of mobility and independency and who will not? 
In order to change outcome for these elderly patients, identifying risk factors for 
poor outcome and therewith patients at risk for poor outcome, preferably at an early 
(preoperative) stage, is essential and “hot” goals for research. Knowing these risk factors, 
valuable prediction models can be developed to predict, for example, the risk for delirium 
or discharge to an alternative location at an early stage.
aims of the thesis
The first goal of this thesis is to evaluate clinical and functional outcome of a large cohort 
of hip fracture patients. The second goal is to identify risk factors for poor outcome, both 
in a clinical and a functional perspective. Finally, specific risk scores for delirium and 
discharge to an alternative location have been developed and validated. 
Outline of the thesis
This thesis has three parts; discussing the clinical outcome of hip fracture patients (part I), 
the functional and social outcome after fracture treatment (part II) and finally establishing 
reliable prediction models for delirium and discharge location of these patients (part III). 
I. CLINICaL OUtCOME 
Although observational cohort studies can be biased by selection of included patients 
(e.g. non-consecutive series, lost of follow-up, non-blinded evaluation et cetera), this 
type of research remains the basis for novel research questions. An advantage of large 
cohort studies is the possibility of subpopulation analyses. To this end, a large, mostly 
retrospectively collected, cohort was created. To counter the limitations of retrospective 
research, the missing items during the first period (2005-2008) of the studied cohort 
were made obligatory in routine clinical care from 2008 as part of better quality 
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1admissions between 2005 and 2009 of hip fracture patients aged ≥50 years was created. 
All patients from Reinier de Graaf Hospital, Delft and the Bronovo Hospital, The Hague 
during that period were included. Three analyses were performed using this database; 
the impact of anemia and blood transfusions on outcome, a comparison of the oldest old 
(nonagenarians) with their younger peers and an analysis on concomitant fractures in hip 
fracture patients. The results are presented in chapters two to four.
anemia at admission and blood transfusion
Hip fracture patients are often old and suffer from several comorbidities, often referred 
to as the “frailty syndrome”. (24) One of the typical comorbidity features of this syndrome 
is the anemic status of the patient at admission. (24) 
Increasing evidence suggests that low hemoglobin concentration is common in elderly 
patients and adversely affects morbidity and mortality risk, especially if they are in need 
of surgery. (24–27) Several studies on anemia in hip fracture patients reported increased 
morbidity, prolonged admission, higher readmission rate and increased mortality rate. 
(28–30) Studies on allogeneic blood transfusion (ABT) in hip fracture patients show 
ambivalent findings regarding outcome and mortality. (31–37)
The purpose of the study presented in chapter two was to evaluate the effect of 
preoperative hemoglobin level and perioperative ABT on mortality, delirium incidence, 
length of hospital stay, discharge to a nursing home and the 90-day readmission rate.
Nonagenarians versus younger patients
The number of nonagenarians is rapidly increasing and therewith the numbers of hip 
fracture patients aged 90 years and older. (2,4) Nonagenarian patients frequently suffer 
from comorbidities and functional impairment; both have a huge impact on outcome 
after hip fracture treatment. (37–39) In chapter three the results of a large consecutive 
series of nonagenarian hip fracture patients in comparison to hip fracture patients aged 
65–89 years are presented.
Contralateral hip fractures and other concomitant fractures 
An increased risk exists to sustain subsequent fractures of both the ipsilateral and 





































initial fracture. (40,41) In chapter four, the one-year and absolute risk of sustaining a 
contralateral hip fracture and other osteoporosis-related fractures was assessed as well 
as possible risk factors for sustaining a contralateral hip fracture. 
 
II. FUNCtIONaL aND SOCIaL OUtCOME
As mentioned in the introduction, in the last two decades “social morbidity” due to lower 
level of activities of daily living, loss of independence and change of place of residence 
has increasingly become the subject of research, since these factors have a major impact 
on the outcome of the individual patient. (9,11) 
A prospective hip fracture patient cohort of 498 consecutive admissions in Reinier 
de Graaf Hospital, Delft between 2008 and 2009 of hip fracture patients aged ≥50 years 
was created. They were evaluated with respect to return to the pre-fracture place of 
residence and the pre-fracture level of mobility (chapters five and six).
return to pre-fracture place of residence 
Discharge to an alternative location (i.e another place than pre-fracture place of residence) 
or the necessity to provide additional postoperative care at home after discharge could 
both contribute to a longer stay in the hospital and will thus create additional costs. 
(21,22) 
In chapter five preoperative risk factors for failure to return to the pre-fracture place of 
residence are evaluated at three and 12 months postoperatively.
regaining pre-fracture level of mobility 
As a result of the loss of mobility after the initial treatment of a hip fracture, patients 
are often restricted in their daily activities, resulting in loss of confidence and loss of 
independence. (8,10) Healthcare costs are severely affected by loss of mobility, medical 
costs for hip fracture patients are about threefold larger compared to the background 
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1Risk factors for failing to return to the pre-fracture level of mobility in the first year 
after a hip fracture are evaluated in chapter six. 
III. PrEDICtION MODELS
Delirium risk Screening and Haloperidol Prophylaxis Program 
Delirium is a common and serious complication in hip fracture patients, which results 
in limited functional abilities, longer hospital stay, impaired cognitive function, more 
admissions to long term special care facilities and higher mortality rates. (42–45) In 2008 
an integrated hip fracture care pathway that included a Risk Model for Delirium was 
introduced at Reinier de Graaf Hospital. (46) The results of using this model are evaluated 
in chapter seven.
Validation of the risk Model for Delirium
The Risk Model for Delirium (RD) score was developed in Reinier de Graaf Hospital. (46) 
This is a simple and easy to use model for prediction of the risk for delirium in an acute 
admission setting. The results, validity and feasibility of this RRD-score in daily practice 
are described in chapter eight.
Development and external validation of the Discharge of Hip fracture Patients score 
(DHP) 
Early prediction of hospital discharge location of hip fracture patients who lived 
independently in their own home prior to sustaining a hip fracture, is an important quality 
indicator for both patients and their family. The Discharge of Hip fracture Patients score 
(DHP) was developed to predict the risk of discharge to an alternative location (chapter 
nine).
External validation of the DHP score was performed in a cohort of 125 hip fracture 
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Background: Anemia is more often seen in older patients. As the mean age of hip fracture 
patients is rising, anemia is common in this population. Allogeneic blood transfusion 
(ABT) and anemia have been pointed out as possible risk factors for poorer outcome in 
hip fracture patients.
Methods: In the timeframe 2005-2010, 1262 admissions for surgical treatment of a hip 
fracture in patients aged 65 years and older were recorded. Registration was prospective 
from 2008 on. Anemic and non-anemic patients (based on hemoglobin level at admission) 
were compared regarding clinical characteristics, mortality, delirium incidence, LOS, 
discharge to a nursing home and the 90-day readmission rate. Receiving an ABT, age, 
gender, ASA classification, type of fracture and anesthesia were used as possible 
confounders in multivariable regression analysis.
results: The prevalence of anemia and the rate of ABT both were 42.5%. Anemic patients 
were more likely to be older and men and had more often a trochanteric fracture, a higher 
ASA score and received more often an ABT. In univariate analysis, the 3- and 12-month 
mortality rate, delirium incidence and discharge to a nursing home rate were significantly 
worse in preoperatively anemic patients.
In multivariable regression analysis, anemia at admission was a significant risk 
factor for discharge to a nursing home and readmission < 90 days, but not for mortality. 
Indication for ABT, age and ASA classification were independent risk factors for mortality 
at all moments, only the mortality rate for the 3-12 month interval was not influenced 
by ABT. An indication for an ABT was the largest negative contributor to a longer LOS (OR 
2.26, 95% CI 1.73-2.94) and the second largest for delirium (OR 1.67, 95% CI 1.28-2.20).
Conclusions: This study has demonstrated that anemia at admission and postoperative 
anemia needing an ABT (PANT) were independent risk factors for worse outcome in hip 
fracture patients. In multivariable regression analysis, anemia as such had no effect on 
mortality, due to a rescue effect of PANT. In-hospital, 3- and 12-month mortality was 







































Due to the ageing of the Western population, the number of elderly people will 
increase. Although age-adjusted incidence of hip fractures in many countries, like the 
US and Sweden, declined in the population of 50 years and older, there is a right-shift 
in hip fracture distribution towards the highest age groups [1]. These old patients have 
several co-morbidities, often described as the “frailty syndrome” [2]. One of the typical 
features of this syndrome is an anemic status [2]. Increasing evidence suggests that low 
hemoglobin concentration is common in elderly patients and adversely affects morbidity 
and mortality, especially if they are in need of surgery [2-5].
Several studies on anemia in hip fracture patients reported on increased morbidity, 
prolonged admission, higher readmission rate and increased mortality rate [6-8]. Studies 
on allogeneic blood transfusion (ABT) in hip fracture patients show ambivalent findings 
regarding outcome and mortality [9-14].
In this study, the effect of preoperative hemoglobin level and perioperative ABT was 
evaluated in a large cohort follow-up study of 1262 admissions for surgical treatment for 
hip fracture in patients of 65 years and older. The focus of our analysis was on mortality, 
incidence of delirium, length of hospital stay, discharge to a nursing home and the 90-day 
readmission rate.
Methods
An observational cohort study was conducted on hip fracture patients admitted to a 350- 
and a 450-bed teaching hospital in The Hague and Delft.
aim of the study
To determine whether anemia at admission and perioperative allogeneic blood transfusion 
(ABT) have an independent negative effect with mortality, occurrence of a delirium, 
length of hospital stay (LOS), discharge to a nursing home and 90-day readmission rate 
in surgically treated hip fracture patients, aged 65 years and older. Delirium has been 






































All patients were extracted from our digital database that contains all consecutive hip 
fracture patients, admitted from January 2005 to January 2010. Data were collected 
retrospectively for patients in the timeframe 2005-2007 and prospectively for those in 
the period 2008-2009.
The exclusion criteria for this study were: age < 65 years, a pathologic hip fracture, 
a high-energy injury and conservative treatment. Duration of follow-up in all patients 
was 12 months. This resulted in a cohort of 1262 admissions for a hip fracture, in 1222 
patients.
From the hospital’s records (both digital and paper files), age, gender, ASA 
classification, type of fracture, type of treatment, type of anesthesia, pre- and post- 
operative hemoglobin level, perioperative need for an ABT, occurrence of a delirium, LOS 
and discharge location were collected onto a case record form (CRF) [15].
Diagnosis of delirium was based on criteria of the DSM IV [16]. Signs of a delirium 
are recorded in the medical and nursing records as a standard part of documentation 
of the daily characteristics of a patient. Delirium incidence in this series was scored 
based on these medical and nursing staff records. To calculate the 90- day readmission 
rate, all readmissions within 90 days after discharge were extracted from the digital 
hospital admission registration system. Postoperative mortality has been documented 
meticulously by repeated consultation of the population registers of the counties in the 
region of both hospitals as well as the hospital’s patient registration systems. If present, 
readmissions and date of death were recorded at the CRF. As of 2008, all data were 
recorded prospectively in the CRF. All fore mentioned data were complete, both in the 
retrospective and prospective series and was performed by authors AV, BB, PP and AN.
Approval from the local ethical committee was not obtained, as this is an observational 
study without an intervention. Therefore, it is an evaluation of usual care as a part of 
good clinical practice. Since data could not be traced back to the individual patient there 
were no privacy issues.
anemia and aBt policy
In all patients the hemoglobin level was measured at admission. Anemia at admission 
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2
criteria classify anemia as a hemoglobin level below 7.5 mmol/L (12 g/dL) in women and 
below 8.1 mmol/L (13 g/dL) in men. They were tested and found sufficient for elderly by 
Izaks et al in their study on mortality in elderly patients [18].
In the Netherlands, the national CBO guideline advises ABT for subjects aged > 
60 years when hemoglobin level drops below 5.0 mmol/L (8.0 g/dL) in the general 
population or 6.0 mmol/L (9.7 g/dL) if the patient has a serious cardiac condition or when 
anemia becomes symptomatic [19]. This guideline is general practice in both hospitals. 
Hemoglobin level was measured on the first postoperative day as a routine and if 
necessary repeated thereafter based on clinical judgment.
Statistical analysis
Demographic continuous data are presented as means, with standard deviations (SD). 
Categorical data are presented as the number of subjects in the category, along with the 
percentages. Chi-square test and Fisher’s exact test were used for comparing groups of 
categorical data. The cohort was compared regarding differences in clinical characteristics 
and outcome between the anemic and non-anemic patients, based upon hemoglobin 
level at admission.
Univariate analysis performed to test the association between anemia and mortality 
(in-hospital, 3- and 12- month), delirium, LOS categories (≤ versus > 11 days), discharge to 
a nursing home and 90-day readmission rate. Separate logistic regression analyses were 
executed for each outcome, for the mortality Cox proportional hazards regression analysis 
was used to calculate the hazard ratio and 95% confidence interval. In these analyses, 
correction was performed for the possible confounders; age, gender, perioperative risk 
(ASA classification I/II or III/IV), receiving an ABT, type of fracture (neck of femur, (inter-) 
trochanteric or subtro- chanteric), and type of anesthesia (general or spinal). Because of 
the clinical relation between the anemia and receiving an ABT collinearity diagnostics of 
the logistic regression models were examined.
To robustify the analysis for LOS, this parameter was changed into a binary summary 
outcome, i.e. ≤ or > 11 days (the median), as the distribution of the value LOS was very 
wide.
Patients classified ASA I or II and III or IV were combined to two groups, as the 






































P-values lower than 0.05 were considered statistically significant. Odds ratios are 
displayed with a 95% confidence interval if the p-value < 0.05. All data were analyzed in 
SPSS 17.0 (SPSS Inc. Chicago, USA).
results
Clinical characteristics
1262 admissions for a surgical treatment of a hip fracture (1222 patients) were extracted 
from the database; 932 (73.9%) were female. Mean (SD) age was 83.6 (7.1) years and 
mean (SD) follow-up was 3.5 (1.4) years. Mean (SD) hemoglobin level at admission was 
7.7 (1.0) mmol/l. According to the WHO criteria, 536 patients (42.5%) were anemic [17]. 
Transfusion of one or more unit(s) of allogeneic erythrocytes was given to 536 patients 
(42.5%), in the large majority (97.9%) postoperatively. Surgery within 24 hours after 
admission was per- formed in 84.4% of all patients. Overall mortality was
40.4% (510 of 1262 patients).
anemic versus non-anemic patients
The patients were divided in an anemic and non-anemic group, based on the hemoglobin 
level at admission; clinical characteristics of the two populations are shown in Table 1.
The anemic group was significantly different from the non-anemic regarding age, 
gender, ASA, fracture distribution and ABT rate. There was no significant difference in 
mean follow-up. The relative risks for the different outcome parameters according to 
univariate analysis are presented in table 2. In this analysis, LOS and the in-hospital and 
3-12 month interval mortality rate were not significantly different between both groups.
The 90-day readmission rate was significantly higher in anemic patients. Readmission 
for an orthopaedic reason (surgical site infection, revision operation or a contralateral hip 
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mean age in years (SD) 84.9 (6.9) 82.6 (7.0) n/a < 0.001
mean follow-up in months (SD) 42.7 (16.9) 42.2 (15.9) n/a 0.578
Male gender 170 (31.7) 160 (22.0) 1.31 (1.15-1.50) < 0.001
ASA III/IV 200 (37.3) 201 (27.7) 1.28 (1.12-1.45) < 0.001
Fracture type
-neck of femur 252 (47.0) 450 (62.0) < 0.001*
-(inter) trochanteric 266 (49.6) 256 (35.3) 0.70 (0.62-0.80) < 0.001**
-subtrochanteric 18 (3.4) 20 (2.8)
Spinal anesthesia 494 (92.2) 684 (94.2) 0.84 (0.67-1.05) 0.149
ABT 309 (57.6) 153 (21.1) 2.36 (2.08-2.68) < 0.001
Values are given as number (percentage), unless mentioned otherwise.
* P-value comparing 3 treatment groups, **RR and p-value comparing neck of femur with (inter-) 
trochanteric fractures.
RR = relative risk; CI = confidence interval; ASA = American Society of Anesthesiologists Physical 
Status classification, ABT = allogeneic blood transfusion.
table 2 Relative risks for different outcome measures in anemic and non-anemic patients
Anemic Non- anemic RR (CI) P-value
n = 536 n = 726
Mortality
In-hospital 30 (5.6) 31 (4.3) 1.17 (0.90-1.52) 0.277
3-month 113 (21.1) 87 (12.0) 1.42 (1.23-1.64) < 0.001
3-12 month 60 (11.2) 71 (9.8) 1.09 (0.89-1.33) 0.415
12-month 173 (32.3) 158 (21.8) 1.34 (1.18-1.53) < 0.001
Delirium 162 (30.3) 155 (21.3) 1.29 (1.13-1.48) < 0.001
LOS > 11 days 272 (50.7) 368 (50.7) 1.00 (0.88-1.14) 0.984
Discharge to a NH 277 (51.7) 285 (39.3) 1.33 (1.17-1.51) < 0.001
90-day readmission rate 69 (12.9) 65 (9.0) 1.24 (1.04-1.49) 0.025
Values are given as number (percentage), RR = relative risk, CI = confidence interval, LOS = length of 
stay, NH = nursing home
Multivariable logistic and Cox regression analysis
The Spearman’s correlation coefficient between anemia and an ABT was low (0.38, p < 
0.001) and the tolerance and VIF values indicated no multicollinearity.
Anemia at admission was not a significant independent risk factor for mortality at 





































significant independent risk factor for in- hospital, 3- and 12-month mortality, as were 
higher age and ASA classification in all patients (both anemic and non-anemic). However, 
receiving an ABT was not a risk factor for the mortality in the 3 to 12 month interval. 
Anemia was a significant independent risk factor for discharge to a nursing home and 
readmission within 90 days. The odds ratio for anemia in the analysis for LOS was 0.63 
when adjusted for ABT and age. The latter two both had an independent negative impact 
on LOS (OR 2.12 and 1.06). This meant that anemic patients had a shorter stay in hospital 
than non-anemic patients, when they were younger and did not receive an ABT. For 
the outcome parameters besides mortality, i.e. discharge to a nursing home, delirium, 
90-day readmission rate and a LOS > 11 days, age played a more important role than 
ASA classification. Gender and type of anesthesia were of little importance. Type of hip 
fracture was not a significant independent contributor to any of our outcome parameters 
in multivariable analysis.
anemia effecting aBt and vice versa
Mortality in patients with anemia at admission (21.1%) was higher than in non-anemics 
(12%, p < 0.001) and mortality in all patients that received an ABT (22.7%) was higher 
compared to those that did not (11.9%, p < 0.001).
The in-hospital mortality rate of anemic patients that received an ABT (6.5%) compared 
to those who did not (4.4%), was comparable (p = 0.30). However, the mortality rates in 
preoperative non-anemic patients who received an ABT compared to those who did not 
were respectively 9.8% and 2.8% (p < 0.001).
The 3-month mortality in anemic patients was 24.3% in transfused and 16.7% in 
non-transfused patients (p = 0.035) and in non-anemic patients rates 19.6% and 9.9% 
(p = 0.001) in transfused and non-transfused patients respectively.
The relative risk (RR) for 3-month mortality in patients with anemia at admission 
is significantly increased in patients that did not receive an ABT (RR 1.49, CI 1.13-1.96, 
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table 3 Risk factors with a significant HR for mortality and a significant OR for the other outcome 
parameters
Outcome variable Risk factor HR/ OR 95% CI P-value
Mortality*
in-hospital Age in years 1.07 1.02 to 1.11 0.002
ASA 2.76 1.66 to 4.59 < 0.001
ABT 1.88 1.12 to 3.14 0.017
3-month Age in years 1.06 1.04 to 1.09 < 0.001
ASA 1.94 1.47 to 2.57 < 0.001
ABT 1.48 1.10 to 2.01 0.011
Anemia 1.30 0.96 to 1.76 0.088
3-12 month Age in years 1.05 1.02 to 1.08 < 0.001
ASA 1.78 1.26 to 2.52 0.001
12-month Age in years 1.06 1.04 to 1.08 < 0.001
ASA 1.89 1.52 to 2.34 < 0.001
ABT 1.42 1.13 to 1.77 0.002
Delirium Age in years 1.06 1.04 to 1.08 < 0.001
ASA 1.47 1.11 to 1.93 0.006
ABT 1.67 1.28 to 2.20 < 0.001
Male gender 1.99 1.49 to 2.66 < 0.001
LOS > 11 days Anemia 0.63 0.48 to 0.81 < 0.001
Age in years 1.07 1.05 to 1.08 < 0.001
ABT 2.26 1.73 to 2.94 < 0.001
ASA 1.24 0.97 to 1.59 0.089
Discharge to a NH Anemia 1.41 1.10 to 1.81 0.007
Age in years 1.05 1.04 to 1.07 < 0.001
General 1.67 1.05 to 2.64 0.029
anesthesia
Male gender 0.75 0.58 to 0.99 0.038
ABT 1.24 0.96 to 1.61 0.097
Anemia 1.61 1.11 to 2.33 0.011
90-day readmission rate
Age in years 0.97 0.94 to 0.99 0.006
ASA 1.43 0.99 to 2.09 0.060
General 0.35 0.13 to 0.99 0.047
anesthesia
Female gender, ASA classification I-II, having no anemia, receiving no allogeneic blood transfusion 
and spinal anesthesia are reference categories.
* Expressed in HR (Hazard Ratio), all other risk factors in OR (Odds Ratio)
CI = confidence interval, LOS = length of stay, NH = nursing home, ASA = American Society of 





































As demonstrated in Figure 1 and 2, this effect of transfusion on mortality between anemic 
and non-anemic patients disappeared after about 3 months; the curves of anemic and 
non-anemic patients that receive an ABT (Figure 2) are parallel the first 90 days whereas 
the curves of those that do not receive an ABT diverge (Figure 1).
Mortality in patients that received an ABT was comparable in patients that were 
anemic at admission (24.3%) compared to the non-anemic (19.6%, p = 0.26).
In patients that did not receive an ABT mortality was higher in anemic (16.7%) than in 
non-anemics (9.9%, p = 0.07).
The RR for 3-month mortality in patients receiving an ABT was comparable between 
anemic patients (RR = 1.45, CI 1.02-2.06, p = 0.035) and non-anemic patients (1.97, CI 
1.32-2.95, p = 0.001).
The RR for 3-month mortality in patients receiving an
ABT was comparable between anemic patients (RR =
1.45, CI 1.02-2.06, p = 0.035) and non-anemic patients
(1.97, CI 1.32-2.95, p = 0.001).
Discussion
In the current study we demonstrate that receiving an
ABT, an ASA classification III/IV and higher age were
risk factors for postoperative mortality. In the same ana-
lysis, anemia at admission was a significant risk factor
for discharge to a nursing home and readmission within
90 days, but not for a higher mortality. LOS in anemic
patients, corrected for age and ABT, was shorter.
Finally, receiving an ABT was correlated with a longer
LOS and a higher delirium incidence.
Anemic versus non-anemic patients
The incidence of anemia and the rate of ABTs in this
cohort were consistent with previous studies in hip frac-
ture patients [6-9,11-14].
Anemic patients were more likely to be older and to
be men, to have a trochanteric fracture and a higher
ASA score and to receive an ABT; the latter two results
were demonstrated by others as well [7,8]. These studies
[7,8] could not find a difference in gender distribution,
one other could [6]. Others have shown that higher age,
female gender and worse health status are correlated to
intertrochanteric fractures [20-22]. These findings show
the complex correlation between anemia as a mirror of
a poor general condition (expressed in higher ASA
scores), age and fracture type and gender
Multivariable logistic and Cox regression analysis
We found anemia not to be a significant risk factor for
mortality in Cox regression analysis, in contrast to sev-
eral other studies [6-9]. However, the largest of these
studies contained only 791 patients and some methodo-
logical concerns could be identified [6]. We consider
anemia therefore to be more a proxy for frailty than a
direct cause related to mortality.
Receiving an ABT was a risk factor for mortality at all
follow-up moments, but not for the 3 to 12 months
interval with its main effect in the first 3 months.
Mortality in transfused hip fracture patients was either
higher or equal in previous series [10-14]. The two lar-
gest series were described by Johnston et al (n = 3571)
and Carson et al (n = 8787) [12,14]. Johnston et al
found a negative correlation at 120 and 365 days in uni-
variate, but not in in multivariable analysis [12]. Carson
et al found no effect on 30- and 90-day mortality [14].
In contrast, fewer complications were seen in restrictive
ABT regimen patients who had total hip and knee repla-
cements [23].
Age and ASA classification as risk factors for mortality
and poor outcome do not need further explanation; the
negative effect of the latter in hip fracture patients has
recently been published [24].
Younger patients with anemia who received no ABT
had a shorter LOS in our series. LOS is more often
reported upon in studies on anemia than in those on
ABTs [7-14]. Gruson, and Halm found a longer LOS in
anemic patients, whereas Hagino did not [7-9]. The only
study on ABT in hip fracture patients that reported
LOS found no difference [10]. Younger age is most
probably the reason for the shorter LOS, not anemia or
receiving no ABT.
Figure 1 mortality in patients that did not receive an
allogeneic blood transfusion (ABT).
Figure 2 mortality in patients that received an allogeneic
blood transfusion (ABT).
Vochteloo et al. BMC Musculoskeletal Disorders 2011, 12:262
http://www.biomedcentral.com/1471-2474/12/262
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The RR for 3-month mortality in patients receiving an
ABT was comparable between anemic patients (RR =
1.45, CI 1.02-2.06, p = 0.035) and non-anemic patients
(1.97, CI 1.32-2.95, p = 0.001).
Discussion
In the current study we demonstrate that receiving an
ABT, an ASA classification III/IV and higher age were
risk factors for postoperative mortality. In the same ana-
lysis, anemia at admission was a significant risk factor
for discharge to a nursing home and readmission within
90 days, but not for a higher mortality. LOS in anemic
patients, corrected for age and ABT, was shorter.
Finally, receiving an ABT was correlated with a longer
LOS and a higher delirium incidence.
Anemic versus non-anemic patients
The incidence of anemia and the rate of ABTs in this
cohort were consistent with previous studies in hip frac-
ture patients [6-9,11-14].
Anemic patients were more likely to be older and to
be men, to have a trochanteric fracture and a higher
ASA score and to receive an ABT; the latter two results
were demonstrated by others as well [7,8]. These studies
[7,8] could not find a difference in gender distribution,
one other could [6]. Others have shown that higher age,
female gender and worse health status are correlated to
intertrochanteric fractures [20-22]. These findings show
the complex correlation between anemia as a mirror of
a poor general condition (expressed in higher ASA
scores), age and fracture type and gender
Multivariable logistic and Cox regression analysis
We found anemia not to be a significant risk factor for
mortality in Cox regression analysis, in contrast to sev-
eral other studies [6-9]. However, the largest of these
studies contained only 791 patients and some methodo-
logical concerns could be identified [6]. We consider
anemia therefore to be more a proxy for frailty than a
direct cause related to mortality.
Receiving an ABT was a risk factor for mortality at all
follow-up moments, but not for the 3 to 12 months
interval with its main effect in the first 3 months.
Mortality in transfused hip fracture patients was either
higher or equal in previous series [10-14]. The two lar-
gest series were described by Johnston et al (n = 3571)
and Carson et al (n = 8787) [12,14]. Johnston et al
found a negative correlation at 120 and 365 days in uni-
variate, but not in in multivariable analysis [12]. Carson
et al found no effect on 30- and 90-day mortality [14].
In contrast, fewer complications were seen in restrictive
ABT regimen patients who had total hip and knee repla-
cements [23].
Age and ASA classification as risk factors for mortality
and poor outcome do not need further explanation; the
negative effect of the latter in hip fracture patients has
recently been published [24].
Younger patients with anemia who received no ABT
had a shorter LOS in our series. LOS is more often
reported upon in studies on anemia than in those on
ABTs [7-14]. Gruson, and Halm found a longer LOS in
anemic patients, whereas Hagino did not [7-9]. The only
study on ABT in hip fracture patients that reported
LOS found no difference [10]. Younger age is most
probably the reason for the shorter LOS, not anemia or
receiving no ABT.
Figure 1 mortality in patients that did not receive an
allogeneic blood transfusion (ABT).
Figure 2 mortality in patients that received an allogeneic
blood transfusion (ABT).
Vochteloo et al. BMC Musculoskeletal Disorders 2011, 12:262
http://www.biomedcentral.com/1471-2474/12/262
Page 5 of 7
Figure 2 mortality in patients that received an allogeneic blood transfusion (ABT).
Discussion
In the current study we demonstrate that receiving an ABT, an ASA classification III/IV and 
higher age were risk factors for postoperative mortality. In the same analysis, anemia at 
admission was a significant risk factor for discharge to a nursing home and readmission 
within 90 days, but not for a higher mortality. LOS in anemic patients, corrected for age 
and ABT, was shorter. Finally, receiving an ABT was correlated with a longer LOS and a 
higher delirium incidence.
anemic versus non-anemic patients
The incidence of anemia and the rate of ABTs in this cohort were consistent with previous 
studies in hip fracture patients [6-9,11-14].
Anemic patients were more likely to be older and to be men, to have a trochanteric 
fracture and a higher ASA score and to receive an ABT; the latter two results were 
demonstrated by others as well [7,8]. These studies [7,8] could not find a difference in 





































gender and worse health status are correlated to intertrochanteric fractures [20-22]. 
These findings show the complex correlation between anemia as a mirror of a poor 
general condition (expressed in higher ASA scores), age and fracture type and gender.
Multivariable logistic and Cox regression analysis
We found anemia not to be a significant risk factor for mortality in Cox regression analysis, 
in contrast to several other studies [6-9]. However, the largest of these studies contained 
only 791 patients and some methodological concerns could be identified [6]. We consider 
anemia therefore to be more a proxy for frailty than a direct cause related to mortality.
Receiving an ABT was a risk factor for mortality at all follow-up moments, but not for the 
3 to 12 months interval with its main effect in the first 3 months.
Mortality in transfused hip fracture patients was either higher or equal in previous 
series [10-14]. The two largest series were described by Johnston et al (n = 3571) and 
Carson et al (n = 8787) [12,14]. Johnston et al found a negative correlation at 120 and 365 
days in univariate, but not in in multivariable analysis [12]. Carson et al found no effect 
on 30- and 90-day mortality [14]. In contrast, fewer complications were seen in restrictive 
ABT regimen patients who had total hip and knee replacements [23].
Age and ASA classification as risk factors for mortality and poor outcome do not need 
further explanation; the negative effect of the latter in hip fracture patients has recently 
been published [24].
Younger patients with anemia who received no ABT had a shorter LOS in our series. 
LOS is more often reported upon in studies on anemia than in those on ABTs [7-14]. 
Gruson, and Halm found a longer LOS in anemic patients, whereas Hagino did not [7-9]. 
The only study on ABT in hip fracture patients that reported LOS found no difference [10]. 
Younger age is most probably the reason for the shorter LOS, not anemia or receiving no 
ABT.
Receiving an ABT did and anemia did not have a negative effect on delirium incidence 
in this series. None of the studies on anemia and ABTs in hip fracture patients we found, 
reported delirium incidence. We would have expected anemia to be of negative influence 
as well, because higher age and ASA classification and male gender were negative 
contributors; all part of the the anemic patient profile. This is probably due to the fact 
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Finally, anemia at admission was of negative contribution to the 90-day readmission 
rate, ABT was not. Halm et al reported on readmissions, they found a lower 60- day 
readmission rate in patients with a higher hemoglobin level and in those receiving an ABT 
[9,13]. These different findings are probably due to the fact anemia and an ABT are only 
two minor of the many factors influencing the readmission rate.
anemia effecting aBt and vice versa
As demonstrated, receiving an ABT had a rescue effect on mortality in anemic patients 
in the first 3 months. This was probably partly due to correction of the negative effect 
of anemia at admission. The RR for 3-month mortality in patients receiving an ABT was 
comparable between anemic and non-anemic patients; both groups are negatively 
affected by an ABT.
Limitations
Our study had a large sample size and the combined analysis of both anemia at admission 
and ABTs has never been done before. Limitations were that part of the data was collected 
retrospectively and documentation of occurrence of a delirium was based on clinical 
observations as described in the DSM-IV [16]. Although these criteria are sufficient, it is 
better to use a specific delirium score like the Confusion Assessment Score [25].
The time interval from fracture to admission is of no influence on the measured 
hemoglobin level at admission since in the Netherlands the mean interval between an 
accident and admission is no longer than a few hours.
Several limitations of the analysis for the impact of receiving an ABT can be identified. 
The number of ABTs was not reliably registered in the large majority of the patients, 
which made an interesting extra analysis using the number of transfusions not valid. For 
male and female patients different cut-off points for anemia (defined by the WHO) were 
used, but the transfusion threshold was not different [17,19]. Furthermore, the decision 
in daily clinical practice to give an ABT is not only based on the transfusion thresholds, but 
on clinical aspects as well as defined in the CBO guideline [19].
However, this represents daily practice for most hospitals. Because of these limiting 





































parameters and receiving an ABT but we rather call it “postoperative anemia necessitating 
a transfusion, PANT” as a reflection of the whole of the condition of the patient that 
needs an ABT postoperatively.
The outcome of this study can be used for better inform consent, to perform early 
interventions for prevention of a delirium, to anticipate for a longer LOS and to provide 
an alternative discharge location early in patients at risk.
Finally, awaiting the results of large trials on ABTs like the FOCUS trial [26], it might be 
of benefit to use a lower cut-off transfusion threshold in hip fracture patients that are in 
a worse condition, like anemia.
Conclusions
This study has demonstrated that anemia at admission and PANT were independent risk 
factors for worse outcome in hip fracture patients. In multivariable regression analysis, 
anemia at admission as such had no effect on mortality, due to a rescue effect of PANT. 
PANT affected in-hospital, 3- and 12-month mortality negatively, with the main effect in 
the first 3 months postoperatively.
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Do clinical characteristics and outcome 
in nonagenarians with a hip fracture 
differ from younger patients?
Anne JH Vochteloo, Boudewijn LS Borger van der Burg, Wim E Tuinebreijer, Mark R de Vries, Arthur 
HP Niggebrugge, Rolf M Bloem, Andrea B Maier, Rob GHH Nelissen and Peter Pilot






































aim: To compare clinical characteristics and outcome of nonagenarian hip fracture 
patients with younger patients aged 65–89 years.
Methods: This was a cohort follow-up study of admissions for a hip fracture between 
2005–2010 (mean follow up of 3.5 years) in two teaching hospitals in the Netherlands; 230 
nonagenarians and 1014 patients aged 65–89 years were included. Clinical characteristics, 
adverse events, mobility and mortality were compared.
results: Nonagenarians were more likely to be female and anemic (both P < 0.001), 
and had more trochanteric fractures (P = 0.005). The number of American Society of 
Anesthesiologists III/VI classified patients did not differ between the two groups. During 
the hospital stay, adverse events were more frequently observed in nonagenarians 
compared with younger patients (P < 0.001). The length of stay was significantly longer 
in nonagenarians (P < 0.001), and the 90-day readmission rate was similar. Absolute 
mortality was higher in nonagenarians (P < 0.001), excess mortality, however, was 
comparable. Before admission, 40.0% of the nonagenarians lived in their own home, 
and 40.9% had returned 3 months postfracture. The rate of returning to their own home 
was lower compared with younger patients (P < 0.001). Prefracture mobility was worse 
in nonagenarians compared with the younger group, but 3 months after discharge, the 
number of patients that regained prefracture mobility was comparable in both age 
groups.
Conclusions: Nonagenarian hip fracture patients differ significantly from younger 
patients aged 65–89 years with respect to clinical characteristics and long-term outcome. 
However, almost half of the nonagenarians returned to their own home and more 
than half regained their prefracture level of mobility. Given these findings, prevention 
strategies for hip fracture and adverse events during hospital stay that focus particularly 







































The number of nonagenarians is rapidly increasing and therewith the number of hip 
fracture patients aged 90 years and older.1,2 Nonagenarian patients frequently suffer from 
comorbidities and functional impairment,3–5 which have a huge impact on outcome after 
hip fracture treatment. Previous studies have shown that advanced age is associated with 
increased mortality rates and worse functional recovery after a hip fracture.6–12
Just two previous reports have compared clinical characteristics of nonagenarians 
with younger hip fracture patients;13,14 other reports are based on case series of 
nonagenarians or include relatively small numbers of patients.15–23 These studies show 
differences in clinical characteristics, number of adverse events, functional outcome and 
mortality rates.13–23 The differences in outcome might be as a result of a large variation in 
cohort characteristics and incomparability of the outcome variables.
Detailed clinical characteristics of nonagenarian hip fracture patients and their outcome 
after fracture treatment become increasingly important as life expectancy has been 
growing extensively over the last decades.24 The aim of the present study was to assess 
clinical characteristics and outcome in a large Dutch cohort of 230 nonagenarian patients 




This was an observational cohort study including all consecutive patients with a hip 
fracture admitted to two middle-sized teaching hospitals in Delft (Reinier de Graaf 
Hospital) and The Hague (Bronovo Hospital), in the Netherlands from January 2005 to 
January 2010. In total, 230 patients aged 90 years and older, and 1014 patients aged 65–
89 years were included. The study was prospective from January 2008 onwards. Exclusion 
criteria were a pathological hip fracture and high-energy trauma. Minimum follow up 





































the groups (65–89 years: 3.6 years [1.4], 90 years and older: 3.5 years [1.3]). Approval 
from the local ethical committee was not necessary, as no intervention was carried out 
and the study was an evaluation of standard usual care as part of good clinical practice. 
Furthermore, as data could not be traced back to the individual patient, no privacy nor 
ethical issues were at stake.
Outcome parameters
Available characteristics for all patients were age, sex, American Society of Anesthesiologists 
(ASA) Physical State classification,25 type of fracture, surgical treatment and anesthesia, 
time to surgery (since admittance in hospital), presence of anemia at admission (based on 
the criteria of the World Health Organization as hemoglobin level below 7.5 mmol/L [12 
g/dL] in women and below 8.1 mmol/L [13 g/dL] in men),26 need for blood transfusion, 
in-hospital adverse events (delirium, cardiac adverse events, urinary tract infection, 
surgical site infection, bleeding problems, pressure sores, minor/ major strokes), length 
of hospital stay (LOS), discharge location, and 90-day readmission rate.
The national guideline from the Dutch Institute for healthcare Improvement (CBO) 
for red blood cell (RBC) transfusion was applied; a transfusion is indicated for patients 
aged 60 years or older if the hemoglobin level is lower than 5.0 mmol/L (8.0 g/dL) or 6.0 
mmol/L (9.7 g/ dL), if the patient has a serious cardiac condition or if anemia becomes 
symptomatic.27
Mortality of all patients was scored meticulously by repeated consultation of the 
population registers of the counties in the region of both hospitals, as well as the hospital’s 
patient registration systems. In-hospital, 3-month and 1-year follow-up data for mortality 
were available for all patients; data on 2-year follow up were available for 198 (85.3%) 
nonagenarians and 827 (81.6%) patients aged 65–89 years due to inclusion in 2009.
Patients with prospective follow up
In January 2008, a new hip fracture protocol was implemented as part of the regular 
care in both hospitals. Since then, place of residence, the level of activities of daily living 
expressed with the Groningen Activity Restriction Scale (GARS),28 and the level of mobility 
were reported at admission and 3 months thereafter during the routine follow-up visit 
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The GARS assesses competence in abilities in 11 personal basic activities of daily 
living (ADL) and seven instrumental activities of daily living (IADL). A summed score was 
calculated for basic IADL ranging from 18, indicating the ability to carry out all activities 
without assistance or undue effort, to 72, indicating disability.28
Mobility was divided into four categories: mobile without use of an aid in- and 
outdoors, mobile in- and outdoors with the use of an aid, only mobile indoors (regardless 
the use of an aid) and immobile. A cane, crutch(es) or walker were considered an aid. 
Patients in a wheelchair were considered to be immobile.
Statistical analysis
Continuous data are presented as means, with standard deviations (SD). The independent 
Student’s t-test was used to compare groups of continuous data. Categorical data are 
presented as the number of participants in the category, along with the percentages. The 
c2-test and Fisher’s exact test were used for comparing groups of categorical data.
We compared the two age groups with respect to distribution of sex, ASA classification, 
presence of anemia, type of fracture, treatment and anesthesia, time to surgery, need for 
blood transfusion, in-hospital adverse events, LOS, 90-day readmission rate and mortality 
rates. Patients classified as ASA I or II and III or IV were combined into two groups, as 
the separate groups of patients with an ASA I or IV classification were too small to be 
analyzed separately. LOS was changed into a binary outcome; that is, 211 days or >11 
days, based on the median LOS of the whole cohort. Both absolute mortality and excess 
mortality were compared between the two age groups. Excess mortality was defined 
as the mortality added by the hip fracture; that is, mortality of these groups minus the 
baseline mortality of the background Dutch population in 2005–2009, provided by the 
Central Bureau of Statistics.29
Within the group of nonagenarians, patients who died during hospital stay or those 
that had died in the first year postoperatively were compared with the survivors, with 
regards to the same parameters as aforementioned.
From January 2008 to January 2010, 77 nonagenarians and 347 patients aged 65–89 
years were admitted. Both groups were compared with respect to place of residence at 
admission, hospital discharge location and at 3 months postfracture treatment, level of 





































Analysis for likelihood of returning to place of residence was carried out only in 
patients living in their own home or in a residential home at admission. Nursing home 
patients were excluded, as they all returned to this location.
P-values lower than 0.05 were considered statistically significant. Relative risks (RR) 
are shown with a 95% confidence interval if the P-value <0.05. All data were analyzed in 
SPSS 17.0 (SPSS, Chicago, IL, USA).
results
Clinical characteristics
Table 1 shows the characteristics of the study cohort. A total of 230 nonagenarians 
with a mean (SD) age of 93.5 years (2.6) were compared with 1014 patients aged 65–89 
years (mean [SD] age 81.3 years [5.8]). Nonagenarian patients were more often female, 
suffered more frequently from anemia and trochanteric fractures, but had similar ASA 
classifications compared with the younger group. In the group of nonagenarians, surgery 
was less frequently carried out within 1 day after admittance to the hospital. LOS was 
more frequently longer than 11 days in nonagenarians compared with the younger group.
Clinical adverse events and readmissions
Table 2 shows adverse clinical outcomes during hospital stay. A total of 77.8% of the 
nonagenarians had one or more clinical adverse events during admission compared 
with 61% of the patients aged 65–89 years (P < 0.001). Blood transfusion need, delirium 
and cardiac adverse events were significantly more often observed in nonagenarians. 
None of the other adverse events were significantly different in both groups. The 90-day 
readmission rate was lower in the group of nonagenarians compared with the patients 
aged 65–89 years. A deep wound infection or a revision of a failed osteosynthesis was the 
reason for readmission in five out of the 13 (38.5%) nonagenarians, and in 38 of the 117 
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table 1 Clinical characteristics of patients aged 65–89 years and older than 90 years
65–89 years 390 years P-value
n = 1014 n = 230
Mean age, years (SD; range) 81.3 (5.8; 65–89.9) 93.5 (2.6; 90–103.5) <0.001
Female 729 (71.9) 191 (83.0) <0.001
ASA III/IV 322 (31.8) 80 (34.8) 0.38
Anemia 393 (38.8) 130 (56.5) <0.001
Fracture type 0.01*
Neck of femur fracture 589 (58.1) 109 (47.4)
(Inter-) Trochanteric fracture 397 (39.2) 112 (48.7) 0.005**
Subtrochanteric fracture 28 (2.8) 9 (3.9)
Non-operative treatment 11 (1.1) 7 (3.0) 0.03
Surgery 21 day 855 (84.3) 176 (76.5) 0.005
Days to surgery, mean (SD) 0.86 (1.12) 0.97 (1.10) 0.18
Spinal anesthesia 938 (92.5) 207 (90.0) 0.71
LOS > 11 days 482 (47.5) 143 (62.2) <0.001
*P-value comparing three treatment groups, **P-value comparing (inter) trochanteric with neck 
of femur fracture. Values are given as number (percentage) if not given otherwise. ASA, American 
Society of Anesthesiologists Physical State classification; LOS, length of stay.
table 2 Adverse events for hip fracture patients aged 65–89 years and older than 90 years
65–89 years 390 years RR (95% CI) P-value
n = 1014 n = 230
Readmission <90 days 117 (11.5) 13 (5.7) 0.88 (0.30–0.87) 0.008
RBC transfusion for anemia 328 (32.3) 120 (52.2) 1.94 (1.54–2.44) <0.001
Delirium 228 (22.5) 77 (33.5) 1.55 (1.21–1.97) <0.001
Cardiac complications 104 (10.3) 44 (19.1) 1.75 (1.32–2.32) <0.001
Urinary tract infection 111 (10.9) 34 (14.8) 1.31 (0.95–1.81) 0.10
Bleeding 52 (5.1) 18 (7.8) 1.42 (0.94–2.16) 0.11
Pneumonia 75 (7.4) 22 (9.6) 1.25 (0.85–1.84) 0.27
Surgical site infection 41 (4.0) 10 (4.3) 1.06 (0.60–1.88) 0.83
Pressure sores 35 (3.5) 12 (5.2) 1.40 (0.85–2.32) 0.21
Minor/major stroke 16 (1.6) 4 (1.7) 1.08 (0.45–2.62) 0.78
Values are given as number (percentage). CI, confidence interval; RBC, red blood cell; RR, relative 
risk.
Mortality
Table 3 shows the all-cause mortality rate for both age groups. All cause mortality rates, 
except the 3–12-month interval, were significantly higher in the group of nonagenarians. 





































for the patients aged 65–90 years and 26.5% for the nonagenarians. The excess 1-year 
mortality of both groups was comparable; 19.4% in the patients aged 65–90 years and 
16.1% for the nonagenarians (P = 0.29).
table 3 Relative risks for mortality of patients aged 65–89 years and older than 90 years
Mortality 65–89 years 390 years RR (95% CI) P-value
n = 1014 n = 230
In-hospital 41 (4.0) 22 (9.6) 1.98 (1.38–2.84) <0.001
1 month 70 (6.9) 35 (15.2) 1.95 (1.44–2.63) <0.001
3 months 136 (13.4) 69 (30.0) 2.17 (1.71–2.76) <0.001
3–12 months 99 (9.8) 29 (12.6) 1.26 (0.89–1.77) 0.200
1 year 235 (23.2) 98 (42.6) 2.03 (1.61–2.55) <0.001
2 years 303 (29.9) 124 (53.9) 2.24 (1.78–2.82) <0.001
Values are given as number (percentage). The patients aged 65–89 years are the reference category. 
CI, confidence interval; RR, relative risk.
Comparison of surviving and deceased nonagenarians
The mean age of nonagenarians that died during hospital stay was higher compared 
with surviving patients (94.7 vs 93.4 years, P = 0.02). The percentage of patients treated 
conservatively (13.6 vs 1.9%, RR 1.60, CI 0.84– 3.04, P = 0.02) was higher in the deceased 
nonagenarians. The percentage of patients with a LOS >10 days was lower in those who 
died during admission compared with those that did not. (64.9 vs 36.4%, RR 0.89 CI 0.80 
to 0.98, P = 0.009)
The frequency of cardiac complications (63.6 vs 14.4%, RR 1.40, CI 1.14–1.72, P 
< 0.001) and presence of pneumonia (40.9 vs 6.3%, RR 1.59, CI 1.12–2.25, P < 0.001) 
was significantly higher in the nonagenarians who died in hospital, contrary to other 
complications, which were similar between the age groups.
Compared with the surviving nonagenarians, nonagenarians who died in the first year 
after they sustained a hip fracture, the mean age was higher (94 vs 93.1 year, P = 0.012), 
the ASA classification was more often III/IV (48 vs 25%, RR 1.60, CI 1.20–2.13, P < 0.001) 
and patients were more often treated conservatively (6.1 vs 0.8%, RR 4.11, CI 0.67–25.33 
P = 0.04). Cardiac complications (26.5 vs 18%, RR 1.50, CI 1.03–2.18. P = 0.014) and 
pneumonia (15.3 vs 5.3%, RR 1.89, CI 1.01–3.52, P = 0.011) were found significantly more 
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Patients with prospective follow up
Table 4 shows differences between nonagenarians and the patients aged 65–89 years 
that had a prospective follow up considering place of residence and level of ADL and 
mobility.
table 4 Place of residence, mobility and nutritional status of the subgroup of patients aged 65–89 
years and older than 90 years with a prospective follow up
65–89 years 390 years RR (95% CI) P-value
n = 347 n = 77
Place of residence at admission <0.001*
In their own home 244 (70.5) 30 (40.0) 1.36 (1.18–1.58)
Residential home 66 (19.1) 35 (46.7) <0.001**
Nursing home 36 (10.4) 10 (13.3)
Discharge to an alternative location
Home-based patients 156 (65.3) 26 (89.7) 1.13 (1.05–1.21) 0.008
Residential home-based patients 37 (59.7) 25 (83.3) 1.40 (1.08–1.81) 0.023
Alternative location at 3 months <0.001
Home-based patients 52 (23.6) 13 (59.1) 1.19 (1.05–1.35)
Residential home-based patients 15 (27.8) 8 (38.1) 1.15 (0.82–1.61) 0.38
GARS, mean (SD) 41.0 (18.0) 50.3 (15.4) n/a <0.001
Mobility at admission
Mobile without an aid 134 (38.7) 12 (16.0) <0.001
Mobile with aid 159 (46.0) 31 (41.3) n/a
Only mobile indoors 47 (13.6) 26 (34.7)
Immobile 6 (1.7) 6 (8.0)
Regained mobility at 3 months† 136 (45.0) 24 (52.2) 0.78 (0.46–1.34) 0.37
Mortality at 3 months 36 (10.4) 28 (36.4) 3.21 (2.20–4.70) <0.001
*P-value comparing three groups. **Relative risk (RR) and P-value comparing residential home 
patients with patients living in their own home. †Information was missing in five of the patients 
aged 390 years and in nine of the patients aged 65–89 years. Values are given as n (percentage) if 
not given otherwise. CI, confidence interval; GARS, Groningen Activity Restriction Score; RR, relative 
risk.
Place of residence
At admission, 40.0% of the nonagenarians lived in their own home and 46.7% lived in a 
residential home. Both at discharge and after 3 months, nonagenarians were less likely 
to return to their own home compared with the younger group of patients. At 3 months 





































those living in a residential home at admission had returned to their original place of 
residence.
Level of aDL and mobility
The level of ADL at admission was significantly lower in the nonagenarians compared with 
the younger group. A total of 57.3% of the nonagenarians were still mobile both in- and 
outdoors. The prefracture level of mobility was significantly worse compared with the 
younger group. At 3 months postfracture, 52.2% of the nonagenarians had regained their 
prefracture level of mobility, which was not significantly different from the patients aged 
65–89 years.
Discussion
In the present study, nonagenarian hip fracture patients were more often female and 
anemic, and suffered more often a trochanteric fracture than patients aged 65–89 years. 
Furthermore, more adverse events, higher mortality rates, a lower level of mobility 
and a higher percentage of patients not returning to their own home were found in the 
group of nonagenarians compared with the patients aged 65–89 years. Excess mortality 
(because of the hip fracture), however, was comparable between both age groups. Before 
admission, almost half of the nonagenarians lived in their own home and the majority 
was able to walk in- and outdoors. At 3 months, approximately half of the nonagenarians 
regained their prefracture mobility and had returned to their original place of residence.
Just two other studies compared nonagenarians with a younger age group with 
respect to clinical characteristics, such as age, fracture type, ASA classification and 
mortality after a hip fracture: a smaller USA-based study with comparable age of the 
patient groups to the present study and a very large Scottish study of patients aged 95 
years and older compared with patients aged 75–89 years.13,14 In line with the present 
study, patients were more often female in the latter study.14
We found a similar distribution of the ASA classification between both age groups, 
contrary to both former studies that found significantly more ASA III and IV patients at 
older ages.13,14 Regional differences in health status and socioeconomic background might 
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In concordance with the literature, most nonagenarians suffered from a trochanteric 
fracture.13,14,17–20,22,23 Trochanteric fractures are associated with older age and female sex, 
probably because of differences in the type and rate of bone loss in the sexes, or the 
changing rate and pattern of falling with aging.30–32
Timing of surgery in the oldest older patients with comorbidities might influence the 
outcome, as early surgery might prevent adverse events, such as pneumonia and pressure 
sores, but postponing surgery to optimize patients with comorbidities might improve 
their outcome. This is still at the center of debate.33,34 In the Netherlands, surgery within 
24 h is a quality indicator, used to assess surgical care by the government. The latter might 
explain our relative short time to surgery (0.97 days) compared with non-Dutch studies 
(1.3– 5.7 days).15,19,23 It is, however, comparable with another Dutch cohort.17
The LOS in the present study was shorter than in previous reported studies.17,19,21,23 
LOS is a frequently reported outcome variable in literature indicating quality of care. 
However, LOS might not be the best parameter to compare the outcome of different 
cohorts, as it is influenced by many factors, of which several are non-medical. The 
difference in LOS between studies is likely not to be explained by differences in patient 
characteristics, such as adverse event rates. They show differences in organization of 
after-care and rehabilitation, and differences in social home environment between the 
different countries.35
The 90-day readmission rate of nonagenarians was lower compared with the younger 
group. Only one previous study on nonagenarians reported readmission rates being 
higher compared with the present study population, which might be a result of a higher 
number of ASA III/IV-classified patients in that study.23
Delirium, cardiac adverse events and postoperative anemia requiring a blood 
transfusion were significantly more often reported adverse events in the nonagenarians. 
Receiving blood products can be a risk factor for developing delirium.36 As the number 
of patients receiving a blood transfusion was higher in nonagenarians, this might partly 
explain the difference in delirium incidence. Other reasons might be multimorbidity and 
polypharmacy; however, these factors were not registered in the present study. The 





































at admission. The reported rate of adverse events in literature differ widely between 14.6 
and 100%, most probably because of differences in the thoroughness of registration and 
definition of an adverse event.13,15,18,19,23 Type of adverse events were mentioned in just 
two reports.18,19
In-hospital mortality of nonagenarian hip fracture patients was comparable with 
recent studies (6–11.6%),13,17,19–23 whereas older studies showed higher mortality rates 
(18–24%),15,18 most probably as a result of a longer LOS. In the Netherlands, 1-year 
mortality for women aged 90–94 years is reported to be 21%, which is half of the 
percentage of the nonagenarian hip fracture population (42.6%) in the present study.29 
In a large series from the Scottish Hip Fracture Audit (SHFA), mortality in patients aged 
85 years and older returned to that of the background population within 2–5 years.37 
These findings differ strongly from Alarcon et al., showing that excess mortality had 
disappeared after 2 months.23 However, they compared an older cohort (1961–1970) of 
younger patients (mean age 73.9 years) as a reference.23,38 There was no difference in the 
excess mortality between both age groups in this cohort. The two age groups-comparing 
papers did not compare excess mortality.13,14 This is a very interesting finding; the negative 
impact of a hip fracture on mortality is apparently the same in younger patients as it is 
in nonagenarian patients. Previously reported higher mortality rates in nonagenarians 
might therewith simply be caused by the effect of chronological aging.13,14
The frequency of cardiac complications and pneumonia was significantly higher in 
nonagenarians who died during hospital stay or in the first year after the hip fracture, 
compared with the surviving nonagenarians. A large series of younger patients from the 
UK (2448 patients, mean age 82 years) reported a higher 1-year mortality in patients with 
these same complications as well.39
Almost half of the nonagenarians still lived in their own home before admission and 
more than half of them had returned to their own home 3 months postfracture. Half 
of the nonagenarians lived in a residential home. None of the other studies mentioned 
a residential home as a place of residence. Either their own home or a nursing home 
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a very heterogeneous form of living, ranging from an apartment in a complex with the 
availability of support to a location with full support for ADL. Because of large differences 
between countries in types of housing and traditions for homes for elderly people, the 
place of residence is hard to compare between studies.40 This is reflected in the wide 
range of numbers of patients living in a nursing home before admission in the other 
studies (4.7–28.1%).20,21,23
The lower level of mobility of the nonagenarians in comparison with the patients 
aged 65–89 years is in line with another report.13 Approximately half of the nonagerians 
regained their prefracture mobility after, which is also in concordance with previous 
studies.13,16,19–21,23 Compared with a cross-sectional cohort of Dutch people aged 85 years 
and older that lived in their own home, a slightly reduced level of ADL at admission 
in nonagenarians was found, showing the higher daily dependence of the studied 
population.41
The strengths of the current study are its sample size, without bias as a result of 
exclusion criteria, except for pathological fractures and high-energy trauma fractures, 
and the meticulous registration of all variables including mortality. Limitations were the 
retrospective collection of a part of the data, and the relative smaller number of patients 
used for evaluation of mobility and place of residence. Furthermore, we did not have 
detailed information for all patients on medication and number of comorbidities, and no 
data on cognitive assessment were available. Significant differences were found between 
both age groups, most of which were most probably as a result of the effect of aging and 
not specific to hip fracture patients as such.
Most of our outcomes confirm the percentages previously presented in the literature. 
However, as the number of nonagenarians is rapidly growing, it is of importance to have 
reliable and reproducible data on clinical characteristics of these elderly patients.
Our data are valuable for not only the research community, but also for daily clinical 
practice, even if one does not find large new issues. With independent data, the latter 
also underscores the importance of predictive factors for morbidity in this category of 
patients. Furthermore, former studies came from the USA and UK, with very different 





































To conclude, nonagenarian hip fracture patients differ significantly from patients aged 
65–89 years with respect to clinical characteristics and long-term outcome. However, 
almost half of the nonagenarians returned to live in their own home and more than half 
regained their prefracture level of mobility. Given these findings, hip fracture prevention 
strategies and prevention of adverse events during hospital stay that focus particularly on 
the group of frail nonagenarians are highly recommended.
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Contralateral hip fractures and other 
osteoporosis-related fractures in hip fracture 
patients: incidence and risk factors. 
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Purpose To report risk factors, 1-year and overall risk for a contralateral hip and other 
osteoporosis-related fractures in a hip fracture population.
Methods An observational study on 1,229 consecutive patients of 50 years and older, 
who sustained a hip fracture between January 2005 and June 2009. Fractures were scored 
retrospectively for 2005–2008 and prospectively for 2008–2009. Rates of a contralateral 
hip and other osteoporosis-related fractures were compared between patients with and 
without a history of a fracture. Previous fractures, gender, age and ASA classification were 
analysed as possible risk factors.
results The absolute risk for a contralateral hip fracture was 13.8 %, for one or more 
osteoporosis-related fracture(s) 28.6 %. First-, second- and third-year risk for a second 
hip fracture was 2, 1 and 0 %. Median (IQR) interval between both hip fractures was 
18.5 (26.6) months. One-year incidence of other fractures was 6 %. Only age was a risk 
factor for a contralateral hip fracture, hazard ratio (HR) 1.02 (1.006–1.042, p = 0.008). 
Patients with a history of a fracture (33.1 %) did not have a higher incidence of fractures 
during follow-up (16.7 %) than patients without fractures in their history (14 %). HR for a 
contralateral hip fracture for the fracture versus the non-fracture group was 1.29 (0.75–
2.23, p = 0.360).
Conclusion The absolute risk of a contralateral hip fracture after a hip fracture is 13.8 %, 
the 1-year risk was 2 %, with a short interval between the 2 hip fractures. Age was a risk 







































The incidence of osteoporosis has increased over the last decades in our aging population 
[ 1– 3]. As advanced age and osteoporosis lead to enhanced bone fragility and increased 
fracture risk, the amount of osteoporosis-related fractures has also increased. Lifetime 
risk for developing an osteoporotic fracture is 30 % with an estimated amount of 9.0 
million fractures worldwide in the year 2000 [4, 5]. Fractures of the proximal femur, 
distal radius, proximal humerus and vertebrae are the most frequently seen types of 
osteoporosis-related fractures. These fractures are related with increased morbidity and 
mortality. Hip fractures have the most devastating impact on a patients’ life with 1-year 
mortality rates of 18 up to 32 %, compared to 15 % after a vertebral fracture [ 2, 6– 8]. 
Half of all hip fracture patients will never recover to their pre-fracture functional capacity 
and 25 % of these patients reside in a long-term care institution 1 year after sustaining a 
hip fracture [ 9– 11].
Besides high mortality and high morbidity rates, an osteoporosis-related fracture 
has been identified as an important risk factor for sustaining subsequent fractures, 
particularly during the first 2 years after the initial fracture [ 12, 13]. The risk of sustaining 
a contralateral hip fracture within 2 years after the initial hip fracture is reported to be 
4–10 % [ 14, 15]. As hip fractures are the most devastating fractures for patients, the 
main goal of this study was to assess the 1-year risk and absolute risk of sustaining a 
contralateral hip fracture in our cohort. Secondary, possible risk factors for sustaining a 
contralateral hip fracture were identified.
Materials and methods
An observational cohort study of 1,229 consecutive hip fracture patients of 50 years and 
older, admitted to two teaching hospitals from January 2005 to July 2009. The study was 
retrospective for patients admitted between 2005 and 2008, and prospective for patients 
admitted between 2008 through June 2009. The first hip fracture sustained within this 
time frame was marked as the index hip fracture. Patients with a fracture due to a 
high-energy trauma or with a pathologic fracture were excluded. Osteoporosis-related 





































the history of all patients were retrospectively scored. All hospital databases (emergency 
department, clinical and radiological records and operating theatre database) were used 
to collect fracture data. All admissions of the patients were entered into our database. 
When a patient was not admitted to hospital, emergency room data were still entered 
into the database. By combining the digital files of emergency department admittance, 
hospital records and operating theatre data all potential hip and other fractures were 
scored as complete as possible.
From the hospital’s records, patient demographics like age, gender, ASA physical status 
classification, type of fracture, type of treatment, type of anaesthesia, were collected 
onto a case record form (CRF) [ 16].
Postoperative mortality has been documented by repeated consultation of the 
population registers present in every county in The Netherlands. For the assessment of 
concomitant fractures both before and after the index hip fracture, the patients record in 
the picture and archives system (PACS) was evaluated from January 2003 (2 years before 
the index fracture) up to January 2010. This time frame was chosen since 2003 a PACS 
was used in both hospitals. All low-energy trauma fractures of the contralateral hip, distal 
radius, proximal humerus and vertebrae at any level were scored. The patient record 
files were evaluated for notes on previous history for fractures occurred before 2003. If 
present, they were recorded at the CRF. As of 2008 all data were recorded prospectively 
at the CRF.
The 1-year incidence and prevalence of fractures of the contralateral hip, distal 
radius, proximal humerus and vertebrae both prior to and after the index hip fracture 
were determined.
Patients with bilateral hip fractures were compared to those with a unilateral hip 
fracture, regarding general demographics (age, gender, ASA classification, type of fracture 
and treatment), prevalence and 1-year incidence of concomitant fractures. This was done 
for patients with and without fractures prior to the index hip fracture. Finally, the different 
groups were compared regarding mortality rates.
It was not necessary to obtain approval from the local ethical committee due to 
the observational character of this surveillance study. Therefore, it is an evaluation of 
usual care as a part of good clinical practice. Since data could not be traced back to the 







































Categorical data are presented as the number of subjects in the category, along with the 
percentages. Chi-square tests and Fisher’s exact test were used for comparing groups of 
categorical data. All continuous data are presented as means with standard deviations 
(SD). The independent Student’s t test was used to compare groups of continuous data.
Fracture and mortality rates were expressed for different time periods calculated 
using the Kaplan–Meier method. Univariable and multivariable Cox regression analysis 
was used to calculate the hazard ratios and 95 % confidence interval (CI) to compare the 
difference in mortality and fracture risk in patients with or without previous fractures. 
In multivariable analysis the hazard ratios were adjusted for possible confounders: age, 
gender and general condition expressed as the ASA classification (I/II vs. III/IV).
Combining ASA I or II and III or IV classified patients in two groups was done as the 
separate groups of ASA I (n = 108) and ASA IV (n = 44) classified patients were too small 
to be analysed separately.
Age was categorized in three groups: 50–65, 65–85 years and older than 85 years.
results
Characteristics
1,229 hip fracture patients above 50 years were included, 891 female and 338 male. The 
median follow-up after the index hip fracture was 17.8 months [interquartile range (IQR) 
28.6]. Mean (SD) age at admission for the index hip fracture was 81.7 (9.5) years. Women 
(mean 82.6, SD 9.0) were older than men (mean 79.4, SD 10.3, p < 0.001).
The majority of patients were treated with osteosynthesis (60.5 %), followed by 
(hemi-) arthroplasty (38.1 %). A small group was treated conservatively (1.4 %).
The overall 1-year mortality rate of the 1,229 patients was 23 % (95 % CI 21–26 %). 





































table 1 Characteristics of unilateral and bilateral hip fracture patients and results of the univariable 
Cox regression analysis
Study Unilateral Bilateral HR (CI) p value
population hip fracture hip fracture
N (%) N (%) N (%)
1,229 (100) 1,060 (86.2) 169 (13.8)
Median (IQR) follow-up in days 543 (873) 536 (886) 563 (810) 0.81*
Gender
Female 891 (72.5) 768 (72.5) 123 (72.8) 1.15 (0.82–1.62) 0.41
Male 338 (27.5) 292 (27.5) 46 (27.2)
Age, mean (SD) 81.7 (9.5) 81.7 (9.4) 82.0 (9.9) 0.74#
Age HR per year 1.02 (1.01–1.04) 0.011
Age HR per decade 1.25 (1.05–1.48) 0.011
ASA classification
I–II 849 (69.1) 727 (68.6) 122 (72.2) 1.07 (0.76–1.49) 0.71
III–IV 380 (30.9) 333 (31.4) 47 (27.8)
Fracture type
Neck of femur 704 (57) 617 (58) 87 (51.5)
(Inter) trochanteric 485 (39) 412 (39) 73 (43.2)
Subtrochanteric 40 (3) 31 (3) 9 (5.3) 0.11
Anaesthesia
Spinal 1,129 (92) 1,032 (92) 97 (91)
General 83 (7) 75 (7) 8 (7) 0.94
Female gender and ASA I–II are reference categories
HR Hazard ratio, CI confidence interval, IQR interquartile range, ASA American society of 




169 of the 1,229 patients had bilateral hip fractures, indicating an absolute risk of 13.8 
%. The first-, second-, and third-year risk of a contralateral hip fracture was 2, 1, and 0 %, 
respectively (Table 2).
Of the 169 patients with bilateral hip fractures, 115 sustained a hip fracture before 
the index hip fracture, i.e., the index fracture was their second hip fracture. In 54 patients 
the second hip fracture occurred during follow-up after the index fracture, i.e., the 
index fracture was the first hip fracture. The median (IQR) interval between the two hip 
fractures in all 169 patients was 18.5 months (26.6), 36.1 % occurred with 1 year and 
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The median (IQR) interval between both hip fractures in the 54 patients that suffered 
a contralateral hip fracture during follow-up was 231 (434) days. As the follow-up of this 
group was too short to calculate reliable fracture incidence ratios, further analysis was 
performed in the entire population of 169 patients.
The mean (SD) age of patients at admission for their first hip fracture in the bilateral 
hip fractures group was 75.9 (11.5) years. This was lower than the mean (SD) age 81.7 
(9.4) years, of the 1,060 unilateral hip fracture patients (p < 0.001). The mean (SD) age 
at time of the second hip fracture was 82.0 (9.9) years, not different from the unilateral 
fracture group. The male to female ratio, the mean age, type of fracture and type of 
anaesthesia in the unilateral group were equal to the bilateral hip fracture group (Table 
1).
In univariable Cox regression analysis, the hazard ratio for men versus women to 
sustain a second hip fracture was 1.15 (0.82–1.62, p = 0.41), for ASA III–IV versus I–II 1.07 
(0.76–1.49, p = 0.71), for age per year 1.02 (1.01–1.04, p = 0.011) and age per decade 1.25 
(1.05–1.48, p = 0.011).
In multivariable Cox regression analysis, the hazard ratio for men versus women for 
sustaining a contralateral hip fracture was 1.24 (0.88–1.75, p = 0.22), for ASA III–IV versus 
I–II 0.98 (0.69–1.38, p = 0.90), for age per year 1.02 (1.01–1.04, p = 0.008) and age per 
decade 1.27 (1.06–1.51, p = 0.008).
table 2 Absolute risk and risk per year after the index fracture (both in %) for a subsequent (hip) 
fracture and for mortality during follow-up
Absolute Year Year Year Year
risk 1 2 3 4
Subsequent fracture 28.6 6 3 1 1
risk
Subsequent hip 13.8 2 1 0 0
fracture risk
Mortality risk 36.0 23 11 10 11
Concomitant osteoporosis-related fractures and risk factors
In 407 patients (33.1 %) an osteoporosis-related fracture prior to the index hip fracture 
was found. This group of 407 was compared to the 821 patients who did not suffer 





































The absolute risk of a contralateral hip fracture during follow-up in the group with 
fractures was 5.1 % (n = 21) and in the group without fractures 4.0 % (n = 33). The 1-year 
risk for a contralateral hip fracture for the prior fracture versus the non-prior fracture 
group was 3.0 versus 2.0 %. In univariable Cox regression analysis the hazard ratio for 
sustaining a contralateral hip fracture for the fracture versus the non-fracture group was 
1.29 (0.75–2.23, p = 0.36).
The absolute risk of sustaining an osteoporosis-related fracture in the population 
without fractures in their medical history was 14.0 % with a 1-year risk of 9 %. In the group 
that did sustain prior fractures, the absolute risk was 16.7 % and the 1-year risk 9 %. In 
univariable Cox regression analysis the hazard ratio for sustaining an osteoporosis-related 
fracture in the population with fractures in their medical history versus the population 
without fractures in their medical history was 1.19 (0.88–1.61, p = 0.25).
The risks of sustaining different osteoporosis-related fractures after previous 
sustained fractures are listed in Table 3. A previous fracture was only a significant risk 
factor for sustaining a distal radius fracture (HR 1.66, 1.07–2.59, p = 0.025).
The 1-year risk after the index fracture for osteoporosis-related fractures was 9 % in 
both women and men and 4 % in both men and women in the second year. In univariable 
Cox regression analysis, the hazard ratio for sustaining an osteoporosis-related fracture 
for male gender versus female was 0.95 (0.68–1.31, p = 0.74).
The absolute risk of sustaining osteoporosis-related fractures after the index hip 
fracture was 15.9 % for ASA I/II and 12.6 % for ASA III/IV classified patients. The 1-year 
risk of osteoporotic fractures was 9 % for ASA I/II versus 8 % in ASA III/IV. In univariable 
Cox regression analysis the hazard ratio for sustaining an osteoporosis-related fracture for 
ASA III–IV versus ASA I–II was 0.79 (0.57–1.09, p = 0.15).
No differences were seen in fracture risks in different age categories. More 






































































































































































































































































































































































































































































































































































The 1-year mortality risk and hazard ratios for mortality for the age categories, gender, 
ASA classification, the occurrence of a bilateral hip fracture, a fracture in the history, a 
fracture during follow-up and a hip fracture during follow-up are presented in Table 5. 
The hazard ratios for mortality were significantly higher for the age categories 65–85 
years and older than 85 years, male gender and ASA III–IV, but not for the occurrence of 
a bilateral hip fracture, a fracture in the history and not for having a (hip) fracture during 
follow-up compared with the reference categories.
table 5 Mortality for age categories, gender, ASA classification, for patients with or without bilateral 
hip fractures, a fracture in the history, a fracture during follow-up and a hip fracture during follow-up




50–65 87 (7.1) 3
65–85 633 (51.5) 20 5.24 (2.33–11.81) <0.001
>85 509 (41.4) 33 9.10 (4.05–20.47) <0.001
Gender
Female 891 (72.5) 23
Male 338 (27.5) 26 1.23 (1.00–1.51) 0.046
ASA
I–II 849 (69.1) 20
III–IV 380 (30.9) 33 1.94 (1.61–2.35) <0.001
Bilateral hip fracture
No 1,060 (86.2) 25
Yes 169 (13.8) 19 0.76 (0.57–1.03) 0.073
Fracture in history
No 821 (66.8) 24
Yes 408 (33.2) 24 0.88 (0.72–1.08) 0.22
Fracture during FU
No 1,046 (85.1) 25
Yes 183 (14.9) 21 0.91 (0.70–1.18) 0.47
Hip fracture during FU
No 1,175 (95.6) 24
Yes 54 (4.4) 19 0.87 (0.55–1.38) 0.56
Age 50–65, female gender and ASA I–II are reference categories








































Our main goal was to describe the 1-year risk and absolute risks of sustaining a subsequent 
second hip fracture and other osteoporosis-related fractures in a hip fracture cohort. The 
absolute risk of a contralateral hip fracture was 13.8 %, the 1 year risk 2 %, for the other 
osteoporosis-related fractures this was 28.6 and 6 %, respectively. The median interval 
between the first and the second hip fracture was rather short, 18.5 months. The risk of 
a new osteoporosis-related fracture was not higher in patients with a fracture in their 
medical history than in those that did not.
Our second goal was to describe independent risk factors for sustaining a subsequent 
second hip fracture. We compared the population with a bilateral hip fracture with the 
unilateral population. There was no difference between patient’s gender distribution, 
ASA classification, and type of fracture or mortality rate between the uni- and bilateral 
hip fractures population. A higher age was the only risk factor that could be identified for 
sustaining a contralateral hip fracture.
Providing reliable concomitant fracture incidence rates and identifying risk factors 
in hip fracture patients can help in decision-making policies for fracture prevention, like 
osteoporosis prophylaxis. Furthermore, more accurate information about the future can 
be provided to both patient and family with respect to be expected fractures.
In our population, the 1-year risk of a second hip fracture was 2.0 %. Lawrence et al. 
[ 17] found in their recent study of a large cohort of 6,331 patients a comparable 1 year 
inci-dence of 2.7 %. Other prospective studies found the same incidence of around 2 % [ 
18, 19]. However, Lönnroos et al. [ 14] found a higher contralateral hip fracture incidence 
of 5 %. The fact that they analysed a smaller population (501 patients) might account 
for the difference. Overall, 28.6 % of our patients had one or more osteoporosis-related 
fractures in our cohort. This resembles the lifetime risk for developing an osteoporotic 
fracture as reported by Klotzbuecher and Cummings [ 2, 4]. Our 1- and 2-year risk for 
other osteoporosis-related fractures were 6 and 3 %. This resembles the figures reported 
by van Helden et al. [ 13] who found a cumulative incidence of 10.8 % after 2 years follow-
up. Although female gender is described as a risk factor in many studies, our cohort did 
not support this suggestion [ 3, 9, 20]. Rates of successive fractures after admission for a 





































to those without. We found that a previous fracture was only a risk factor for sustaining 
a distal radius fracture in the future, not for other types of fractures. This is contrary to 
other series that reported a previous fracture at any site to be a significant risk factor 
for a future fracture. This might be explained by our retrospective collecting of data of 
previous fractures, accounting for a possible loss of fractures. A limitation is the potential 
loss of fractures in the retrospective review of medical charts. This might have led to an 
underestimation of fracture rates, thus influencing the calculated risk factors.
A multivariable Cox regression analysis on risk factors for a contralateral hip fracture 
showed only a significant influence of age, not of gender and ASA classification. This is an 
expected outcome; the more years lived, the more risk to sustain a fracture.
Patient’s characteristics of the entire population and the bilateral hip fracture 
population were comparable. However, patients admitted for a second hip fracture did 
sustain their first hip fracture on a significant lower age than patients admitted for their 
first hip fracture (75.9 vs. 81.7 years, p < 0.001). Therefore, it might be good practice 
to screen patients who sustain their first hip fracture at a younger age thoroughly for 
osteoporosis and other risk factors.
The median (IQR) interval between the two hip fractures in all 169 patients was 18.5 
months (26.6), 36.1 % occurred with 1 year and 61.5 % was sustained in 2 years. Nymark 
[ 21] (9,990 patients) showed that 50 % of the contralateral hip fractures occurred within 
12 months in men, and within 19 months in women. Other reported mean intervals 
between two hip fractures differ from 2.1 years (Chevally, 4,115 patients), 2.3 years 
(Kok, 1,604 patients), 3.3 years (Schroder, 3,898 patients) to 4.3 years (Fukushima 835 
patients) [ 22– 25]. The latter reported more that 70 % of all contralateral hip fractures 
to occur within 5 years, resembling our findings [ 25]. Therefore, the interval between 
two hip fractures is relatively short. The effectiveness of osteoporosis medication is 
high, with relatively early results; commonly used osteoporosis agents like risedronate 
and alendronate significantly reduce the incidence of non-vertebral fractures (21–39 %) 
compared to placebo during 3 or more years of follow-up [ 26– 31]. In post hoc analyses 
of these trial data, the reduction of non-vertebral fractures was present at 6 months 
for 5 mg daily dosing of risedronate [ 32] and at 12 months for 10 mg daily dosing of 
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These findings emphasize the importance of early screening for osteoporosis after a 
fracture; starting osteoporosis medication can prevent subsequent fractures in the future.
We presented a large series on hip fracture patients with a median follow-up of 
2 years. The main limitation of our study was the retrospective collection of a part of 
the fracture patient data. This might potentially have led to an underestimation of the 
incidence of fracture from the medical chart. Although in this retrospective part of the 
study we vigorously analysed all radiographs and patient charts for presence of fractures 
after the index hip fracture, thus minimizing this potential error of underestimating 
fracture incidence. Furthermore, the reported fracture rates are comparable to a recent 
Dutch study [ 13]; therefore, the level of underestimation of the incidence of fractures 
might be low. Another limitation is the lack of data on bone mineral density; the actual 
number of patients suffering from osteoporosis is unknown. Finally, no data on the 
start of osteoporosis medication after the index fracture were available. This could have 
influenced the fracture rates during follow-up.
In conclusion, this large series adds important information to existing literature on 
hip fracture incidence rates and identifies risk factors. It emphasizes the importance of 
osteoporosis screening and treatment to prevent subsequent fractures because of the 
good and early effectiveness of current osteoporosis medication. Our outcomes can 
be used as a baseline for evaluating the efficacy of present osteoporosis screening and 
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Introduction Long-term place of residence after hip fracture is not often described in 
literature. The goal of this study was to identify risk factors, known at admission, for 
failure to return to the pre-fracture place of residence of hip fracture patients in the first 
year after a hip fracture.
Methods This is a prospective longitudinal study of 444 consecutive admissions of hip 
fracture patients aged 65 years. Place of residence prior to admission, at discharge, 
after 3 and 12 months was registered. Patients admitted from a nursing home (n = 49) 
were excluded from statistical analysis. Multivariable logistic regression analysis was 
performed, using age, gender, presence of a partner, ASA-score, dementia, anaemia at 
admission, type of fracture, pre-fracture level of mobility and level of activities of daily 
living (ADL) as possible risk factors.
results Two hundred eightynine patients lived in their own home, 31.8% returned 
at discharge, 72.9% at 3 months and 72.8% at 12 months. Age, absence of a partner, 
dementia, and a lower pre-fracture level of ADL or mobility were independent contributors 
to failure to return to their own home at discharge, 3 or 12 months. 106 patients lived 
in a residential home; 33.3% returned at discharge, 68.4% at 3 months and 64.4% at 12 
months. Age was an independent contributor to failure to return to a residential home.
Conclusions Age, dementia and a lower pre-fracture level of ADL were the main significant 
risk factors for failure to return to the pre-fracture residence. As the 3- and 12-month 








































The total number of hip fracture patients aged 50 years and older has been estimated 
to increase to over half a million in the US by 2040 and 6.3 million by 2050 worldwide 
[ 1, 2]. Elderly hip fracture patients suffer frequently from comorbidities and the 1-year 
mortality rate is high [ 3]. Social morbidity as measured by limited activities of daily life, 
loss of independency and the impact of a sudden change in place of residence due to a 
hip fracture has little focus in research, despite its importance for the quality of life for 
the patient [ 4]. Socio-economically, the impact of a hip fracture and its sequelae is large 
as well. Discharge to an alternative location or arranging additional postoperative care at 
home after discharge can attribute to a longer stay in hospital and creates additional costs 
[ 5, 6]. Only a limited number of prospective studies on pre- and post-fracture place of 
residence have been published. Most of them are focused on the discharge location, but 
not on the long-term place of residence [ 7– 12].
The aim of the current study was to identify risk factors, known at admission, for 
failure to return to the pre-fracture place of residence at discharge, 3- and 12-month post-




A prospective longitudinal observational cohort study of 444 consecutive admissions 
for a hip fracture in 437 patients of 65 years and older was conducted. All patients 
were admitted to the orthopaedic or trauma surgery ward in a 450-bed teaching 
hospital in Delft, the Netherlands, from January 2008 to December 2009. In both wards 
professionals worked with a standardized care pathway for hip fracture patients that has 
been developed by a multidisciplinary team, including orthopaedic and trauma surgeons, 
geriatricians, psychiatrists and nurses from the emergency department, wards and liaison 
service. Patients with a fracture due to a high-energy trauma, with a pathologic fracture 





































nursing home (n = 49, 12-month mortality 46.9%) were excluded from the analysis for 
failure to return to their pre-fracture nursing home as they all returned to the nursing 
home or died. Length of follow-up for all patients was 12 months or up to death.
It was not necessary to obtain approval from the local ethical committee due to 
the observational character of the study evaluating usual care as a part of good clinical 
practice. Since data could not be traced back to the individual patient, there were no 
privacy issues.
Data collection
Uniform collection and recording of data of all patients were achieved by standard 
evaluation at admission and after 3 and 12 months according to the standardized care 
pathway for hip fracture patients. Age, gender, presence of a partner, American Society 
of Anesthesiologists (ASA) physical status classification score, presence of dementia, 
presence of anaemia at admission, type of fracture, fracture treatment, anaesthesia, 
length of stay (LOS), discharge location and the in-hospital, 3- and 12-month mortality 
rate were registered [ 13]. One observer (AV) rated the ASA score of all patients. Mortality 
of the patients was scored meticulously by repeated consultation of the population 
registers of the counties in the region as well as the hospital’s patient registration systems 
for the full length of follow-up.
Place of residence, level of mobility and level of activities of daily living (ADL) were 
obtained at admission and at 3- and 12-month post-fracture [ 14]. These parameters were 
registered during routine follow-up in the outdoor clinic or by a questionnaire sent to the 
patient or caretakers in case of dementia.
Anaemia
In all patients the haemoglobin level at admission was obtained. Anaemia at admission 
was defined based on the criteria of the World Health Organization (WHO) [ 15]. These 
criteria classify anaemia as a haemoglobin level below 7.5 mmol/L (12 g/dL) in women 







































Patients were divided into three groups based on pre-fracture place of residence at 
admission, i.e. living in their own home, in a residential home or in a nursing home.
Living in their own home was defined as living independently, alone or with a partner.
A residential home is a heterogeneous form of living, ranging from the availability of 
support to almost full-time help in daily activities.
A nursing home is a residential facility caring for persons with predominant diffculties 
in activities of daily living.
Level of mobility and aDL
Mobility both in- and outdoors prior to hip fracture was classified as mobile without an 
aid, mobile with an aid or not able to ambulate (“immobile”). A cane, crutch(es) or walker 
were all considered an aid, patients in a wheelchair were considered to be immobile. The 
level of mobility was divided into four main categories; mobile without use of an aid in- 
and outdoors, mobile in- and outdoors with the use of an aid in- and/or outdoors, only 
mobile indoors (regardless the use of an aid) and immobile both in- and outdoors.
The Groningen Activity Restriction Score (GARS) is a functional ADL score [ 14]. It assesses 
competence in abilities in 11 personal basic ADL and 7 instrumental activities of daily living 
(IADL). A summed score was calculated ranging from 18 (indicating ability to perform all 
activities without assistance or undue effort) to 72 (indicating disability).
Statistical analysis
Continuous data are presented as mean with standard deviations (SD). The independent 
Student’s t test or one-way anova was used to compare groups of continuous data. 
Categorical data are presented as the number of subjects in the category, along with the 
percentages. Chi-square test and Fisher’s exact test were used for comparing groups of 
categorical data.
Bivariate and multivariable logistic regression analysis was performed to identify risk 
factors for patients living in their own home or in a residential home prior to admission 
for failure to return to the pre-fracture place of residence at discharge, 3- and 12-month 
post-fracture. For both analysis, only risk factors known at admission were used; age, 





































anaemia at admission, pre-fracture level of mobility (using the four categories of mobility), 
pre-fracture level of ADL (expressed with the GARS) and type of fracture [neck of femur, 
(inter) trochanteric or sub-trochanteric].
Patients classified as ASA I or II and III or IV were combined to two groups, as the 
separate groups of ASA I (n = 22) and ASA IV (n = 26) classified patients were too small to 
be analyzed separately. LOS was changed into a binary summary outcome based on the 
median, i.e. ≤ or >11 days.
The likelihood ratio backward test was used to find the best-fit model by selecting 
the variables one by one. The probability for entry was set at 0.05, and the probability 
for removal at 0.10. To calculate odds ratios (OR), logistic regression analysis was used. P 
values lesser than 0.05 were considered statistically significant. All data were analysed in 
SPSS 17.0 (SPSS Inc. Chicago, USA).
results
Table 1 shows characteristics of all patients, based on the pre-fracture place of residence. 
Mean (SD) age of all patients was 83.4 years (7.3), 73.2% were female. Prior to hip 
fracture, the majority of patients (n = 289, 65.1%) lived in their own home and nearly one 
quarter (n = 106, 23.9%) lived in a residential home. A small group (n = 49, 11.0%) resided 
in a nursing home. Patients living in their own home were younger, more often male, had 
lower ASA scores, were less often known with anaemia and dementia and had more often 
a partner compared to patients living in a residential home or a nursing home.
A conservative treatment was chosen in 12 patients, who therefore did not receive 
any form of anaesthesia.
Mortality at 3 months was 15.1% (n = 67) and 26.4% (n = 117) at 12 months of the 
entire group, being higher in the group of patients that lived less independently. At 
3-month follow-up, no data about place of residence were available in 13 patients (2.8%), 
and at 12-month follow-up this information was missing in 6 patients (1.4%).
Data on some variables were missing (most of them less than 4%, Table 1), since they 
were not entered in the prospective database at admission and could not be retrieved at 
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table 1 Characteristics of patients with a hip fracture dependent on residency at admission
Study 
population




Own home Residential home Nursing home
(n = 289) (n = 106) (n = 49)
Mean age in years (SD) 83.4 (7.3) 81.9 (6.9) 86.9 (7.4) 85.2 (6.2) <0.001
Female gender 325 (73.2) 200 (69.2) 87 (82.1) 38 (77.6) 0.010
Partner at admissiona 133 (32.4) 116 (40.4) 11 (10.8) 6 (27.3) <0.001
ASA score
I/II 289 (65.1) 205 (70.9) 59 (55.7) 25 (51.0) <0.001
III/IV 155 (34.9) 84 (29.1) 47 (44.3) 24 (49.0)
Dementiab 111 (25.9) 31 (11.2) 44 (42.3) 36 (76.6) <0.001
Anaemia at admission 188 (42.5) 105 (36.5) 52 (49.5) 31 (63.3) <0.001
Mobility at admission <0.001
Without an aid in- and outdoors 152 (34.3) 133 (46.0) 14 (13.2) 5 (10.4)
With an aid in- and outdoors 200 (45.1) 136 (47.1) 46 (43.4) 18 (37.5)
Only mobile indoors 78 (17.6) 18 (6.2) 42 (39.6) 18 (37.5)
Immobile 13 (2.9) 2 (0.7) 4 (3.8) 7 (14.6)
Mean GARS (SD)c 42.9 (17.8) 34.8 (14.5) 55.3 (13.5) 63.7 (9.0) <0.001
Fracture type
Neck of femur 257 (57.9) 169 (58.5) 57 (53.8) 31 (63.3) 0.140
(Inter) trochanteric 169 (38.1) 106 (36.7) 45 (42.5) 18 (36.7)
Subtrochanteric 18 (4.1) 14 (4.8) 4 (3.8) 0 (0)
Treatment
Osteosynthesis 248 (55.9) 162 (56.1) 64 (60.4) 22 (44.9) 0.093
(Hemi) arthroplasty 184 (41.4) 120 (41.5) 38 (35.8) 26 (53.1)
Conservative 12 (2.7) 7 (2.4) 4 (3.8) 1 (2.0)
Anaesthesia
Spinal/epidural 406 (91.4) 268 (92.7) 94 (88.7) 44 (89.8) 0.302
General 26 (5.9) 14 (4.8) 8 (7.5) 4 (8.2)
Not applicable 12 (2.7) 7 (2.4) 4 (3.8) 1 (2.0)
LOS >10 days 209 (47.1) 133 (46.0) 62 (58.5) 14 (28.6) <0.001
Mortality
In-hospital 20 (4.5) 6 (2.1) 10 (9.4) 4 (8.2) 0.004
3 months 67 (15.1) 22 (7.6) 28 (26.4) 17 (34.7) <0.001
3- to 12-month 50 (11.3) 26 (9.0) 18 (17.0) 6 (12.2) 0.017
12 months 117 (26.4) 48 (16.6) 46 (43.4) 23 (46.9) <0.001
Values are given as number (percentage) unless mentioned otherwise
LOS length of stay, GARS Groningen Activity Restriction Score, ASA American Society of 







































Patients living in their own home at admission
Discharge directly to their own home occurred in 90 patients (31.8%). At 3 months, 186 
patients (72.9%) and at 12 months 171 patients (72.8%) returned to their own home. All 
values were corrected for mortality; in-hospital mortality was 2.1% (n = 6), mortality at 3 
months was 7.6% (n = 22) and 16.6% (n = 48) at 12 months.
Risk factors for failure to return to their own home
Data of the bivariate regression analysis for risk factors for failure to return to home 
are shown in Table 2. Age, absence of a partner, dementia, a lower level of mobility 
and a lower level of ADL (i.e. a higher GARS) were significant contributors to failure to 
return to their own home at discharge, at 3 and at 12 months after discharge. Figure 
1 shows the positive association of chronological age and failure of returning home at 
discharge and after 3 and 12 months. Multivariable logistic regression analysis showed 
that age, dementia and a lower level of ADL (i.e. a higher GARS) were the main significant 
independent contributors to failure to return to their own home at discharge, at 3 or at 
12 months, as demonstrated in Table 3. Absence of a partner was a significant risk factor 
for failure to return to their own home only at discharge.
 
 
















































































































































































































































































































































































































































































































































































































































































































































































































































































table 3 Risk factors known at admission for failing to return to their own home
Independent variables Odds ratio 95% CI P value
At dischargea Age (per year) 1.10 1.05 to 1.16 <0.001
Female gender 2.23 1.17 to 4.26 0.015
Absence of a partner 2.00 1.06 to 3.78 0.032
Dementia 4.84 1.02 to 23.0 0.047
GARS (per 10 units) 1.48 1.16 to 1.89 0.002
At 3 monthsb Age (per year) 1.10 1.03 to 1.16 0.003
Dementia 9.21 3.14 to 27.0 <0.001
GARS (per 10 units) 1.84 1.42 to 2.35 <0.001
At 12 monthsc Age (per year) 1.09 1.03 to 1.16 0.003
Dementia 5.96 2.23 to 15.9 <0.001
Mobility categoryd
With an aid in- and/or outdoors 2.97 1.39 to 6.32 0.005
Only mobile indoors 6.03 1.39 to 26.2 0.016
Multivariable logistic regression analysis
Analysis performed in a 268 patients, b 242 patients; c 225 patients
d Reference category is mobile without an aid
GARS Groningen Activity Restriction Score
Patients living in a residential home at admission
Discharge directly to their residential home occurred in 32 patients (33.3%). At 3 months 
54 (68.4%) and at 12 months 38 (64.4%) patients were residing in their pre-fracture 
residential home again. All values were corrected for mortality; in-hospital mortality was 
9.4%, mortality was 26.4% at 3 months and 43.4% at 12 months.
Risk factors for failure to return to their residential home
Data of the bivariate analysis for risk factors for failure to return to a residential home are 
shown in Table 4. A lower level of ADL (higher GARS) was a risk factor for failure to return 
to the residential home at 3- and at 12-month post-fracture. Age and female gender were 
risk factors at discharge.
Multivariable logistic regression analysis (96 patients available) showed that age 
was the only independent contributor to failure to return to their residential home at 
discharge (OR 1.09, 95% CI 1.02–1.16, P = 0.007). None of the other potential risk factors 
reached significance at discharge, at 3- or at 12-month follow-up. The latter two analyses 



































































































































































































































































































































































































































































































































































































































































































































































































































The majority of the hip fracture patients in the studied population aged 65 years and 
older lived in their own home, whilst sustaining a hip fracture. During the first year after 
fracture treatment, three quarters of the surviving population had returned to their own 
home. Multivariable logistic regression analysis identified higher age, dementia and a 
lower level of mobility as the most important risk factors for failure to return to their own 
home at discharge, but also at 3- and at 12-month post-fracture.
The percentage of patients returning to their pre-fracture residence was stable 
between 3 and 12 months, the 3-month time mark can be used as an evaluation end 
point in future research. This is in line with a previous study which concluded that the 
4-month time mark is adequate to evaluate ADL and residential status in hip fracture 
patients [ 16].
The medical and social morbidity of patients living in a residential home was worse 
compared to patients living in their own home, this is reflected in a higher 1-year 
mortality rate and a more limited level of mobility of the residential home patients. The 
overall 1-year mortality rate in our cohort (mean age 83 years) was 26%, comparable to 
the result of an US study (495 patients, mean age 85 years, 1-year mortality 26%) and a 
large Scottish cohort (27,475 patients, aged 50 and older, 1-year mortality 31%) [ 17, 18].
Early and reliable information on the potential discharge location after the hospital 
admission is of importance for both patients and caregivers to plan postoperative care. 
Furthermore, it is of socio-economical impact. When extrapolating the results of this 
study to different countries, one must be aware of bias at several levels. First, large 
differences between countries exist in type of housing and traditions for homes for 
elderly people [ 19]. In the Netherlands, a residential home is very heterogeneous form of 
living, as defined earlier in this paper. Secondly, large regional, national and international 
differences exist on discharge policies, like locations of discharge and availability of 
different kinds of temporary rehabilitation units [ 20, 21].
In a large Scottish series, the number of hip fracture patients living in their own home 
prior to sustaining a hip fracture and the percentage of these patients returning to this 
location after 4 months were comparable to our results [ 22]. In a series of hip fracture 
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prior to the hip fracture, but only 20% could be immediately discharged home from the 
hospital. At 6 months, 83% had returned back to their own residence [ 10]. Finally, in a 
comparison of a Finnish and a British cohort of hip fracture patients, 62 and 69% lived in 
their own home prior to the hip fracture, of whom 44 and 54% respectively, had returned 
home four months after hospital discharge, which is less than that in our study [ 20].
Risk factors for not returning to their own home after hospital discharge were higher 
age, presence of dementia, absence of a partner, a lower level of mobility and a lower 
level of ADL prior to the hip fracture. Beside these risk factors, a longer LOS was also 
a risk factor for failure to return to their own home. A longer LOS is often associated 
with a higher rate of adverse outcomes during admission and might be related to worse 
outcome thereafter [ 23, 24]. LOS was not included in the statistical analysis, since the 
purpose of the current study was to identify risk factors known at admission of the 
patient. Subsequently, a prediction model for discharge location already at admission 
can be developed with these risk factors. If discharged to another location other than the 
patient’s own home, length of hospital stay is usually longer, with subsequent additional 
costs [ 5, 6]. An instrument that predicts the discharge location already at admission 
would therefore be of great value, not only for liaison services but also for patients and 
their family.
Advanced age, dementia, a walking disability and con-comitant chronic systemic 
diseases were previously reported to be risk factors for failure to return to the patient’s 
own home at discharge from hospital [ 7]. This is largely in concordance with our 
findings, although we used a more general categorisation for scoring the overall degree 
of comorbidities (ASA classification). But, others have shown that ASA score and the 
number and type of comorbidities are associated [ 13]. We found a higher ASA score to 
be a significant risk factor in the bivariate analysis, but not in the multivariable logistic 
regression analysis. Other papers identified presence of a partner, good general health, 
good cognition, a higher level of ADL and mobility (both pre-fracture and 2 weeks after 
surgery), a lower number of medication, and moderate use of nursing interventions (like 
bathing) as important variables predicting discharge to an own residence [ 7– 10, 25, 26]. 
These findings are in line with our study. Other risk factors like anaemia at admission and 
fracture type were of small importance in the bivariate analysis and lost significance in 
the multivariable analysis. This is most probably because both anaemia and fracture type 





































Deakin et al. [ 9] published the largest series (3,240 patients) on discharge location of 
hip fracture patients. Their analyses were not specified for pre-fracture place of residence. 
Pre-injury dependence, age, male gender and injury sustained whilst in hospital were 
identified as the main risk factors for discharge to an alternative location (DAL). In contrast 
to their findings, we identified female gender as an independent risk factor for DAL This 
conflicting outcome is most probably due to diVerence in sample size between our and 
the former study. Furthermore, we only included patients admitted for a hip fracture at 
the emergency department; no patients with an in-hospital hip fracture were included.
Some limitations exist; first, the analyses of patients living in a residential home 
at admission were troubled by the limited numbers and a high mortality rate. At the 
3-month follow-up, 86 patients could be analyzed; at 12 months only 66 patients. This 
is the main reason we could only identify age as a risk factor for failure to return to 
their residential home at discharge in the multivariate analysis. A lower level of ADL 
independency was the most important risk factor for not returning to their residential 
home in the bivariate analysis. A second limitation was the fact that the diagnosis of 
dementia was based on medical history. Cognitive performance was not assessed during 
hospital stay. The third limitation was that the type and number of comorbidities were 
not registered. Finally, many factors influence the location of residence after hospital 
discharge. Of these other factors, the role of the social network might be one of the 
largest. They can play an important role in the decision of an older person whether or not 
to stay living independently or to move to a residential home.
In conclusion, the large study population, the prospective character, adequate 
information on mortality rates and long follow-up make the study results valuable for 
analysis of socio-economic aspects after hip fracture treatment, especially for the patients 
living in their own home prior to hip fracture. This study identified higher age, dementia 
and a lower pre-fracture level of ADL as the most important independent risk factors for 
failure to return to the pre-fracture residence in patients living in their own home prior 
to hip fracture. In residential home patients, age was identified as the only risk factor, 
possibly due to the small patient numbers.
We will use these risk factors to develop a model that predicts discharge location at 
admission to provide better information for patients, family and physicians regarding the 
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More than half of hip fracture patients do not 
regain mobility in the first postoperative year
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aim: To measure functional recovery and determine risk factors for failure to return to 
the prefracture level of mobility of hip fracture patients 1 year postoperatively.
Methods: A prospective cohort follow-up study of 390 hip fracture patients aged 65 years 
and older was carried out. Patients were stratified in categories based on prefracture 
mobility: mobile without aid, with aid in- and outdoors, or only mobile indoors. Immobile 
patients were excluded. Risk factors for not regaining prefracture mobility were identified.
results: Nearly half of all patients regained their prefracture level of mobility after 1 year. 
Mobile patients without an aid were less likely to return to their prefracture mobility level 
compared with patients who were mobile with aid or mobile indoors. After 1 year, 18.7% 
of all patients had become immobile. Most important independent risk factors for failure 
to return to the prefracture level of mobility were a limited prefracture level of activities 
of daily living and a delirium during admission.
Conclusions: The risk not to regain prefracture mobility is highest in mobile patients 
without an aid. The risk of becoming immobile is higher in those having a lower prefracture 
mobility. Activities of daily living dependence and delirium were the main risk factors for 







































Hip fractures are an important cause of loss of function in the aging Western population.1–4 
Increasing life expectancy is accompanied by a higher number of fragility fractures.5 
The total number of hip fracture patients aged 50 years and older has been estimated 
to increase to over 500 000 in the USA by 2040.5 The reported percentage of patients 
regaining their prefracture level of mobility varies largely between 11% and 82%, 
depending on the studied patient population.1,3,4,6–9 As a result of the loss of mobility 
after a hip fracture, patients are often restricted in their daily activities, causing loss of 
confidence and independence.1,4 Economically, the impact of deterioration of mobility 
is large as well; medical costs for hip fracture patients were about threefold greater 
than those of age-and residence-matched controls without a fracture.10 Older age, poor 
health status, a limited prefracture level of activities of daily living (ADL) and cognitive 
impairment have previously been identified as the main negative contributors to long-
term functional outcome after a hip fracture.11 Many other factors, such as sex, race, 
prefracture residence, hemoglobin level, type of fracture, delirium during admission and 
length of stay, show inconsistent results with respect to long-term outcome.4,12–17
The majority of previous studies describe functional outcome (i.e. the level of daily 
activities and dependency)2–4,12,14,16–18 rather than walking ability solely.7–9,13,15 Furthermore, 
just a few had a follow up of 1 year or longer.3,6,8,12,16
In this study, we present the mobility of hip fracture patients before admission, and at 
3 and 12 months post-operatively. The main goals were to measure functional recovery 
and to identify risk factors for failing to return to the prefracture level of mobility in the 
first year after a hip fracture.
Methods
Patient cohort
A prospective observational cohort study of 444 consecutive admissions for a hip fracture 
in 429 patients was carried out. All patients were aged 65 years and older, and were 





































and December 2009. Patients with a fracture as a result of a high-energy trauma or with 
a pathological fracture were not included in this cohort. Patients with a contralateral 
hip fracture within the time window of the study (n = 15), those who were treated 
conservatively (n = 12) and patients who were immobile before admission (n = 12) were 
excluded from the current study. Thus, 390 patients were included for final analysis. The 
length of follow up for all patients was 12 months.
Data collection
Uniform collection and recording of all patient’ data was achieved by standard evaluation 
at admission, and after 3 and 12 months according to the standardized care pathway for 
hip fracture patients. Age, sex, presence of a partner and prefracture place of residence 
(living in their own home or in institutionalized care; i.e. a residential home or a nursing 
home) were registered at admission.
Clinical characteristics obtained during the hospital stay were American Society of 
Anesthesiologists (ASA) Physical Status classification, presence of dementia (based on 
the medical history and history-taking from patients, family and caretakers) or anemia 
at admission based on the criteria of the World Health Organization (hemoglobin level 
below 7.5 mmol/L [12 g/dL] in women and below 8.1 mmol/L [13 g/dL] in men), type of 
fracture and treatment, diagnosis of delirium based on Diagnostic and Statistical Manual 
of Mental Disorders (DSM)-IV criteria, and length of stay (LOS).19,20
The in-hospital, 3- and 12-month mortality rate of the patients was scored meticulously 
by repeated consultation of the population registers of the counties in the region of both 
hospitals, as well as the hospital’s patient registration systems for the full length of follow 
up.
Level of mobility and activities of daily living
Mobility was registered at admission, and at 3 and 12 months after hip fracture during 
routine follow up in the outpatient clinic, or by a questionnaire sent to patients or 
caretakers in case of dementia. Mobility was divided into four categories: mobile in- and 
outdoors without the use of an aid, mobile in- and outdoors with the use of an aid in- 
and/or outdoors, only mobile indoors regardless of the use of an aid, and those who were 
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Patients in a wheelchair or those who were bedridden were considered to be immobile. 
As aforementioned, immobile patients (n = 12) were excluded from the present study.
The Groningen Activity Restriction Score (GARS) was used to assess the functional 
ADL.21 It includes competence in abilities in 11 personal basic ADL and seven instrumental 
ADL. A summed score for the ADL was calculated ranging from 18 (indicating ability to 
carry out all activities without assistance or undue effort) to 72 (indicating disability). A 
higher GARS score therefore represents a lower level of ADL.
Statistical analysis
Categorical data are presented as the numbers, along with the percentages. The c2-test 
and Fisher’s exact test were used for comparing groups of categorical data.
Bivariate analysis was carried out for the whole cohort and for the three different 
prefracture mobility categories. Age, sex, presence of a partner, intraoperative risk (ASA 
classification I/II vs III/IV), dementia, anemia at admission, prefracture level of ADL (high 
vs low GARS), prefracture place of residence (own home vs institutionalized care), type 
of fracture (intra- vs extracapsular hip fracture) or treatment (osteosynthesis vs [hemi-] 
arthro-plasty), delirium during admission and LOS (2 or >10 days) were included in the 
analysis, being possible independent risk factors.
Age, ADL and LOS were used as a binary outcome, based on the median value. For the 
analysis of the three mobility categories, the median values of the age and GARS of the 
specific category were used, LOS was 2 or >10 days in all analysis. Multivariable logistic 
regression analysis was carried out in the same groups using the same possible risk factors 
to identify independent risk factors for failure to return to the prefracture mobility level 
at 3 and 12 months postoperatively. The likelihood ratio backward test was carried out to 
find the model by selecting the variables one by one. The probability for entry was set at 








































Table 1 shows the characteristics of the whole cohort and stratified by mobility category. 
The mean (SD) age of all patients was 83.4 years (7.1), 72.8% were female and the 12-month 
mortality was 24.9%. Patients that were mobile without an aid were significantly younger 
and in better general condition. The type of fracture or treatment was not related to a 
specific mobility category.
Mobility at follow up
At 3-month follow up, no data about the level of mobility and ADL was available in eight 
patients (2.3%). At 12-month follow up, this information was missing in four patients 
(1.3%). All percentages at 3- and 12-month follow up that are mentioned were corrected 
for mortality.
Figure 1 shows the percentage of patients who were able to regain their prefracture 
mobility for the whole cohort and stratified by mobility category. Overall, approximately 
half of the patients regained their prefracture mobility level. Mobile patients without an 
aid showed the lowest level of regaining mobility, and were the only subgroup with a 
significant improvement of mobility between 3 and 12 months.
Furthermore, Figure 1 shows the percentage of patients being immobile at 3- and 
12-months follow up for the whole cohort and stratified by mobility category as well. In 
total, 18.7% of all patients became immobile.
The more limited the level of prefracture mobility, the higher the number of patients 
that became immobile. Solely patients who were only mobile indoors showed a significant 






























































































































































































































































































































































































































































































































































































































































































































































































































































































fig 1 Chapter 6 
 
Figure 1 Percentages of patients who were able to regain their prefracture mobility and became 
immobile for the whole cohort and stratified by mobility category. *P < 0.05.
risk factors for not regaining prefracture mobility
Table 2 shows the relative risks of the different variables for not regaining prefracture 
mobility at 3 months for the whole cohort and stratified by mobility category. For the 
whole cohort, dementia, living in institutionalized care before admission and a delirium 
during admission were significant risk factors for not regaining the pre-fracture level of 
mobility. In addition to these items, a longer LOS and a lower ADL level were significant 
in the two groups of patients that were mobile in- and outdoors (regardless the use of 
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Table 3 shows the relative risks of the different variables for not regaining prefracture 
mobility at 12 months, which were the same as at 3-month follow up. The additional risk 
factors in the group that was mobile with an aid in the analysis at 3 months lost their 
significance at 12 months.
The outcome of the multivariable regression analysis of the risk factors for not regaining 
prefracture mobility for the whole cohort and stratified by mobility category is shown in 
Table 4. A lower level of ADL was, together with the occurrence of a delirium, the most 
important independent risk factor for not regaining the prefracture level of mobility in 
the whole cohort and the subgroups, without a difference between 3- and 12 month 
follow up. In the bi- and multivariable regression analysis of the group of patients who 
were only mobile indoors, none of the risk factors reached significance.
table 4 Results of multivariable regression analysis of risk factors for not regaining prefracture level 
of mobility
Risk factor 3-month follow up 12-month follow up
OR 95% CI P-value OR 95% CI P-value
All patients§ Lower level of ADL† 3.01 1.40 to 6.45 0.005 3.79 1.69 to 8.50 0.001
Delirium 3.94 1.92 to 8.07 <0.001 3.04 1.42 to 6.49 0.004
LOS >10 days 1.71 1.00 to 2.92 0.050 2.81 1.58 to 4.98 <0.001
Institutionalized before 
admission
2.72 1.40 to 5.28 <0.001 2.42 1.18 to 4.99 0.016
Prefracture mobility‡
<0.001 <0.001Mobile with an aid 0.08 0.04 to 0.17 0.12 0.06 to 0.27
Only mobile indoors 0.05 0.025 to 0.24 <0.001 0.12 0.04 to 0.37 <0.001
Mobile without Lower level of ADL† 4.86 1.79 to 13.17 0.002 6.19 2.46 to 15.57 <0.001
an aid¶ LOS >10 days 2.74 0.83 to 9.07 0.099 4.09 1.35 to 12.38 0.013
Older age† 2.71 1.07 to 6.85 0.035 1.85 0.78 to 4.42 0.164
Mobile with Lower level of ADL† 6.06 2.81 to 13.09 <0.001 4.04 1.89 to 8.63 <0.001
an aid†† Delirium 3.40 1.42 to 8.11 0.006 3.14 1.30 to 7.60 0.011
†Based on the median of the different groups. ‡Mobile without an aid is the reference category. 
Analysis was carried out on: §330 patients at 3-month follow up and 289 patients at 12-month 
follow up; ¶124 patients at 3-month follow up and 119 at 12-month follow up; and ††155 patients at 






































In the present study, approximately half of the patients had regained their prefracture 
mobility 3 months after a hip fracture. The majority of mobile patients without an aid 
did not regain their mobility, but improved their level of mobility between 3 and 12 
months postoperatively. The level of mobility of patients in the other mobility categories 
did not significantly improve after 3-month follow up. Furthermore, the more limited 
the prefracture level of mobility, the higher the number that became immobile after 
12 months. The most important independent risk factors for failure to return to the 
prefracture level of mobility were a lower prefracture level of ADL and a delirium during 
admission.
Previous series from Western societies reporting specifically on walking ability showed 
either a comparable3,6,9 or a much lower (11–16%)7 percentage of patients returning to 
their prefracture level. The pre-fracture level of mobility in these series was higher7,9 or 
defined differently.3,6
A Japanese cohort was younger and less mobile before fracture than our cohort, 
but had a comparable level of mobility after 12 months.8 The number of patients that 
became immobile at follow up was within the previous reported range of 5–21%.6,7,9 The 
huge impact of a hip fracture can be shown by the percentage of patients becoming 
immobile. The present study showed that 60% of the patients who were mobile only 
indoors before the fracture occurred became immobile during the postoperative course 
of 1 year. Furthermore, the mobility of those patients deteriorated even more during the 
1-year postoperative course, the latter has not been shown before.
Previous studies showed that functional recovery after hip fracture occurs within 
the first 4–6 months post-fracture.1,4,8,18 In the current study, functional recovery was 
stratified by prefracture mobility. We found an improvement of mobility in patients who 
were mobile without an aid between 3 and 12 months, and no significant difference in 
the other subgroups. These results were confounded by age and mortality, as the less 
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Comparison between studies is limited because of different definitions of walking 
ability and functional outcome. A recent review showed that higher age, worse health 
condition and cognitive status, and lower pre-fracture functional level were the strongest 
risk factors for worse functional outcome after a hip fracture.11 In the present study, 
dementia, lower level of ADL, living in an institutionalized care environment, delirium 
and a LOS >10 days were the main risk factors in the bivariate analysis. Dementia lost 
significance in the multivariable logistic regression analysis. In patients who were mobile 
without an aid, age was an additional risk factor in both bivariate and multivariable 
analysis at 3 months.
As previously reported, a limited level of ADL is one of the most important contributors 
to poor outcome.6,7,11,12 Delirium as a risk factor was either confirmed or denied to be 
a risk factor in previous studies; in the present study, it was a risk factor in the whole 
cohort, as well as in the group that was mobile with an aid.12,16 Most probably, patients 
who suffer from a delirium are generally in worse general condition, contributing to the 
loss of mobility.22
A longer LOS was reported by Magaziner et al. to be a risk factor for a poorer post-
fracture functional level.4 This might be because of the fact that a longer LOS often means 
more complications and therefore worse functional outcome on the long term.
Finally, living in institutionalized care was a risk factor for not regaining mobility in 
the whole cohort, but not in the subgroups. Others found worse functional out-comes in 
institutionalized patients compared with patients living independently.15,17
This is one of the few prospective studies reporting on the level of mobility from 
admission to 1 year after a hip fracture. The sample size, its prospective character, the 
accurate information on clinical characteristics, and the length and high rate of follow up 
make this study valuable. Its main limitation was the absence of more detailed data on 
cognitive function. Furthermore, we did not use an objective measuring instrument, such 
as the Confusion Assessment Method, to establish a delirium; the diagnosis was based on 
clinical examination, as stated in the DSM-IV.20,23 Another limitation is the fact that we did 
not have more objective data on the level of mobility (such as gait speed), besides the use 
of a walking aid or not. Finally, the number of patients that was categorized in the group 





































In the present study, less than half of the patients regained their prefracture mobility 12 
months after hip fracture. Just one-quarter of the mobile patients without an aid regained 
their level of mobility at 3-month follow up, this improved to approximately one-third at 
12 months. The groups with a lower level of mobility regained their prefracture level of 
mobility in over half of the cases, but did not improve after 3 months. The most important 
independent risk factors for failure to return to the prefracture level of mobility were the 
prefracture level of ADL and a delirium during admission.
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Background: Delirium in patients with hip fractures lead to higher morbidity and 
mortality. Prevention in high-risk patients by prescribing low dose haloperidol is currently 
under investigation.
Methods: This prospective cohort surveillance assessed hip fracture patients for risk of 
developing a delirium with the Risk Model for Delirium (RD) score. High-risk patients 
(score ≥ 5 points) were treated with a prophylactic low-dose of haloperidol according to 
hospital protocol. Primary outcome was delirium incidence. Secondary outcomes were 
differences between high- and low-risk patients in delirium, length of stay (LOS), return to 
pre-fracture living situation and mortality. Logistic regression analysis was performed with 
age, ASA-classification, known dementia, having a partner, type of fracture, institutional 
residence and psychotropic drug use as possible confounders.
results: 445 hip fracture patients aged 65 years and older were admitted from January 
2008 to December 2009. The RD-score was completed in 378 patients, 173 (45.8%) high-
risk patients were treated with prophylactic medication. Sensitivity was 71.6%, specificity 
63.8% and the negative predictive value (NPV) of a score < 5 was 85.9%.
Delirium incidence (27.0%) was not significantly different compared to 2007 (27.8%) 
2006 (23.9%) and 2005 (29.0%) prior to implementation of the RD- protocol.
Logistic regression analysis showed that high-risk patients did have a significant 
higher delirium incidence (42.2% vs. 14.1%, OR 4.1, CI 2.43-7.02). They were more likely 
to be residing at an alternative living situation after 3 months (62.3% vs. 17.0%, OR 6.57, 
CI 3.23-13.37) and less likely to be discharged from hospital before 10 days (34.9% vs. 
55.9%, OR 1.63, CI 1.03-2.59). Significant independent risk factors for a delirium were 
a RD-score ≥ 5 (OR 4.13, CI 2.43-7.02), male gender (OR 1.93, CI 0.99-1.07) and age (OR 
1.03, CI 0.99-1.07).
Conclusions: Introducing the delirium prevention protocol did not reduce delirium 
incidence.
The RD-score did identify patients with a high risk to develop a delirium. This high-risk 
group had a longer LOS and returned to pre-fracture living situation less often.
The NPV of a score < 5 was high, as it should be for a screening instrument. Concluding, 







































Delirium is a common and serious complication in hip fracture patients. It leads to lower 
functional abilities, longer hospital stay, impaired cognitive function, more admissions 
to long term special care facilities and higher mortality rates [1- 5]. This advocates the 
importance of preoperative delirium risk assessment.
Reported post-operative incidence rates range widely from 16 to 62% [6]. This broad 
range can be explained by patient inclusion criteria and different scoring methods for 
delirium. Furthermore, delirium is frequently undetected or misdiagnosed [7].
Haloperidol is widely used for symptomatic treatment of delirium. However, 
prophylaxis with haloperidol did not lower delirium incidence, it did reduce duration of 
episodes and the severity in a recent randomized controlled trial [8].
In 2008 we introduced an integrated hip fracture care pathway that included a 
Risk Model for Delirium [9]. This model should identify high-risk patients that are 
subsequently prescribed prophylactic haloperidol. Primary purpose of this surveillance 
study was to determine whether using prophylaxis would diminish delirium incidence 
in hip fracture patients. The second aim was to investigate the value of the score and 
differences between low- and high-risk patients (as determined by the risk model) in 
delirium incidence, length of stay, return to pre-fracture living situation and mortality.
Methods
A surveillance was conducted on a series of consecutive admissions for a hip fracture to a 
450-bed teaching hospital in Delft, the Netherlands.
Patients
From January 2008 to December 2009, all consecutive admissions for a hip fracture were 
registered and prospectively studied with respect to presence of delirium. Thus 529 
admissions (522 patients) were recorded. These were all patients with a hip fracture due 
to a low-energy trauma and of non-pathologic origin. For this study, patients of 65 years 





































The control group for evaluating the effect of the use of the Risk Model for Delirium 
(RD-score) was a historical consecutive series of 611 hip fracture patients of 65 years and 
older admitted between 2005-2007, prior to implementation of our RD protocol.
As this study is an evaluation of our delirium protocol, it is considered to be a “Post 
Marketing Surveillance”. Therefore, approval of a medical ethical committee was not 
necessary.
Assessment measures
Uniformed data collection of all patients was achieved by evaluating all patients on 
admission in a standard procedure and recording, according to our local hip fracture 
protocol [9]. The following data was collected of all patients; age, gender, having a 
partner, history of dementia, RD-score, pre-fracture living situation, ASA classification 
[10], psychotropic drug use, type of fracture, treatment and anaesthesia, in-hospital 
complications, discharge location, in hospital mortality and length of stay (LOS).
Diagnosis of delirium was based on criteria of the DSM IV [1]. Patients were observed 
for these criteria by both doctors and nursing staff during their daily rounds and 
assessments. When signs of delirium were notified, they were recorded in the medical 
and nursing records. Delirium incidence in this series was scored based on these medical 
and nursing staff records, directly after discharge. Living situation was assessed at 3 
months post-admission by questionnaires sent to all patients. Mortality was assessed 
until 1 year after hospitalisation, using the digital registration system of the hospital.
Delirium incidence in the historical group (2005-2007) was drawn from our hip 
fracture database that was built retrospectively by evaluation of the patients’ files and 
complication register.
Assessing the risk for a delirium at admission, using the RD-model (table 1), is a 
standard part of our local hip fracture protocol [9]. This model was developed in 2004 
by the department of Psychiatry in our hospital and uses pre-disposing risk factors for 
delirium that were weighted, based on known literature at that moment [11- 17]. The 
model was designed with a cut-off point of 5; patients scoring 5 or more points were 
considered high-risk patients. For this group delirium prophylaxis is prescribed, being 2 
times a day 1 mg of haloperidol. In the case of contra-indications for the use of haloperidol, 
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When patients developed a delirium, they were fully assessed to exclude a somatic cause 
and treated by the psychiatric department. The RD-score and the delirium protocol were 
implemented fully on the departments of Orthopaedics and Trauma surgery in 2008, as a 
part of the integrated hip fracture care pathway.
table 1 The Risk Model for Delirium
Predisposing risk factors for delirium Points
Delirium during previous hospitalization 5
Dementia 5
Clock drawing (displaying 10 past 11)
- Small mistakes 1
- Big mistakes, unrecognizable or no attempt 2
Age
- 70 to 85 years 1
- Older than 85 years 2
Impaired hearing (patient is not able to hear speech) 1
Impaired vision (vision less than 40%) 1
Problems in activities of daily live
- Domestic help or help with meal preparation 0.5
- Help with physical care 0.5
Use of heroin, methadone or morphine 2
Daily consumption of 4 or more alcoholic beverages 2
Total score
Outcome
The current cohort was analyzed for differences between low- (< 5) and high-risk (≥ 5) 
patients for delirium incidence, length of stay (LOS), alternative living situation (ALS) 3 
months post-fracture (compared to the pre-fracture situation) and in-hospital, 3- and 
12-month mortality.
Statistical analysis
Categorical data are presented as the number of subjects, along with the percentages. 
Continuous data are presented as means with standard deviations (SD). The value of the 
RD-score was evaluated using sensitivity, specificity, the negative predictive value of a low 





































Chi-square test, Fisher’s exact test and independent Student’s t-test were used as 
applicable for univariate analysis. A P-value lower than 0.05 was taken as the threshold of 
significance. LOS was divided in two groups at the level of the median (10 days).
The ability of the RD to discriminate was estimated by the receiver-operating 
characteristic (ROC) curve.
Univariate analysis was followed by multivariable logistic regression to test the 
association between the RD and delirium, mortality (in-hospital, 3 and 12-month), 
LOS, and ALS at 3 months. In these analyses age, gender, ASA score (I/II versus III/
IV), psychotropic drug use, institutional residence and known dementia were seen as 
possible confounders. The analysis regarding return to the pre-fracture living situation 
was performed on patients that lived independent at home before they broke their hip. 
To this analysis “having a partner” was added as an extra possible confounder.
The likelihood ratio backward test was conducted to find the best-fit model by selecting 
the variables one by one. The probability for entry was set at 0.05, the probability for 
removal at 0.10.
All data were analyzed with SPSS 17.0 (SPSS Inc. Chicago, USA)
results
Patients
In 378 of the 445 patients (85%) the RD-score was completed correctly. A delirium was 
diagnosed in 102 of them (27.0%). Due to the inability of patients to participate or a 
patient-to-nurse ratio that was too high at some moments, the RD-score was incomplete 
or not performed in 67 patients.
These 67 discarded patients, as of an incomplete RD-score, had a delirium incidence 
of 28.4%, not significantly different from study cohort (P = 0.816). Furthermore, there 
was no difference in age (82.4 vs. 83.8 years; P = 0.168), nor LOS (15.0 vs. 13.2 days, P = 








































The mean age of the prospective cohort 2008-2009 (83.7 years) was not significantly 
different from the historical cohort 2005-2007 (82.9 years) (P = 0.082) The percentage 
of male patients was 26.2% in the prospective cohort and 24.3% in the historical cohort 
were the same as well (P = 0.515). No significant differences in delirium incidence were 
found between the prospective 2008/2009 (27%) and the historical cohorts; 2005 (29.0%, 
P = 0.28), 2006 (23.9%, P = 0.81) and 2007 (27.8%, P = 0.44). (Chi Square-test)
rD protocol
The protocol was violated in 49 out of 378 patients (13%); prophylaxis was not started in 
26 patients with a score of ≥ 5 and was started in 23 patients scoring < 5.
Delirium incidence in the 23 low-risk patients was 34.8%, significantly higher than in 
the 182 that were not prescribed prophylaxis, 11.5%. (Pearson Chi-Square, P = 0.003). 
Delirium incidence in the 26 high-risk patients not started on prophylaxis was 50.0%, not 
significantly higher than in the 147 that were prescribed prophylaxis, 40.8%. (Pearson 
Chi-Square, P = 0.38) When the protocol violations were excluded, high-risk patients still 
had a higher risk of delirium (P < 0.001), a longer LOS (P < 0.001) a higher likelihood of 
living at an alternative living situation after 3 months (P = 0.001) and higher mortality 
rates at 3 and 12 months (P < 0.001).
Value of the rD-score
A receiver-operating characteristic (ROC) curve (Figure 1), made of the continuous 
outcome of the RD-score showed an area under curve of 0.722 (CI 0.674-0.767, P < 0.0001) 
The best cut-off point for balancing sensitivity and specificity was 5, corresponding with 
the pre-study chosen cut-off point.
Sensitivity of the cut-off point was 71.6% (73/102), specificity was 63.8% (176/276). 
Excluding patients who were not treated according to the protocol, the sensitivity became 
74.1% (60/81) and the specificity 64.9% (161/248).
The negative predictive value of a score < 5 (i.e. no delirium) was 85.9% (176/205), 





































value for a score of ≥ 5 (i.e. delirium) was 42.2% (73/
173)
High- and low-risk patients
Specific details of 205 low-risk (score < 5) and 173 high-
risk (score of ≥ 5) patients are shown in table 2. High-
risk patients were significantly older, more often female,
suffering from dementia, ASA classification III-IV, hav-
ing no partner, residing in an institution, using psycho-
tropic drugs and receiving spinal/epidural anesthesia
during surgery.
At univariate analysis (table 2), patients with a RD-
score of ≥ 5 had a higher risk for a delirium, (P <
0.001). Furthermore, they had a longer LOS, a higher
chance of living at an alternative living situation after 3
months and a higher 3- and 12-month mortality rate
(all P < 0.001).
Multivariable analysis per outcome variable is dis-
played in table 3. The RD-score was a significantly con-
tributing variable for delirium, length of stay and
alternative living situation at 3 months. Age and ASA
classification were strong independently contributing
variable as well.
Discussion
Identification of hip fracture patients at risk for delirium
is important in order to start early treatment with medi-
cation and psycho-geriatric consultation. Therefore, it is
of great value to have an accurate but simple to use,
screening instrument.
We used the Risk Model for Delirium (RD-score) to
identify patients at risk for delirium and started
prophylactic haloperidol in the high-risk group. Large
differences between high- and low-risk patients regard-
ing delirium incidence, length of stay, discharge location
and mortality were anticipated. However in this study,
prophylactic treatment of high-risk patients as identified
by our RD-score, did not reduce delirium incidence
compared to our historical data. The score did indentify
patients with poorer outcome regarding delirium inci-
dence, LOS and return to pre-fracture living situation.
The RD-score had a moderate sensitivity (71.6%) and
specificity (63.8%), this is in accordance with other risk
models [18]. The negative predictive value (NPV) of a
score < 5 was quite high (85.9%), which is very impor-
tant as a screening instrument should have a high NPV.
The consequence of a false positive test (i.e. prophylactic
treatment with low-dosis haloperidol in a non-delirious
patient) is generally modest as very few side effects of a
low dose of haloperidol can be expected. Therefore, its
moderate positive predictive value (42.2%) is of lesser
importance.
The pre-study chosen cut-off value for the RD-score
of 5 was confirmed to be right by the ROC curve analy-
sis. This cut-off point provided a high-risk group with a
significant higher relative risk of developing a delirium;
OR (adjusted for age and gender) 4.13. Higher age and
ASA classification, residing in an institution and absence
of a partner suggested a higher vulnerability of the high-
risk group. This is demonstrated in outcome; high-risk
patients had a longer hospital stay, higher 3- and 12-
month mortality, and a higher risk of staying at an alter-
native living situation at 3 months in univariate analysis.
In multivariable analysis, the effect of the RD-score for
mortality disappeared.
Several authors described a model that tried to iden-
tify high-risk patients for delirium. One study used a
cohort of vascular surgery patients [18], another major
elective (non-cardiac) surgery patients [15] and 4 others
used cardiac surgery cohorts [19-22]. All these models
contained items that were not applicable to our patients,
while they were patient group specific and designed for
an elective surgery population. Kalisvaart et al [8] used a
population that contained both elective hip surgery and
hip fracture patients. They used visual impairment, dis-
ease severity (expressed by the Apache II score) [23],
mental impairment (Mini Mental State Examination,
MMSE) [24] and dehydration (expressed by blood urea
nitrogen/creatinine ratio) as parameters. We chose to
develop a simpler model that was easy to use in an
acute admission, to achieve maximum use in daily prac-
tice. This has been accomplished; 85% of all patients
had a complete RD-score. Despite the integration of the
RD in a standard patient file, the prophylaxis protocol
was violated in 13% of patients. High turnover of
screening score








Figure 1 ROC curve of the RD-score with 95% confidence
intervals. The diagonal indicate results no better than chance.
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Figure 1 ROC curve of the RD-score with 95% confidence intervals. The diagonal indicate results no 
better than chance.
High- and low-risk patients
Specific details of 205 low-risk (score < 5) and 173 high-risk (score of ≥ 5) patients are 
shown in table 2. High-risk patients were significantly older, more often female, suffering 
from dementia, ASA classification III-IV, having no partner, residing in an institution, using 
psychotropic drugs and receiving spinal/epidural anesthesia during surgery.
At univariate analysis (table 2), patients with a RD-score of ≥ 5 had a higher risk for a 
delirium, (P < 0.001). Furthermore, they had a longer LOS, a higher chance of living at an 
alternative living situation after 3 months and a higher 3- and 12-month mortality rate 
(all P < 0.001).
Multivariable analysis per outcome variable is dis-played in table 3. The RD-score 
was a significantly contributing variable for delirium, length of stay and alternative living 
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table 2 Relative risks for different demographic characteristics and outcome parameters with a RD- 
score ≥ 5 (univariate analysis)
Score ≥ 5 Score < 5 Relative risk (CI) P value
(n = 173) (n = 205)
Age, mean ± SD 86.6 ± 6.5 81.4 ± 7.1 n/a < 0.001***
Female gender 79.2% 69.3% 1.35 (1.01-1.80) 0.029
Dementia 51.4% 0% 3.44 (2.87-4.12) < 0.001
ASA -III-IV 45.7% 22.9% 1.68 (1.36-2.07) < 0.001
Institutional residence 61.8% 10.2% 3.17 (2.54-3.95) < 0.001
Having no partner 79.3% 60.9% 1.74 (1.26-2.41) < 0.001
Psychotropic drug use 51.4% 24.4% 1.82 (1.47-2.25) < 0.001
Fracture type
neck of femur 56.1% 59.0% 0.85*
(inter) trochanteric 39.5% 37.0% 0.95 (0.78-1.15) 0.59**
subtrochanteric 4.4% 4.0%
Treatment
osteosynthesis 60.5% 50.3% 0.077*
(hemi-) arthroplasty 38.5% 46.8% 1.19 (0.98-1.44) 0.072**
conservative 1.0% 9%
Spinal/epidural anesthesia 97.5% 91.1% 2.26 (1.05-4.85) 0.006
Delirium 42.4% 14.1% 1.98 (1.62-2.41) < 0.001
Length of stay ≥ 10 days 65.1% 44.1% 1.61 (1.27-2.05) < 0.001
Alternative living situation at 3 months* 62.3% 17.0% 4.25 (2.65-6.80) < 0.001
In-hospital mortality 5.8% 2.0% 1.60 (1.12-2.26) 0.050
3-month mortality 23.1% 8.3% 1.69 (1.37-2.10) < 0.001
12-month mortality 37.0% 14.6% 1.77 (1.45-2.17) < 0.001
* Only calculated for the patients not yet living in institutions (n = 218, n = 32 missing), * Comparing 
3 treatment groups; ** RR and p-value comparing femur neck with (inter) trochanteric fractures and 





































table 3 Results of the multivariable logistic regression analysis per outcome variable
Outcome variable Independent variables Odds ratio 95% CI P value
Delirium Screening score ≥ 5 4.13 2.43-7.02 < 0.001
Age in years 1.03 0.99-1.07 0.082
Male gender 1.93 1.10-3.39 0.022
Length of hospital stay ≥ 10 days Screening score ≥ 5 1.63 1.03-2.59 0.037
Age in years 1.06 1.03-1.10 < 0.001
ASA III-IV 1.55 0.97-2.47 0.069
Alternative living situation at 3 months Screening score ≥ 5 6.57 3.23.-13.37 < 0.001
Age in years 1.09 1.04-1.06 0.001
In-hospital mortality Age in years 1.14 1.03-1.26 0.014
ASA III-IV 3.83 1.13-13.0 0.031
Institutional residence 3.54 0.89-14.0 0.072
3-month mortality Age in years 1.11 1.05-1.17 < 0.001
ASA III-IV 2.48 1.33-4.61 0.004
Institutional residence 2.97 1.55-5.68 0.001
12-month mortality Age in years 1.08 1.03-1.12 0.002
ASA III-IV 2.78 1.60-4.84 < 0.001
Having no partner 2.22 1.07-4.61 0.033
Institutional residence 2.06 1.16-3.68 0.014
Female, having a partner, ASA I-II, screening score < 5, not residing in an institution are reference 
categories
Discussion
Identification of hip fracture patients at risk for delirium is important in order to start 
early treatment with medication and psychogeriatric consultation. Therefore, it is of great 
value to have an accurate but simple to use, screening instrument.
We used the Risk Model for Delirium (RD-score) to identify patients at risk for delirium 
and started prophylactic haloperidol in the high-risk group. Large differences between 
high- and low-risk patients regarding delirium incidence, length of stay, discharge location 
and mortality were anticipated. However in this study, prophylactic treatment of high-risk 
patients as identified by our RD-score, did not reduce delirium incidence compared to our 
historical data. The score did identify patients with poorer outcome regarding delirium 
incidence, LOS and return to pre-fracture living situation.
The RD-score had a moderate sensitivity (71.6%) and specificity (63.8%), this is in 
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5 was quite high (85.9%), which is very important as a screening instrument should have 
a high NPV. The consequence of a false positive test (i.e. prophylactic treatment with low-
dosis haloperidol in a non-delirious patient) is generally modest as very few side effects 
of a low dose of haloperidol can be expected. Therefore, its moderate positive predictive 
value (42.2%) is of lesser importance.
The pre-study chosen cut-off value for the RD-score of 5 was confirmed to be right 
by the ROC curve analysis. This cut-off point provided a high-risk group with a significant 
higher relative risk of developing a delirium; OR (adjusted for age and gender) 4.13. 
Higher age and ASA classification, residing in an institution and absence of a partner 
suggested a higher vulnerability of the high-risk group. This is demonstrated in outcome; 
high-risk patients had a longer hospital stay, higher 3- and 12-month mortality, and a 
higher risk of staying at an alternative living situation at 3 months in univariate analysis. 
In multivariable analysis, the effect of the RD-score for mortality disappeared.
Several authors described a model that tried to identify high-risk patients for delirium. 
One study used a cohort of vascular surgery patients [18], another major elective (non-
cardiac) surgery patients [15] and 4 others used cardiac surgery cohorts [19- 22]. All these 
models contained items that were not applicable to our patients, while they were patient 
group specific and designed for an elective surgery population. Kalisvaart et al [8] used 
a population that contained both elective hip surgery and hip fracture patients. They 
used visual impairment, disease severity (expressed by the Apache II score) [23], mental 
impairment (Mini Mental State Examination, MMSE) [24] and dehydration (expressed 
by blood urea nitrogen/creatinine ratio) as parameters. We chose to develop a simpler 
model that was easy to use in an acute admission, to achieve maximum use in daily 
practice. This has been accomplished; 85% of all patients had a complete RD-score. 
Despite the integration of the RD in a standard patient file, the prophylaxis protocol was 
violated in 13% of patients. High turnover of doctors in the emergency department may 
have contributed to these violations.
Older age, cognitive impairment, use of psychotropic drugs (for example 
benzodiazepines), functional impairment (both in daily activity and clock drawing) visual 
and hearing impairment were all included parameters that were found to be associated 
with delirium in a systematic review by Dasgupta et al [25]. Besides these, they found 





































and medical co-morbidity to be important delirium risk factors. We used institutional 
residence as a possible confounder in regression analysis, which was of non-significant 
contribution to risk for a delirium. However, it was a strong predictor of mortality at 3 and 
12 months. Psychotropic drug use was associated with a RD-score ≥ 5, but not a predictor 
of delirium or other outcome in multivariable analysis.
Base on our analysis, adding the factor “male gender” to the RD-score might improve its 
efficacy as this was a significant contributor to delirium (OR 1.93). This is in contrast to 
Dasgupta et al [25] who did not find a correlation between male gender and delirium.
Twenty-three low-risk patients were prescribed haloperidol prophylaxis, against 
the protocol. This group had a higher percentage of delirium than the rest of the low-
risk group, which was not hypothesized. The doctor that prescribed haloperidol against 
protocol might be triggered by patient factors that are not taken into consideration by 
the score but that do predispose to a delirium as they have a higher delirium incidence.
The prospective character of the study, its large sample size and the use of a predefined 
risk-stratification model are important issues for interpretation of our results. The main 
limitations are the subjectivity of determining a delirium and mental impairment of a 
patient. In our study, delirium was diagnosed based on clinical examination, as stated 
in the DSM IV [1]. We did not use a measuring instrument like a Confusion Assessment 
Method [7] to establish delirium. A second limitation was, that in cognitively impaired 
patients it is difficult to distinguish between delirium and cognitive impairment. 
Furthermore, patients were scored for known dementia based on history taking and 
information from digital patient files, a cognitive impairment score like the MMSE was 
not used [24]. Another limitation is the comparison of the delirium incidence in the whole 
cohort with the historical cohort. Ideally, we would have compared only the high-risk 
groups of both cohorts. However, we could not identify high-risk patients in the historical 
group as the RD-score was implemented fully in 2008. We did demonstrate that both 
cohorts were comparable regarding mean age and number of male patients, being the 
main risk factors in the multivariable analysis of the prospective cohort, besides a high 
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Haloperidol is widely used for symptomatic treatment of delirium, as prophylaxis it 
has a more disputable reputation. In one small study in gastrointestinal surgery patients, 
haloperidol prophylaxis was proved effective in reducing delirium incidence [26]. However, 
a large study in hip fracture patients [8] did not support this finding. Our protocol was 
developed with the intention to reduce delirium incidence by earlier identification of 
patients at risk with an objective scoring system, the RD-score. Compared to our historical 
data, however, we saw no decline in delirium incidence. This corresponded with a recent 
Cochrane review [27] on interventions preventing delirium. It stated that pro-active 
geriatric consultation could reduce delirium incidence, but that low-dose haloperidol 
prophylaxis did not diminish delirium rates [27]. Kalisvaart et al. [8] showed that low-
dose haloperidol prophylaxis can reduce severity and duration of delirium and that this 
may shorten LOS. During the study period, we started using the Delirium Observation 
Scale [28] to monitor depth and duration of a delirium. However, this instrument was not 
yet used in a consistent way over the study period to take these data in account for this 
analysis. Further research should focus more on depth and duration of delirium instead 
of incidence, since this might give better inside in efficacy of prophylactic treatment. 
We believe that more emphasis should be given on non-pharmalogical interventions to 
prevent a delirium. These interventions include providing orientation with calendars, 
clocks and photographs and maintain day-night rhythm. However, they take valuable 
manpower from the nursing staff. When these interventions can be targeted to the high-
risk group (as identified with the RD-score) it would be preferable.
Conclusions
Prescribing profylactic Haloperidol to high-risk patients as identified by the Risk Model for 
Delirium did not reduce delirium incidence in a cohort of hip fracture patients.
The RD-score did prove to be an accurate tool for indentifying high-risk patients with 
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Objective: The Risk Model for Delirium (RD) score is a 10-item questionnaire that allocates 
hip fracture patients after admission to hospital to be either at high or at low risk for 
delirium. This allows targeted preventive actions. Clinical reliability, validity and feasibility 
of the RD score are discussed.
Methods: Demographic data, RD score and delirium incidence of all consecutive 
admissions for hip fractures in patients 65 years and older were collected. In 102 patients, 
the RD score was repeated. Interobserver reliability and validity were determined. The 
correlation between delirium and items both included and not included in the RD score 
was calculated.
results: A total of 378 patients were included; 102 (27%) were diagnosed with a delirium. 
The intraclass correlation coefficient of the RD score was 0.77 [confidence interval (CI) 
0.68–0.84]. Sensitivity was 80.4% (71.4–87.6), and specificity was 56.2% (50.1-62.1). Area 
under the receiver operating characteristic curve was 0.73 (CI 0.68–0.77). A multivariable 
logistic regression analysis showed that besides the RD score, a trochanteric fracture and 
male gender were independent risk factors for delirium.
Conclusions: The RD score is a reliable, feasible and valid instrument for predicting 







































Delirium in hip fracture patients is a serious complication, leading to higher morbidity 
and mortality [1–4]. A recent Cochrane review states that proactive geriatric consultation 
can reduce delirium incidence [5]. To optimize patient care, it is important to perform 
a preoperative risk assessment in order to target preventive interventions. This risk 
assessment should be simple and brief to increase participation of both patients and 
medical professionals.
Several authors described a model that identifies patients at high-risk for delirium. These 
models were applied in cohorts of vascular surgery patients [6], elective (non-cardiac) 
surgery patients [7] and four cohorts of cardiac surgery patients [8–11]. All these models 
contained items that are not applicable to hip fracture patients. On the contrary, these 
models are not only patient group specific, but are also designed for elective surgery 
patients. Kalisvaart et al. published the outcome of a risk score for delirium in a population 
that contained both elective hip replacement surgery and hip fracture patients [12]. They 
scored visual impairment, disease severity [using the Acute Physiology and Chronic Health 
Evaluation (APACHE) II score] [13], mental impairment [scored with the Mini Mental State 
Examination (MMSE)] [14] and dehydration (expressed by blood urea nitrogen–creatinine 
ratio). We chose to develop a simpler model that is easy to use in an acute admission 
setting to achieve maximum use in daily practice: the Risk Model for Delirium (RD) score. 
Recently, we published the results of the use of the RD score in daily practice [15].




All consecutive admissions for a hip fracture to a 450-bed Dutch teaching hospital 
between January 2008 and December 2009 were registered prospectively. This was part 
of daily care and monitoring according to our local hip fracture protocol [16]. Patients of 





































Sixty-seven patients were excluded because the RD score was not completed 
sufficiently. Final analysis was therefore performed in 378 patients with a mean (S.D.; 
range) age of 83.8 (7.3; 65–101) years; 279 (73.8%) were female.
Failure to complete the RD score was mainly because of lack of time of medical 
personnel at the emergency department (ED) or refusal of patients to cooperate. The 
excluded patients had a delirium incidence of 28.4%, not significantly different from the 
included study cohort (27%, P=.82). Furthermore, there was no difference in mean (S.D.) 
age between these groups [82.4 (7.4) vs. 83.8 (7.3) years; P=.17].
The following baseline characteristics were collected at admission: age, gender, 
presence of a partner, presence of dementia, pre-fracture living situation, American 
Society of Anaesthesiologists (ASA) physical status classification, psychotropic drug use 
(antidepressant, antipsychotic or any form of tranquillizer), RD score, type of fracture, 
hip fracture treatment, type of anesthesia and occurrence of a delirium during admission 
[17]. Presence of dementia was determined upon history taking from patients, families 
and caretakers. Ward nurses observe patients three times a day for clinical signs of a 
delirium as described in the Diagnostic and Statistical Manual of Mental Disorders, Fourth 
Edition
(DSM-IV) criteria [18]. Symptoms of a delirium were registered in both the medical and 
nursing staff records. Directly after discharge, both records were examined independently 
by two authors (S.M. and A.V.) to register prevalence of a delirium. In case of doubt (36 
patients), a psychiatrist was consulted, who diagnosed a delirium in 27 patients.
RD score
The RD score was developed in 2004 by the Department of Psychiatry of the Reinier de 
Graaf Hospital, Delft, the Netherlands [15]. At that moment, the most important known 
risk factors for a delirium were used in the RD score [7,19–24]. Fig. 1 shows the score, its 
items and the value assigned to the specific item. Predisposing, instead of precipitating, 
factors were selected while these are present at admission and more easy to use. Points 
assigned to each item were derived from the relative risk of that factor to develop a 
delirium [7,19–24]. Based on the clinical experience, patients with a score of 5 or more 
points were considered to be high-risk patients. At admission at the ED, nurses (or doctors) 
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to the hospital’s delirium protocol, high-risk patients (with a score of 5 or more points) 
received two times daily 1 mg of haloperidol as delirium prevention (in case of absence of 
contraindications). Independent of the RD score, all patients were monitored for delirium 
during hospitalization as described above. When patients developed a delirium, they 
were fully clinically assessed to exclude a somatic cause and treated in collaboration with 
the psychiatric department.
Predisposing risk factors for delirium Points
Delirium during previous hospitalization 5
Dementia 5
Clock drawing (displaying 10 past 11)
- Small mistakes 1
- Big mistakes, unrecognizable or no attempt 2
Age
- 70 to 85 years 1
- Older than 85 years 2
Impaired hearing (patient is not able to hear speech) 1
Impaired vision (vision less than 40%) 1
Problems in activities of daily live
- Domestic help or help with meal preparation 0.5
- Help with physical care 0.5
Use of heroin, methadone or morphine 2
Daily consumption of 4 or more alcoholic beverages 2
Total score
Figure 1. The Risk Model for Delirium.
In 102 patients, the ward nurse at the orthopaedic department performed the RD score 
a second time when the patient and his or her family arrived on the ward. These 102 
patients together with the raters [both ED and ward nurses (doctors)] were selected 
randomly. Ward and ED nurses (or doctors) completed the score independent of each 
other. We used these independently executed RD scores to calculate the interobserver 
variability.







































All items of the questionnaires were imported into IBM SPSS Statistics 19. (IBM 
Corporation, Somers, NY, USA)
Clinical reliability
The clinical reliability of the RD score was analyzed using the intraclass correlation 
coefficient (ICC) and the kappa coefficient. The ICC and the kappa coefficient are measures 
of the interobserver reliability, which assesses the degree in which observers assign the 
same ratings. Values of 0–0.20 were regarded as slight agreement, 0.21–0.40 as fair, 
0.41–0.60 as moderate, 0.61–0.80 as substantial and 0.81–1 as almost perfect agreement 
[25]. As a measure of test–retest agreement, the standard error of measurement was 
calculated by dividing the mean difference in score between the initial test and the retest 
by the square root of 2 [26]. The standard error of measurement must be interpreted 
in relation to the mean. To account for this relationship, the coefficient of variation was 
calculated. In order to test the validity of the results of this retrospective analysis of the 
RD score, a post hoc power analysis was performed. A sample size of 70 subjects with 
two observations per subject achieved an 84% power to detect an ICC of 0.70 under the 
alternative hypothesis when the ICC under the null hypothesis is 0.50 using an F-test with 
a significance level of .05 (calculated with PASS 2008, version 08.05).
Validity
A receiver operating characteristics curve (ROC) was created by plotting the sensitivity 
(true-positive rate) versus the 1−specificity (false-positive rate). The actual area under 
the ROC (AUROC) measures the ability of the instrument to classify correctly the patients 
with and without a high risk for delirium to identify the best cutoff point.
The percentages of scores below 5 and above 14 for the RD score were calculated to 
assess floor and ceiling effects.
Test items statistics
Reliability of the individual items of the RD score was expressed using the ICC of these 
items. Spearman correlation coefficient was calculated between items of the RD score 
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odds ratio (OR) of each score item for the prevalence of a delirium was calculated using 
logistic regression analysis with the score items separately as independent variables. To 
test whether risk factors other than the RD score items would improve the risk model, 
a multivariable logistic regression was repeated with the RD score dichotomized in high- 
(score≥4) and low-risk (score<4) patients. The items age, gender, ASA score, fracture type, 
psychotropic drug use, presence of a partner and institutional residence were used as 
possible predictors for delirium [27,28]. Based on the ROC curve analysis, the optimal 
cutoff point of the RD score was considered to be 4 instead of the clinical cutoff of 5 
points. The likelihood ratio backward test was conducted to find the best-fit model by 
selecting the variables one by one. The probability for entry was set at .05, and the 
probability for removal at .10.
Feasibility
To assess the clinical feasibility, all the RD score sheets were evaluated for errors in 
interpreting or skipping items and summation of the individual item scores.
results
Patients
Final analysis was performed in 378 patients; 110 (29.1%) had a partner at admission, 83 
(22%) suffered from dementia, 250 (66.1%) lived noninstitutionalized, 252 (66.7%) had an 
ASA classification of I/II, and 124 (32.8%) used psychotropic drugs.
The mean (S.D.) RD score was 4.9 (3.7), 221 (58.5%) patients were classified as low 
risk (<5 points), and 157 (41.5%) patients were classified as high risk (≥5 points) based on 
the clinical cutoff point. Delirium was diagnosed in 102 (27%) patients, 29 (14.1%) in the 
low-risk and 73 (42.4%) in the high-risk group.
Clinical reliability
In 102 patients (26.9%), an independent nurse performed the RD score for the second 
time. The ICC for a single measure was 0.77 (90% CI 0.68–0.84). ICC for an average measure 





































of these 102 duplicate tests was 1.73. The coefficient of variation of the standard error 
of measurement was 29.4%. RD scores ranged from 0 to 17 points. The RD score was 5 
points or less in 56.6% of all patients (i.e., clear floor effect); 2.4% of the cohort scored 15 
points or more (i.e., no ceiling effect).
Validity
Fig. 2 shows the ROC; the AUROC was 0.73 (95% CI 0.68–0.77), and the best cutoff point 
for balancing sensitivity and specificity was 4 points. This was different from the cutoff 
point of 5 points that was used in daily practice to define high-risk patients.
of 0–0.20 were regarded as slight agreement, 0.21–0.40 as
fair, 0.41–0.60 as moderate, 0.61–0.80 as substantial and
0.81–1 as almost perfect agreement [25]. As a measure of
test–retest agreement, the standard error of measurement
was calculated by dividing the mean difference in score
between the initial test and the retest by the square root of 2
[26]. The standard error of measurement must be
interpreted in relation to the mean. To account for this
relationship, the coefficient of variation was calculated. In
order to test the validity of the results of this retrospective
analysis of the RD score, a post hoc power analysis was
performed. A sample size of 70 subjects with two
observations per subject achieved an 84% power to detect
an ICC of 0.70 under the alternative hypothesis when the
ICC under the null hypothesis is 0.50 using an F-test with a
significance level of .05 (calculated with PASS 2008,
version 08.05).
2.3.2. Validity
A receiver operating characteristics curve (ROC) was
created by plotting the sensitivity (true-positive rate) versus
the 1−specificity (false-positive rate). The actual area under
the ROC (AUROC) measures the ability of the instrument to
classify correctly the patients with and without a high risk for
delirium to identify the best cutoff point.
The percentages of scores below 5 and above 14 for the
RD score were calculated to assess floor and ceiling effects.
2.3.3. Test items statistics
Reliability of the individual items of the RD score
was expressed using the ICC of these items. Spearman
correlation coefficient was calculated between items of
the RD score and the occurrence of delirium to
determine the convergent validity. Furthermore, the
odds ratio (OR) of each score item for the prevalence
of a delirium was calculated using logistic regression
analysis with the score items separately as independent
variables. To test whether risk factors other than the RD
score items would improve the risk model, a multivar-
iable logistic regression was repeated with the RD score
dichotomized in high- (score≥4) and low-risk (scoreb4)
patients. The items age, gender, ASA score, fracture
type, psychotropic drug use, presence of a partner and
institutional residence were used as possible predictors
for delirium [27,28]. Based on the ROC curve analysis,
the optimal cutoff point of the RD score was considered
to be 4 instead of the clinical cutoff of 5 points. The
likelihood ratio backward test was conducted to find the
best-fit model by selecting the variables one by one. The
probability for entry was set at .05, and the probability
for removal at .10.
2.3.4. Feasibility
To assess the clinical feasibility, all the D score sheets
were evaluated for errors in interpreting or skipping items
and summation of the individual item scores.
3. Results
3.1. Patients
Final analysis was performed in 378 patients; 110
(29.1%) had a partner at admission, 83 (22%) suffered
from dementia, 250 (66.1%) lived noninstitutionalized, 252
(66.7%) had an ASA classification of I/II, and 124 (32.8%)
used psychotropic drugs.
The mean (S.D.) RD score was 4.9 (3.7), 221 (58.5%)
patients were classified as low risk (b5 points), and 157
(41.5%) patients were classified as high risk (≥5 points)
based on the clinical cutoff point. Delirium was diagnosed in
102 (27%) patients, 29 (14.1%) in the low-risk and 73
(42.4%) in the high-risk group.
3.1.1. Clinical reliability
In 102 patients (26.9%), an independent nurse performed
the RD score for the second time. The ICC for a single
measure was 0.77 (90% CI 0.68–0.84). ICC for an average
measure of the two observers was 0.87 (90% CI 0.81–0.91).
The standard error of measurement of these 102 duplicate
tests was 1.73. The coefficient of variation of the standard
error of measurement was 29.4%. RD scores ranged from
0 to 17 p in s. Th RD score was 5 points or le s in 56.6% of
all patients (i.e., clear floor effect); 2.4% of the cohort scored
15 points or more (i.e., no ceiling effect).
3.1.2. Validity
Fig. 2 shows the ROC; the AUROC was 0.73 (95% CI
0.68–0.77), and the best cutoff point for balancing
sensitivity and specificity was 4 points. This was different
from the cutoff point of 5 points that was used in daily
practice to define high-risk patients.
The ability to predict a delirium for cutoff points of 4 and
5 is shown in Table 1. The likelihood ratio of an RD score≥4
was 1.86, which means that the probability of a score≥4
being associated with delirium is 1.86 times higher than the














Fig. 2. ROC curve of the RD score with 95% CIs. The diagonal indicate
results no better than by chance.
3S. Moerman et al. / General Hospital Psychiatry xx (2012) xxx–xxx
Figure 2. ROC curve of the RD score with 95% CIs. The diagonal indicate results no better than by 
chance.
The ability to predict a delirium for cutoff points of 4 and 5 is shown in Table 1. The 
likelihood ratio of an RD score≥4 was 1.86, which means that the probability of a score≥4 
being associated with delirium is 1.86 times higher than the probability of this outcome to 
be associated with no delirium. The likelihood ratio of an RD score<4 was 0.33, meaning 
that the probability of having <4 points and a delirium is 0.33 less than the probability of 
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table 1 Results of the validity analysis of the RD for two cutoff points of the RD score
≥4 points ≥5 points
Sensitivity % (CI) 81.4 (72.2–88.1) 68.6 (58.6–77.3)
Specificity % (CI) 56.2 (50.1–62.1) 66.3 (60.4–71.8)
Positive predictivity % (CI) 40.7 (33.9–47.8) 42.9 (35.3–50.9)
Negative predictivity % (CI) 89.1 (83.2–93.1) 85.1 (79.5–89.5)
Likelihood ratio positive 1.86 (1.6–2.2) 2.04 (1.6–2.5)
(sens/1−spec)
Likelihood ratio negative 0.33 (0.2–0.5) 0.47 (0.4–0.6)
(1−sens/spec)
Correlation with delirium 0.33 0.31
CI=90% confidence interval.
Test items included in the RD
The RD score of all patients was analyzed per item as scored on the form. The prevalence 
of the following risk factors for a delirium was as follows: a delirium during a previous 
hospitalization was found in 50 patients (13.2%), 87 patients (23%) suffered from 
dementia, 89 patients (28.6%) made small mistakes, and 99 patients (33.7%) made 
big mistakes during clock-drawing. An impaired hearing was scored for in 100 (26.5%) 
patients, an impaired vision in 66 (17.5%), 214 patients (56.6%) needed help with the 
preparation of their meals or help for domestic work, and 158 patients (41.8%) received 
help with physical care. Nine patients (2.4%) had a daily consumption of more than four 
alcoholic beverages, and only five (1.3%) used heroin, methadone or morphine.
The reliability (ICC and kappa) of the items of the RD score is displayed in Table 2. The 
reliability of dementia was almost perfect: an ICC and kappa of 0.86. The use of heroin, 
methadone or morphine showed only a slight reliability (ICC and kappa of 0.01).
The correlations between delirium and items in the RD score expressed in OR are 
displayed in Table 2. Table 3 shows the correlation between the items and delirium 
expressed in ICCs. “Impaired hearing,” “impaired vision,” “use of heroin, methadone or 
morphine” and “daily consumption of four or more alcoholic beverages” had no significant 
correlation (both the ICC and OR) with delirium.
In the multivariable logistic regression analysis, an RD score of ≥4 (OR 7.1, CI 3.87–
13.02, P<.001), a trochanteric fracture (OR 1.79, CI 1.07–3.01, P=.03) and male gender 































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































In 378 out of 445 patients (84.9%), the RD score was completed sufficiently. In some of 
these scores, mistakes were made in interpreting or skipping items and summation of 
the individual item scores. As a result of this, nine patients were categorized in the wrong 
group; four should have been qualified as low-risk instead of high-risk patients, and five 
vice versa.
Interpretation of the form and specific items
In nine patients who lived in a nursing home, no points were assigned for help with meal 
preparation or domestic help, or for help with physical care. None of these patients 
would have shifted to another risk group if corrected. In two patients that suffered from 
dementia according to the medical records, no points were assigned for this item, and in 
five patients who did receive points for dementia, this diagnosis was not mentioned in 
their medical records. Correcting for this error would lead to a shift of two patients from 
low to high risk and five from high to low risk. In 22 patients, the points for age were not 
correctly assigned; 17 patients were appointed too few points, the other five too many. 
Three of these patients would be treated as high-risk patients instead of low-risk patients 
if the age points had been assigned correctly. One patient would shift to the low- from 
the high-risk group.
Skipping items
In 84 (22.2%) patients, the clock-drawing part of the RD score was not completed, and 
no points were assigned to this item. In 47 of the 84 patients, an RD score of more than 
5 points was already achieved based on the other items. In eight patients with no points 
on any other items on the RD score, clock-drawing was not performed; therefore, it was 
without consequences for shifting to the high-risk group. In the other patients that did 
not perform the clock-drawing, nine would have shifted to the high-risk group if they 







































In six patients, errors were made in summation of the points of the individual score 
items; two patients were treated as low-risk patients while they were actually high-risk 
patients. In the other four patients, the summation error had no consequence. Three 
other patients were assigned 1 point for, respectively, delirium or dementia (instead of 5 
points). This had no consequence for the risk group that they were assigned to originally.
Discussion
In this paper, we analyze the validity of the RD score, a valuable new risk model for 
delirium in hip fracture patients. The RD score showed good reliability and validity. 
Furthermore, its clinical feasibility was reasonable, with an acceptable participation rate 
in daily use. The validity of the RD score was improved by adding the items “male gender” 
and “type of fracture” and removing the items “daily consumption of more than four 
alcoholic beverages” and “use of heroin, methadone or morphine.”
The RD score had a good interobserver agreement, which improved when a second 
observer was added. However, in daily practice, the distinction between two groups 
(i.e., low-or high-risk patients) with a single observer will suffice. In this population of 
hip fracture patients, the RD score had a clear floor effect; thus, it is not very sensitive 
to detect a delirium risk in patients with a low score (i.e., low risk). An explanation might 
be that the delirium incidence in our cohort (27%) was too low to differentiate between 
patients at risk or not at risk for delirium in this low-risk group. Another explanation might 
be that the current RD score items are not sensitive enough to differentiate for the risk of 
developing delirium in low-risk patients. The RD score could be improved by adding more 
relevant risk factors in order to diminish this floor effect, as is discussed below.
As for validity, the RD score had a high sensitivity and a moderate specificity using 
the optimum cutoff level of 4 points. The AUC was moderate, and the negative predictive 
value was high; thus, the RD score is suitable as a screening tool for evaluation of the risk 
for delirium in this patient group. The moderate specificity is of less clinical importance 





































All items of the RD score, as well as potential new items (like gender and type of 
fracture), were evaluated for their individual effect (i.e., multivariable regression 
analysis) on the presence of delirium, as was their correlation with each other. The item 
“dementia” of the RD score showed high correlations with the prevalence of delirium 
and with the other RD score items and thus severely influenced the RD score. Two items 
of the RD score could be removed (“use of heroin, methadone or morphine” and “daily 
consumption of four or more alcoholic beverages”). These two items were only scored 
positive in a very low number of hip fracture patients and had no significant correlation 
with the occurrence of a delirium. Two new items (“male gender” and “trochanteric 
fracture”) were added to improve the model. This is in contrast to two meta-analyses on 
delirium which report no or “a non-convincing” correlation between male gender and 
presence of delirium [27,28]. Two other studies did find a negative correlation between 
male gender and delirium [29,30]. However, the individual effect of these two items on 
occurrence of a delirium was smaller than the compound of a high RD score (i.e., 4 and 
more points). As for the effect of “fracture type,” none of the meta-analyses did include 
this risk factor [27,28].
The items of the RD score can easily determined at the ED in an interview with both 
patients and family or caregivers. Adherence to the RD score protocol was good (85%). Of 
the 15% of all RD scores that were not completed, clock-drawing was the most frequently 
not-completed item. Since painful hip fracture patients are in a supine position on a 
stretcher and often have an additional injury to the dominant arm, drawing might be 
difficult. Furthermore, half of the non-completed clock-drawings were found in patients 
that already scored into the high-risk group (4 and more points) due to the other RD 
score risk items. Nevertheless, clock-drawing had a reasonable reliability and correlates 
with delirium. Therefore, better scoring of this item will be facilitated with the addition 
of a short manual explaining the necessity to have the clock-drawing performed by each 
patient.
Several risk models for delirium have previously been published [6–12,31]. However, 
they contained items that were not applicable to hip fracture patients since they were 
either specific for a certain patient group [medical ward, (cardio)vascular surgery] or 
designed for elective admissions. Furthermore, some items of these models take time 
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[12–14]. The RD score is a relatively simple model that works in daily practice and has 
now been validated for acute admissions of hip fracture patients.
The prospective study design, large sample size and the use of a predefined risk 
stratification model are important issues for interpretation of our results. A substantial 
amount of the RD scores was repeated; thus, reliability could be calculated. However, 
two limitations remain. The main limitation is the diagnosis of presence of a delirium and 
mental impairment, this despite the fact that in this study delirium was diagnosed based 
on the DSM-IV classification [18]. We did not use a specific instrument like the Confusion 
Assessment Method to establish delirium [32]. Furthermore, presence of dementia was 
based on history taking; a cognitive impairment score like the MMSE was not used [14].
High-risk patients were treated with prophylactic low-dose haloperidol. A recent 
Cochrane review, a randomized controlled trial of Kalisvaart et al. and our clinical series 
demonstrated that haloperidol did not have a diminishing effect on delirium incidence 
[5,15,33]. Therefore, prophylactic haloperidol most probably did not influence the results 
of the present study. However, labeling patients as “high-risk” might bias the nursing 
staff; they might be triggered to observe patients more closely for presence of a delirium. 
Discarding patients because of an incomplete RD score could potentially have influenced 
our outcome. However, this is highly unlikely since the incidence of delirium and the age 
of these patients were comparable to the evaluated cohort. Finally, we decided to correct 
errors in summation and errors as a consequence of not assigning the right amount of 
points to a specific item. This was only necessary in a limited number of cases, which 
emphasizes the clinical usefulness of the RD score.
Conclusions
The RD score is a recently introduced score that determines the risk for a delirium in 
hip fracture patients. It has a reasonable clinical feasibility and a good reliability and 
validity. It would be of additional value to adjust the model by adding “male gender” 
and ‘trochanteric fracture’ and removing “daily consumption of more than four alcoholic 
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Purpose This paper reports on the development and validity of a new instrument, called 
the discharge of hip fracture patients score (DHP), that predicts at admission the discharge 
location in patients living in their own home prior to hip fracture surgery.
Methods A total of 310 patients aged 50 years and above were included. Risk factors for 
discharge to an alternative location (DAL) were analysed with a multivariable regression 
analysis taking the admission variables into account with different weights based on the 
estimates. The score ranged from 0–100 points. The cut-off point for DAL was calculated 
using a ROC analysis. Reliability of the DHP was evaluated. Results Risk factors for DAL 
were higher age, female gender, dementia, absence of a partner and a limited level of 
mobility. The cut-off point was set at 30 points, with a sensitivity of 83.8%, a specificity of 
64.7% and positive predictive value of 79.2%.
Conclusion The DHP is a valid, simple and short instrument to be used at admission to 
predict discharge location of hip fracture patients.
abbreviations
DHP Discharge of hip fracture patients score
DAL Discharge to an alternative location
ASA American Society of Anesthesiologists
LOS Length of stay
GARS Groningen activity restriction score











































The number of hip fracture patients is growing. It has been estimated that the total 
number of hip fracture patients aged 50 years and older will be around 6.3 million by 
2050 worldwide [ 1, 2].
Traditionally, the focus of research on hip fracture patients has focussed on technical 
aspects, morbidity and mortality. However, in the last two decades social morbidity due to 
a more limited level of activities of daily living, loss of independence and a sudden change 
in place of residence has increasingly become the subject of research. Furthermore, costs 
of caring for this fragile population are rising [ 3, 4].
Discharge to an alternative location (DAL) or the necessity to arrange additional 
postoperative care at home for those that can go home directly after discharge can 
contribute to a longer stay in hospital and thus create additional costs [ 3, 4]. Early planning 
of the date of discharge and the type of discharge location can reduce these costs [ 4– 
6]. An instrument that predicts the discharge location at the time of admission would 
therefore be of great importance, not only for the liaison service but also for patients and 
their family. Although there are some publications about risk factors for DAL [ 7– 11], few 
discharge prediction scores for hip fracture patients have been published [ 12– 14]. These 
scores are of limited value in current daily practice as they are either relatively old, time 
consuming to fill out or not applicable at admission.
In this paper we offer a new instrument, the discharge of hip fracture patients score 
(DHP), that predicts on admission, the discharge location in patients living in their own 
home prior to admission for a hip fracture.
Methods
Patients
This is an analysis of a series of 498 consecutive hip fracture patients aged 50 years and 
older admitted to a 450-bed teaching hospital (Delft, The Netherlands) between January 
2008 and December 2009. Patients with a fracture due to a high-energy trauma or with 





































home prior to admission (n=336) were included. Patients who were treated conservatively 
(n=8), those with incomplete data (n=11) and those who died during hospital stay (n=7) 
were excluded from this group. Thus, 310 patients with complete data were analysed.
Data collection
Uniform collection and recording of data of all patients was achieved by routine evaluation 
at admission, according to the standardised care pathway for hip fracture patients.
Demographic data collected were age, gender, presence of a partner and discharge 
location.
Characteristics obtained during hospital stay were American Society of 
Anesthesiologists (ASA) Physical Status classification, presence of dementia based upon 
history taking from patients, families and carers, presence of anaemia on admission 
based on the criteria of the World Health Organisation (haemoglobin level below 7.5 
mmol/L [12 g/dL] in women and below 8.1 mmol/L [13 g/dL] in men), level of mobility 
and activities of daily living, type of fracture (intra- or extracapsular hip fracture), type 
of fracture treatment (osteosynthesis or arthroplasty), type of anaesthesia (general or 
spinal), diagnosis of dementia based on criteria of the DSM IV and length of stay (LOS) [ 
15, 16].
Pre-fracture level of mobility and activities of daily living
The level of mobility was divided into four main categories: mobile without the use of an 
aid in- and outdoors, mobile in-and outdoors with the use of an aid in- and/or outdoors, 
only mobile indoors (regardless of the use of an aid) and the last group was immobile 
both in- and outdoors. A cane, crutch (es) or walker were all considered an aid, patients 
in a wheelchair were considered to be immobile.
The Groningen activity restriction score (GARS) is a functional activities of daily 
living (ADL) score [ 16]. A summed score for basic ADL was calculated ranging from 
18 (indicating ability to perform all activities without assistance or undue effort) to 72 







































Demographic continuous data are presented as means, with standard deviations (SD). 
Categorical data are presented as the number of subjects in the category, along with 
the percentages. A multivariable logistic regression analysis was used for analysis of 
patients that were discharged from hospital to an alternative location. As we wanted an 
instrument that predicted discharge to an alternative location (DAL) at admission, we 
used risk factors in the multivariable analysis that were known at admission: age, gender, 
presence of a partner, perioperative risk (ASA classification I/II or III/IV), presence of 
dementia, anaemia at admission, pre-fracture level of mobility (using the three categories 
of mobility and the GARS) and type of fracture (intra- or extracapsular hip fracture).
Patients classified ASA I or II and III or IV were combined into two groups, as the 
separate numbers of patients classified ASA I (n=41) and ASA IV (n=9) were too small to 
be analysed separately. Age was categorised into three groups: 50–64.9 years old, 65–
79.9 years old and 80 years old and above.
For the multivariable logistic regression analysis, immobile patients (n=3) were 
excluded due to small numbers.
The likelihood ratio backward test was used to find the best-fit model by selecting the 
variables one by one. The probability for entry was set at 0.05, and the probability for 
removal at 0.10. P-values lower than 0.05 were considered statistically significant.
Discharge of hip fracture patients score (DHP)
All significant risk factors from the multivariable logistic regression analysis were used in 
the model as score items. Each item was assigned a weighing factor based on the beta-
coefficient, in such a way that the score added up to a maximum of 100 points. As the 
subcategory “immobile” was excluded from this analysis, this item was assigned the same 
weighing factor as the “only mobile indoors” category.
Clinical reliability and validity
A receiver operating characteristics curve (ROC) was created by plotting the sensitivity 
(true positive rate) versus the 1-specificity (false positive rate). The actual area under the 
curve measures the ability of the instrument to classify correctly the patients with and 






































The percentages of scores below 10 and above 90 points were calculated to assess 
floor and ceiling effects.
Spearman’s correlation coefficient was calculated between items of the DHP and DAL 
to determine the convergent validity. All data were analyzed in IBM SPSS Statistics 19.0 
(SPSS Inc., Chicago, USA).
results
Patients
Table 1 shows clinical characteristics of the cohort, stratified by discharge location. 
The mean (SD) age of all patients was 78.5 (10.5) years, and 67.1% were female. One 
hundred and nineteen (38.3%) patients were directly discharged from hospital to their 
own home. These patients were younger, less often female and in better general medical 
and social condition compared to those who were discharged to an alternative location. 
Furthermore, they had a shorter LOS.
Discharge of hip fracture patients score (DHP)
Based on outcome of the multivariable logistic regression analysis (Table 2), the model 
for the DHP (Table 3) was developed. Age (categorised in three groups), female gender, 
dementia, absence of a partner and a more limited level of mobility were used as score 
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table 1 Clinical characteristics of the whole cohort and stratified by discharge location
Characteristics Cohort Discharge location P-valuea
Own home Alternative location
n=310 n=119 n=191
Age category <0.001
50–64 years old 45 (14.5) 36 (30.3) 9 (4.7)
65–79 years old 107 (34.5) 54 (45.4) 53 (27.7)
≥80 years old 158 (51.0) 29 (24.4) 129 (67.5)
Female gender 208 (67.1) 63 (52.9) 145 (75.9) <0.001
Dementia 29 (9.4) 28 (14.7) 1 (0.8) <0.001
Partner at admission 174 (56.1) 44 (37.0) 130 (68.1) <0.001
ASA classification III/IV 78 (25.2) 20 (16.8) 58 (30.4) 0.007
Anaemia at admission 100 (32.3) 28 (23.5) 72 (37.7) 0.009
Pre-fracture mobility <0.001
Without an aid 164 (52.9) 92 (77.3) 72 (37.7)
With an aid 127 (41.0) 26 (21.8) 101 (52.9)
Only mobile indoors 16 (5.2) 0 (0.0) 16 (8.4)
Immobile 3 (1.0) 1 (0.8) 2 (1.0)
Mean GARS (SD) 32.8 (14.7) 24.8 (11.2) 37.8 (14.4) <0.001
Intracapsular hip fracture 192 (61.9) 87 (73.1) 105 (55.0) 0.001
Osteosynthesis 195 (62.9) 88 (73.9) 107 (56.0) 0.001
Spinal anaesthesia 297 (95.8) 116 (97.5) 181 (94.8) 0.383
Mean LOS, days (SD) 12.3 (9.2) 8.6 (6.5) 14.6 (9.8) <0.001
LOS length of stay, GARS Groningen activity restriction score, ASA American Society of 
Anesthesiologists Physical Status classification
Values are given as number (percentage) if not stated otherwise
a Bivariate analysis
table 2 Risk factors identified for discharge to an alternative location, as identified with multivariable 
logistic regression analysis
Risk factors Beta coefficient OR 95 % CI P-value
Age categorya
65-79.9 years 1.32 3.76 1.48–9.55 0.005
≥80 years 2.28 9.78 3.68–25.98 <0.001
Female gender 0.79 2.20 1.21–4.02 0.010
Dementia 2.30 9.98 1.23–80.85 0.031
Absence of a partner 0.87 2.39 1.33–4.29 0.004
Mobility categoryb
Mobile with an aid 0.848 2.33 1.25–4.35 0.008
Only mobile indoors 3.58 35.9 3.68–350.1 0.002
OR odds ratio, CI confidence interval
a 40–64.9 years (for age category) 





































table 3 Discharge of hip fracture patients score








Absence of a partner 10
Mobility at admission
Mobile in- and outside without an aid 0
Mobile in- and outside with an aid for either one or both 10
Only mobile indoors 40
Immobile 40
Total score
Clinical reliability and validity
The ROC curve of the DHP is demonstrated in Fig. 1, where the area under the curve was 
0.84 (95% CI 0.79–0.88). The best cut-off point for balancing sensitivity and specificity 
was 30 points. Sensitivity and specificity of the DHP at this cut-off point were 83.8% and 
64.7%; the positive predictive value was 79.2%. The predictive power for two cut-off 
points (≥30 and ≥40 points) is shown in Table 4. The likelihood ratio of a DHP ≥30 was 
2.37, which means that the probability of a score of ≥30 points being associated with 
DAL is 2.4 times higher compared to the probability that the patient is discharged to his 
or her own home.
table 4 Results of the validity analysis of the prediction model for failure to return to own home at 
discharge
Measurement ≥30 points ≥40 points
Value 95 % CI Value 95 % CI
Sensitivity %, (CI) 83.8 77.8–88.7 67.0 59.9–73.6
Specificity %, (CI) 64.7 55.4–73.2 84.0 76.2–90.1
Positive predictivity %, (CI) 79.2 72.8–84.4 87.1 80.3–91.8
Negative predictivity %, (CI) 71.3 61.7–79.4 61.3 53.4–68.8
Likelihood ratio positive (sens/1-spec) 2.37 2.0–2.7 4.20 3.7–4.8
Likelihood ratio negative (1-sens/spec) 0.25 0.20–0.40 0.39 0.20–0.60
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Table 5 shows correlations, expressed with Spearman
correlation coefficient, between DAL and the items of the
DHP and the correlation between the items themselves. All
items had a significant correlation with DAL, indicating
good convergent validity.
The DHP scores ranged from zero to 90 points. The score
was 10 or less points in 39 (16.1%) patients, thereby the floor
effect was small. ADHP score of 90 points or more was present
in only three (1.0%) patients, thus no ceiling effect was present.
Discussion
A new prediction score for the discharge location of hip
fracture patients living in their own home prior to admission
was developed called the discharge of hip fracture patients
score (DHP). This score was established using significant
risk factors from multivariable regression analysis for failure
to return to their own home: higher age, female gender,
dementia, absence of a partner and a lower level of mobility.
The score was easy to use due to readily obtainable data at
admission and it had a good sensitivity and acceptable
specificity.
The DHP can be used to facilitate the work of the liaison
officers to make early arrangements for discharge, i.e. finding
an appropriate alternative location or provide extra facilities
(e.g. a walker or Zimmer frame, toilet seat risers, domestic
help) needed in the first period after discharge. This can
reduce LOS substantially [4–6].
Patients
Mean age, the male to female ratio and fracture distribu-
tion of our series were comparable to a large cohort study
of 3,683 hip fracture patients [17]. Another large series
(3,240 patients) of Deakin et al. found a comparable mean
age and percentage of patients living in their own home
prior to admission [8]. The cohort we analysed was there-
fore representative for a general hip fracture population in
Europe.
Risk factors
We identified higher age, female gender, dementia, absence
of a partner and a lower level of mobility as risk factors for
Table 2 Risk factors identified for discharge to an alternative location,
as identified with multivariable logistic regression analysis
Risk factors Beta coefficient OR 95 % CI P-value
Age categorya
65-79.9 years 1.32 3.76 1.48–9.55 0.005
≥80 years 2.28 9.78 3.68–25.98 <0.001
Female gender 0.79 2.20 1.21–4.02 0.010
Dementia 2.30 9.98 1.23–80.85 0.031
Absence of a partner 0.87 2.39 1.33–4.29 0.004
Mobility categoryb
Mobile with an aid 0.848 2.33 1.25–4.35 0.008
Only mobile indoors 3.58 35.9 3.68–350.1 0.002
OR odds ratio, CI confidence interval
a 40–64.9 years (for age category)
b mobile without an aid (for mobility category)
Table 3 Discharge of hip fracture patients score









Absence of a partner 10
Mobility at admission
Mobile in- and outside without an aid 0
Mobile in- and outside with an aid for either one or both 10
Only mobile indoors 40
Immobile 40
Total score
Prediction score for failure to return to their own home













Fig. 1 Receiver operating characteristic (ROC) curve of the prediction
score with 95% confidence intervals. The diagonal indicates results no
better than by chance
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Figure 1. Receiver operating characteristic (ROC) curve of the prediction score with 95% confidence 
intervals. The diagonal indicates results no better than by chance
Table 5 shows correlations, expressed with Spearman correlation coefficient, between 
DAL and the ite s of the DHP and the correlation between the items themselves. All 
items had a significant correlation with DAL, indicating good convergent validity.
The DHP scores ranged from zero to 90 points. The score was 10 or less points in 39 
(16.1%) patients, thereby the floor effect was small. A DHP score of 90 points or more was 





































table 5 Spearman’s correlation coefficient between discharge to an alternative location and the 
items of the discharge in hip fracture patients score and between the items themselves
Measurement DAL Age Female Dementia Absence of a
categories gender partner
Age categories 0.459b
Female gender 0.238b 0.139a
Dementia 0.231b 0.206b 0.083
Absence of a partner 0.305b 0.316b 0.261b −0.005
Mobility categories 0.392b 0.385b 0.157b 0.171b 0.155b
DAL discharge to an alternative location
a Correlation is significant at the 0.05 level (2-tailed) 
b Correlation is significant at the 0.01 level (2-tailed) 
Discussion
A new prediction score for the discharge location of hip fracture patients living in their 
own home prior to admission was developed called the discharge of hip fracture patients 
score (DHP). This score was established using significant risk factors from multivariable 
regression analysis for failure to return to their own home: higher age, female gender, 
dementia, absence of a partner and a lower level of mobility. The score was easy to use 
due to readily obtainable data at admission and it had a good sensitivity and acceptable 
specificity.
The DHP can be used to facilitate the work of the liaison officers to make early 
arrangements for discharge, i.e. finding an appropriate alternative location or provide 
extra facilities (e.g. a walker or Zimmer frame, toilet seat risers, domestic help) needed in 
the first period after discharge. This can reduce LOS substantially [ 4– 6].
Patients
Mean age, the male to female ratio and fracture distribution of our series were 
comparable to a large cohort study of 3,683 hip fracture patients [ 17]. Another large 
series (3,240 patients) of Deakin et al. found a comparable mean age and percentage 
of patients living in their own home prior to admission [ 8]. The cohort we analysed was 







































We identified higher age, female gender, dementia, absence of a partner and a lower level 
of mobility as risk factors for DAL. Deakin et al. published the largest series on risk factors 
for DAL of hip fracture patients [ 8]. In that study, pre-injury level of dependence, higher 
age, male gender and injury sustained in hospital were identified as main risk factors for 
DAL. Other smaller studies identified age, number or type of comorbidities or a poor 
general health status, dementia, absence of a partner, a trochanteric fracture, a more 
limited level of mobility and ADL or the expectations of the nursing staff as predictors for 
DAL [ 7, 9– 14]. In our study, poor general health (i.e. a higher ASA score) was identified 
as a predictor in the bivariate analysis, but lost its significance in the multivariate analysis.
Other models
Currently, few prediction scores for discharge location after admission following a hip 
fracture are available [ 12– 14]. However, these scores have their drawbacks. One model 
is more than 30 years old, thus data cannot be extrapolated to current day and practice [ 
13]. Furthermore, all these models are based on small patient series (63–108 patients) [ 
12– 14]. Finally, one score used items that were not yet known at admission, i.e. the level 
of ADL and mobility two weeks postoperatively [ 14]. Nevertheless, these three models 
did use similar risk factors as we used in our score [ 12– 14]. Only female gender was 
identified as an additional item compared to previous models, but with a modest impact 
indicated by the lowest weighing factor.
When extrapolating the results of our study to different countries, one must be aware 
of various possible influencing factors. First, there are large differences between countries 
in type of housing and traditions for homes for elderly people [ 18]. Second, as for the 
location and timing of discharge from the hospital, large local, national and international 
differences exist between discharge directly to home or to temporary revalidation units. 
This is reflected in the very wide range (3–81%) of reported rates of discharge to home 





































Clinical reliability and validity
The sensitivity of the DHP was good, the specificity moderate, which is good as is it of 
more importance to have a high number of true-positives (i.e. those patients that were 
labelled DAL, really had a DAL) in a prediction model. Because of the small floor effect, 
it is not possible to further differentiate within patients with low scores. However, this is 
not a real issue as the model is developed for only two options: discharge to their own 
home or to an alternative location.
Limitations
Although this study describes a simple, valuable prediction model for discharge location 
in a well-sized cohort of hip fracture patients, some limitations remain. The first limitation 
was absence of more detailed data of cognitive function. Another limitation is the fact 
that the mobility category “immobile” and the category “only mobile indoors” were 
combined to one group due to the small number of patients who were immobile (n=3). 
Finally, this is a model for the Dutch social situation and might not be applicable to other 
countries. However, the score items we have used were very comparable to those in 
previous models from other countries (United Kingdom, Sweden, United States) [ 12– 14].
Conclusions
In this paper we presented a useful new score that predicts discharge location at admission 
in hip fracture patients living in their own home prior to admission. In the near future, 
we will validate this model and test its inter-observer reliability in another Dutch and a 
Swedish hospital to prove the reliability of the model in different hospitals and countries, 
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Purpose This paper reports the external validation of a recently developed instrument, 
the Discharge of Hip fracture Patients score (DHP) that predicts discharge location on 
admission in patients living in their own home prior to hip fracture surgery.
Methods The DHP (maximum score 100 points) was applied to 125 hip fracture patients 
aged 50 or more years admitted to an academic centre in the northern part of the 
Netherlands (Groningen cohort). The characteristics of this cohort, sensitivity, specificity 
and positive and negative predictive value (PPV, NPV) of the DHP for discharge to an 
alternative location (DAL) were calculated and compared with the original cohort of hip 
fracture patients from the western part of the Netherlands (Delft cohort). Scoring 30 
points or higher indicated DAL.
results The Groningen cohort was younger compared to the Delft cohort, (mean age 
75.4 vs. 78.5 years, P=0.005) but was more often classified ASA III/IV (46.4 % vs. 25.2 %, 
P< 0.001). Sensitivity of the DHP for DAL in the Groningen cohort was 75 % (vs. 83.8 %), 
specificity of 66.7 % (vs. 64.7 %) and a PPV of 86.3 % (vs. 79.2 %), compared to the Delft 
cohort.
Conclusion External validation of the DHP was successful; it predicted discharge location 
of hip fracture patients accurately in another Dutch cohort, the sensitivity for DAL was 
somewhat lower but the PPV higher. Therefore, the DHP score is a useful valid and easily 
applied instrument for general hip fracture populations.
abbreviations
DHP Discharge of Hip fracture Patients score
DAL Discharge to an Alternative Location
ASA American Society of Anesthesiologists
LOS Length of Stay




ROC Receiver Operating characteristics Curve
AUC Area Under the Curve
PPV Positve Predictive Value








































Worldwide, numbers of hip fracture patients are growing with associated rises in costs [ 
1, 2]. Discharge to an alternative location (DAL, compared to the pre-fracture residence) 
or the necessity for arranging additional postoperative care at home for those that can go 
home directly after discharge can contribute to a longer stay in hospital and contributes 
to additional health care costs, which may be preventable [ 3, 4]. Early planning of the 
date and the type of discharge location may thus be a powerful tool in reducing costs [ 
4– 6].
Recently, we described the Discharge of Hip fracture Patients score (DHP) [ 7]. This 
score predicts, on admission, the discharge location in patients living in their own home 
prior to admission for a hip fracture. The DHP was designed on prospective data of a Dutch 
cohort of 310 patients aged 50 or more years admitted to a general teaching hospital 
in the western part of the Netherlands [ 7]. Risk factors for DAL were identified using 
multivariable regression analysis [ 7]. Higher age, female gender, dementia, absence of 
a partner and a limited level of mobility were found to be predictive. These risk factors 
were used as score items, each with a weighing factor, based upon the beta coefficient.
In this paper we present the results of external validation of the DHP in another Dutch 
cohort of hip fracture patients.
Methods
Patients
The DHP was developed using data of 310 hip fracture patients aged 50 years and older 
admitted to a 450-bed teaching hospital (Delft, the Netherlands) between January 2008 
and December 2009 [ 7]. Patients with a fracture due to a high-energy trauma or with 
a pathological fracture, patients not living in their own home prior to admission, those 
treated conservatively and those that died during hospital stay were not included in this 
cohort. This cohort will be referred to as the ‘Delft cohort’.
The DHP was externally validated in a cohort of 125 hip fracture patients admitted to a 





































The same inclusion and exclusion criteria were applied to this cohort. This cohort will be 
referred to as the ‘Groningen cohort’.
Data collection
Uniform collection and recording of data of all patients of both cohorts was achieved 
by standard evaluation on admission, according to the local standardized care for hip 
fracture patients.
Collected demographic data included age, gender, presence of a partner and discharge 
location.
Characteristics obtained on admission were American Society of Anesthesiologists 
(ASA) Physical Status classification, presence of dementia based upon history taking from 
patients, families and carers, presence of anaemia on admission based on the criteria of 
the World Health Organisation (haemoglobin level below 7.5 mmol/L (12 g/dL) in women 
and below 8.1 mmol/L (13 g/dL in men), level of mobility, type of fracture (intra- or 
extracapsular hip fracture) and length of stay (LOS) [ 8, 9].
Pre-fracture level of mobility
The level of mobility was divided into four main categories; mobile without the use of an 
aid in- and out-doors, mobile in- and outdoors with the use of an aid in- and/or outdoors, 
only mobile indoors (regardless the use of an aid) and the last group was immobile both 
in-and outdoors. A cane, crutch(es) or walker were all considered an aid, patients in a 
wheelchair were considered to be immobile.
Discharge of hip fracture patients score (DHP)
The DHP score ranged from zero to 100 points. Higher age, female gender, dementia, 
absence of a partner, and a more limited level of mobility are score items, each with a 
weighting factor based upon the beta coefficient in the multivariable regression analysis. 
The beta coefficients were rounded up and the regression coefficients associated with 
the questions were transformed into a simple score that could be summated up to obtain 
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With ROC analysis, the cut-off point of 30 was calculated. Scoring 30 points or more 
predicted discharge to an alternative location in the Delft cohort with a sensitivity of 83.8 
%, a specificity of 64.7%a negative predictive value of 71.3 % and a positive predictive 
value of 79.2 % [ 7].
table 1 Discharge of Hip fracture Patients score (DHP)
Predisposing risk factors for discharge to an alternative location Points
Age
* 50–64.9 years 0
* 65–79.9 years 10
* ≥80 years 20
Female gender 10
Dementia 20
Absence of a partner 10
Mobility at admission
Mobile in- and outside without an aid 0
Mobile in- and outside with an aid for either one or for both 10




Demographic continuous data are presented as means, with standard deviations (SD 
or median with the interquartile range (IQR) in case of a non-normal distribution). 
Categorical data are presented as the number of subjects in the category, along with the 
percentages. Baseline characteristics of both cohorts were compared, using the Student’s 
T-test. Sensitivity, specificity, positive and negative predictive value (PPV and NPV) for DAL 
and the positive and negative likelihood ratio were calculated for the Groningen cohort 
and compared to the Delft cohort.
A receiver operating characteristics curve (ROC) was created by plotting the sensitivity 
(true positive rate) versus the 1-specificity (false positive rate). The actual area under the 
curve (AUC) measures the ability of the instrument to classify correctly DAL.
P-values lower than 0.05 were considered statistically significant. All data were 







































Table 2 shows clinical characteristics of the Delft and Groningen cohorts, stratified by 
discharge location. The mean (SD) age of the Delft patients was 78.5 (10.5) years, 67.1 
% were female. One hundred and ninety-one (61.7 %) patients were discharged from 
hospital to an alternative location. The mean (SD) age of the Groningen patients was 
75.4 (9.2) years, 69.6 % was female. Ninety-two (73.6 %) patients were discharged to an 
alternative location from hospital in the Groningen cohort.
In both cohorts, patients discharged to an alternative location were older, more 
often classified ASA III/VI and had a longer LOS compared to those who were discharged 
directly to their own home. In the Delft cohort, they were also more often female and 
suffered more from dementia.
Some baseline parameters of both cohorts were significantly different: Patients 
of the Groningen cohort were younger (P=0,002), more often classified ASA III/IV (P< 
0,001) and had a better level of mobility (more patients walked without an aid, P=0.01). 
Furthermore, more patients were discharged to an alternative location in the Groningen 
cohort compared to the Delft cohort (P=0.02).
Validation of the DHP
The DHP was applied to the Groningen cohort; the results are displayed in Table 3.
Compared to the values in the Delft cohort, the PPV was higher (86.3 vs. 79.2 %), but 
the sensitivity (75 vs. 83.8 %) and the NPV for the score in the Groningen cohort were 
lower (48.9 vs. 71.3 %).
Figure 1a shows the ROC curve of the DHP in the Groningen cohort, the AUC was 0.75 








































































































































































































































































































































































































































































































































































































































































































































































































































































































































table 3 Results of the validity analysis of the DHP for discharge to an alternative location, for the 
cut-off point of 30 and higher (out of 100) in the Groningen and Delft cohort
Groningen cohort Delft cohort
95 % CI 95 % CI
Sensitivity 75.0 64.9–83.5 83.8 77.8–88.7
Specificity 66.7 48.2–82.0 64.7 55.4–73.2
Positive Predictive Value 86.3 76.7–92.9 79.2 72.8–84.4
Negative Predictive Value 48.9 33.7–64.2 71.3 61.7–79.4
Likelihood ratio Positive (Sens/1-Spec) 2.25 1.37–3.7 2.37 2.0–2.7
Likelihood ratio Negative (1-Sens/Spec) 0.38 0.24–0.58 0.25 0.20–0.40
Correlation with discharge to alternative location 0.38 n/a 0.50 n/a





Figure 1 ROC curves of the DHP with 95 % confidence intervals in the Groningen (a) and Delft (b) 
cohorts. The diagonal indicate results no better than by chance.
Discussion
The goal of this study was the external validation of the DHP. This score has recently been 
developed in a cohort of Dutch hip fracture patients in Delft showing a good sensitivity 
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By providing early reliable prediction of discharge location, the DHP can be used to 
facilitate the work of the health care professionals, e.g., liaison officers to make early 
arrangements for discharge, thus potentially reducing LOS substantially [ 4– 7]. Since 
population density, hospital and rehabilitation potentials are different between the areas 
in The Netherlands, testing for external validity of a score is a necessity in order to judge 
its applicability in general. When performing an external validation, it is of importance to 
realise two issues. Firstly, appreciation of the important characteristics of the score (i.e., 
sensitivity vs. specificity and PPV vs. NPV), secondly, that external validation often results 
in lower scores in the second cohort compared to the first cohort, since the two cohorts 
are never exactly the same. The latter only underscores the necessity for validation before 
general application.
For example, external validation of a questionnaire for chronic obstructive pulmonary 
disease patients showed poorer discriminating ability (i.e., a smaller AUC) between 
normal and affected patients compared to the primary internal validation [ 10]. This was 
also the case in our study: a smaller AUC with a wider 95 % CI. The wider 95 % CI in the 
Groningen cohort could be attributed to the smaller sample size in this cohort (125 versus 
310 patients) but also to confounders for discharge to an alternate location such as a 
different discharge policy, more potential for day care help at home and rehabilitation 
centres near the hospital.
We consider a good sensitivity and high PPV to be the most important features of the 
score. Sensitivity is the ability of a test to give positive results in true cases and the PPV 
the percentage of true positives of all positive scoring patients. In this study a positive 
result is a score of 30 or more points and true positive is a patient scoring 30 and higher 
on admission who is discharged to an alternative location. In contrast, specificity is the 
ability of a test to give negative results in negative cases, the NPV is the percentage of 
true negatives of all negative scoring patients: In this study a negative result is a score 
under 30 points and true negative is a patient scoring less than 30 who is discharged 
directly to their own home from hospital. In daily practice it is of greater importance and 
impact for both patient and health professionals, e.g., liaison officers to know whether a 
patient will be discharged to an alternative location. Therefore, a better sensitivity and a 
higher PPV are the most important features of the score. The PPV in the Groningen cohort 





































by the fact that predictivity and prevalences are not comparable across groups because 
they depend on the prevalence of the outcome (in our case discharge to an alternative 
location, DAL). The prevalence of DAL in the Groningen cohort was higher (74 % versus 62 
%), resulting in a lower chance of discharge directly to the own home, corresponding with 
the NPV. Finally, the differences in all characteristics of the score can also be explained by 
the fact that there are factors of influence that were not risk items in the DHP but that do 
influence the place of discharge.
We demonstrated in the previous paper on the DHP that the Delft cohort was represen-
tative for a general hip fracture population in Europe with regards to characteristics 
including age, distribution of type of fracture and gender and the number of patients 
living in their own home prior to sustaining a hip fracture [ 7]. The Groningen cohort 
was comparable to the Delft cohort, other than age, poorer general condition (ASA III/
IV) and a higher level of mobility. The latter is directly related to the lower mean age, 
as we demonstrated previously [ 11]. The higher ASA scores despite younger age might 
be due to the fact that it was a cohort from a university hospital, often having more 
comorbidities. Furthermore, significantly more patients were discharged to an alternative 
location in the Groningen cohort compared to the Delft cohort, after a longer LOS. The 
LOS might have been longer due to the poorer general condition. The higher percentage 
of DAL can partially be explained by the longer LOS, often due to a more complicated 
postoperative course [ 4, 12– 14]. Another reason is the difference in local discharge 
policy. The Groningen cohort was more easily discharged to a nursing home compared to 
the Delft cohort. These differences are good for external validation; if a score is valid in a 
population that is somewhat different from the original population, the score might be 
even of higher value than if it would only work in exactly the same type of cohort.
Limitations
Although the DHP is externally validated and the score was easily applicable to the 
Groningen cohort as well, it has its limitations. First: absence of more detailed data of 
cognitive function, combining the mobility categories “immobile” and “only mobile 
indoors” to one group due to the small number of patients who were immobile and 
the fact that it might not be applicable to other countries than the Netherlands with its 



































External validation of the Discharge of Hip fracture Patients score
173
10
comparable to those in previous models from other countries, both with national health 
care as well as private health care systems (UK, Sweden, US) [ 15– 18]. The limitations 
of this validation study are the smaller AUC of the DHP in the Groningen cohort and the 
relatively small sample size, resulting in a wider 95 % CI of the AUC.
Conclusions
The external validity of the DHP for hip fracture patients is good in the Dutch health care 
setting, validated with an acceptable sensitivity and a good PPV. Therewith its use in other 
hip fracture cohorts is recommended. However, before extrapolating our Dutch results to 
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Summary and future perspectives
Overview
Some of the many clinical and functional outcome parameters and risk factors for poor 
outcome in hip fracture patients have been provided in this thesis. Furthermore, two risk 
models (for delirium and discharge to an alternative location) have been evaluated and 
validated. This chapter contains a summary of each chapter and some future perspectives. 
The table below demonstrates the numbers and origin of patients and time frame they 
were treated per chapter. 
Chapter Number of patients Origin of patients Time frame
2 1262 Delft and The Hague 2005-2009
3 230 vs. 1014 Delft and The Hague 2005-2009
4 1229 Delft and The Hague 2005-2009
5 444 Delft 2008-2009
6 390 Delft 2008-2009
7 445 Delft 2008-2009
8 378 Delft 2008-2009
9 310 Delft 2008-2009
10 125 vs. 310 Delft and Groningen 2008-2009
CLINICaL OUtCOME 
Having large databases with reliable data on characteristics and clinical outcome of hip 
fracture patients is crucial to identity specific risk factors for poor outcome. Reliability of 
patient characteristics is often depending on the number of patients included in a study 
cohort. Therefore, a large database of 1269 admissions of hip fracture patients aged ≥50 
years was made, using data that were collected in Reinier de Graaf Hospital, Delft and 





































anemia at admission and blood transfusion
Chapter two describes a retrospective analysis of 1262 admissions for surgical treatment 
of a hip fracture in patients aged 65 years and older. In multivariable regression analysis, 
anemia at admission was a significant risk factor for discharge to a nursing home and 
readmission < 90 days, but not for mortality. Indication for ABT, age and ASA classification 
were independent risk factors for mortality at all moments, only the mortality rate for the 
3-12 month interval was not influenced by ABT. An indication for an ABT was the largest 
negative contributor to a longer LOS and the second largest for delirium.
It is demonstrated that anemia at admission and Postoperative Anemia Needing 
an blood Transfusion (PANT) were independent risk factors for worse outcome in hip 
fracture patients. However, anemia as such had no effect on mortality, due to a rescue 
effect of PANT. In-hospital, 3- and 12-month mortality was negatively affected by PANT, 
with the main effect in the first 3 months postoperatively. This paper demonstrates once 
again the complex interaction of anemia and ABT on outcome. Anemic patients should 
be monitored closely. Recently, the effect of more liberal transfusion regimes is discussed 
in the FOCUS trial. (47) This study showed no difference in morbidity in the first 60 days 
post-surgery between a restrictive and a more liberal transfusion strategy in high-risk 
patients. (47)
Nonagenarians versus younger hip fracture patients
In chapter three, a comparison between 230 nonagenarian hip fracture patients with 
1014 patients aged 65–89 years regarding clinical characteristics, adverse events, mobility 
and mortality and outcome is presented. 
Nonagenarians were more likely to be female and anemic, and more often had a 
trochanteric fracture. The number of patients classified ASA III/VI did not differ between 
the two groups. During the hospital stay, adverse events were more frequently observed 
in nonagenarians, compared with younger patients. The length of stay was significantly 
longer in nonagenarians, the 90-day readmission rate was similar. Absolute mortality was 
higher in nonagenarians however, excess mortality was comparable. Prior to admission, 
40% of the nonagenarians lived in their own home, and 41% had returned there within 
three months. The rate of returning to their own home was lower compared to younger 
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group, but at three months after discharge, the number of patients that regained pre-
fracture mobility was comparable in both age groups.
Nonagenarian hip fracture patients differed significantly from younger patients aged 
65–89 years with respect to clinical characteristics and long-term outcome. However, 
almost half of the nonagenarians returned to their own home and more than half 
regained their pre-fracture level of mobility. Being confronted with growing numbers of 
relatively fit nonagenarians in our society, reliable outcome data is of importance. 
As the excess mortality (the mortality added due to the admission for a hip fracture) 
is comparable to their younger peers, nonagenarians should be treated in the same 
way as all hip fracture patients, with special geriatric attention to prevent avoidable 
complications and fallback in mobility and self-dependence. 
Contralateral hip fractures and other concomitant fractures 
In a cohort of 1229 consecutive patients of 50 years and older, who sustained a hip 
fracture between January 2005 and June 2009, the risk for concomitant fractures was 
evaluated. The absolute risk of a contralateral hip fracture after a hip fracture was 13.8%, 
the one-year risk 2%, with a short interval (median 18.5 months) between the two hip 
fractures. Age was a risk factor for sustaining a contralateral hip fracture; a prior fracture 
was not. Secondly, possible risk factors for sustaining a contralateral hip fracture were 
identified. Fractures were scored retrospectively for 2005–2008 and prospectively for 
2008–2009. Rates of a contralateral hip and other osteoporosis- related fractures were 
compared between patients with and those without a history of a fracture.
The absolute risk for a contralateral hip fracture was 13.8%, for one or more 
osteoporosis-related fracture(s) 28.6%. First-, second- and third-year risk for a second hip 
fracture was 2, 1 and 0 %. One-year incidence of other fractures was 6%. Only age was a 
risk factor for a contralateral hip fracture. Patients with a history of a fracture (33.1%) did 
not have a higher incidence of fractures during follow-up (16.7%) than patients without 





































FUNCtIONaL aND SOCIaL OUtCOME
A prospective one-year follow-up of 498 hip fracture patients treated in Reinier de Graaf 
Hospital, Delft during 2008-2009 was studied in chapters five and six. 
return to pre-fracture place of residence 
This chapter presents the results of a prospective cohort follow-up study of 444 hip 
fracture patients aged 65 years and older, stratified in categories based on pre-fracture 
place of residence. Of the hip fracture patients who lived at their own home prior to 
admission, 32 % returned to their home at discharge, at 3 and 12 months 73% had 
returned home. Age, absence of a partner, dementia, and a lower pre-fracture level of 
ADL or mobility were independent contributors to failure to return to their own home at 
discharge, three or 12 months. 
Of the patients living in a residential home prior to admission, 33% returned at 
discharge, 68% at 3 months and 64% at 12 months. Age was the only independent 
contributor to failure to return to their residential home at discharge. 
In this study, age, dementia and a lower pre-fracture level of ADL were the main 
significant risk factors for failure to return to the pre-fracture residence. 
Many other factors might influence the location of residence after hospital discharge. 
Of these, the social network might have the largest effect on discharge location. 
regaining pre-fracture level of mobility 
This chapter presents the results of a prospective cohort follow-up study of 390 hip 
fracture patients aged 65 years and older, stratified in categories based on pre-fracture 
mobility. The main conclusions of this study were that nearly half of all patients regained 
their pre-fracture level of mobility after one year. Mobile patients without an aid were 
less likely to return to their pre-fracture mobility level compared with patients who were 
mobile with aid or mobile indoors. After one year, 18.7% of all patients had become 
immobile. 
The risk for the latter was higher in those having a lower pre-fracture level of mobility. 
Pre-fracture level of activities of daily living, the level of dependence and sustaining a 
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As mentioned in the discussion of the paper, cognitive impairment might be one of the 
most important of the non-evaluated risk factors for not-regaining mobility.
PrEDICtION MODELS
The Risk Model for Delirium was evaluated (chapter seven) and validated (chapter eight).
A second prediction model, the Discharge of Hip fracture Patients score (DHP) was 
designed (chapter nine) and externally validated (chapter ten).
Delirium risk Screening and Haloperidol Prophylaxis Program 
In 2008 an integrated hip fracture care pathway that included a Risk Model for Delirium 
(RD-score) was introduced in Reinier de Graaf Hospital, Delft. The RD-score is a 10-item 
questionnaire that allocates hip fracture patients after admission to hospital to be either 
at high or at low risk for delirium. High-risk patients (score ≥ 5 points) are subsequently 
prescribed prophylactic haloperidol. This model was evaluated in 445 hip fracture patients 
aged 65 years and older, admitted in 2008 and 2009.
The RD-score was completed in 378 patients, 173 (45.8%) high-risk patients were 
treated with prophylactic medication. The sensitivity of a score < 5 was 71.6%, the 
specificity 63.8% and the negative predictive value (NPV) was 85.9%.
Delirium incidence (27.0%) was not significantly different compared to 2007 (27.8%) 
2006 (23.9%) and 2005 (29.0%), years prior to implementation of the RD-protocol.
Logistic regression analysis showed that high-risk patients had a significant higher 
delirium incidence than low-risk patients (42.2% vs. 14.1%). They were more likely to be 
residing at an alternative place of residence after three months (62.3% vs. 17.0%) and 
less likely to be discharged from hospital within ten days (34.9% vs. 55.9%). Significant 
independent risk factors for a delirium were a RD-score ≥ 5, male gender and age. 
The main conclusion of chapter seven was that the RD-score is a useful tool to identify 
patients with a high risk to develop a delirium and with poorer outcome. However, 
introducing the delirium prevention protocol did not reduce delirium incidence. 
The main limitations of this paper were the lack of detailed information on cognitive 





































Validation of the risk Model for Delirium 
Chapter eight contains the study that evaluated clinical reliability, validity and feasibility 
of the RD-score using demographic data, RD-score and delirium incidence of 378 hip 
fracture patients 65 years and older.
One hundred-and-two 102 (27%) were diagnosed with a delirium. The intra-class 
correlation coefficient of the RRD-score was 0.77 (CI 0.68–0.84), sensitivity 80.4% (CI 
71.4–87.6), and specificity 56.2% (CI 50.1-62.1). The area under the receiver operating 
characteristic curve was 0.73 (CI 0.68-0.77). A multivariable logistic regression analysis 
showed that besides the RD-score, a trochanteric fracture and male gender were 
independent risk factors for delirium. The RD-score proofed to be a reliable, feasible and 
valid instrument for predicting delirium in hip fracture patients. It would be of additional 
value to adjust the model by adding “male gender” and ‘trochanteric fracture’ and 
removing “ daily consumption of more than four alcoholic beverages” and “use of heroin, 
methadone or morphine” as score items.
Discharge of Hip fracture Patients score (DHP)
The goal of the study presented in chapter nine was to develop a reliable instrument that 
predicts the discharge location at admission in hip fracture patients living in their own 
home prior to admission; the discharge of hip fracture patients score (DHP). For this goal, 
310 hip fracture patients aged 50 years and above were analyzed. The score ranged from 
0-100 points. Risk factors for discharge to an alternative location (DAL) were higher age, 
female gender, dementia, absence of a partner and a limited level of mobility. The cut-off 
point was set at 30 points, with a sensitivity of 83.8%, a specificity of 64.7% and positive 
predictive value of 79.2%. 
The DHP is a valid, simple and short instrument to be used at admission to predict 
discharge location of hip fracture patients. Other score systems are available but have 
serious limitations to use in the hip fracture population. Limitations of this study were 
the absence of detailed information on cognitive function and the fact that the mobility 
category “immobile” and the category “only mobile indoors” could not be evaluated 
separately. Finally, this is a model for the Dutch social situation and might not be applicable 
to other countries. However, the score items we have used were very comparable to 
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External validation of the Discharge of Hip fracture Patients (DHP) score
External validation of the DHP was performed with a cohort of 125 hip fracture patients 
aged 50 years and older admitted at the University Medical Centre Groningen. 
The Groningen cohort was younger compared to the Delft cohort, (mean age 75.4 vs. 
78.5 years) but was more often classified ASA III/IV (46.4% vs. 25.2 %). Sensitivity of the 
DHP for discharge to an alternative location (DAL) in the Groningen cohort was 75% (vs. 
83.8%), specificity of 66.7% (vs. 64.7%) and a positive predictive value (PPV) of 86.3% (vs. 
79.2%), compared to the Delft cohort. 
External validation of the DHP was good; it predicted discharge location of hip fracture 
patients accurately in another Dutch cohort, the sensitivity for DAL was somewhat lower 
but the PPV higher. Therefore the DHP score is a useful valid and easy to apply instrument 
for general hip fracture populations in the Netherlands.
Future perspectives
Performing research almost always creates new questions and insights. General and 
specific improvements in hip fracture patient care have to be made to deliver better 
and more efficient care for this vulnerable population. The government and health care 
insurance companies are imposing quality indicators on hospitals and doctors with the 
goal to improve patient care. These indicators of quality should be just and (preferably) 
based on reliable parameters and outcome of hip fracture patients in the Netherlands. 
This can only be done when sufficient base line parameters and characteristics of hip 
fracture patients are registered. The success of the nationwide Dutch arthroplasty register 
LROI (mainly total hip and knee arthroplasties, www.lroi.nl) is an excellent example to 
follow. Some European countries already started a nationwide hip fracture database in 
the last decades. With these hip fracture databases appropriate indicators of good care 
for hip fracture patients can be identified, in order to improve patient care. For example, 
in the NHS system in Scotland outcome is analyzed every year, hospitals with a mortality 
rate that is higher than anticipated are reviewed and where possible care is improved. 
Regaining the pre-fracture level of mobility, place of residence and patient-reported 
quality of life could be important indicators of good hip fracture care. These values can be 
compared and hospitals that underachieve significantly compared to the national mean 





































Rising costs are a real problem for all countries with an aging population. As mentioned 
earlier, these costs are almost two and a half billion euros per year in the UK as presented 
in the Report from the National Hip Fracture Database in 2011. (7)
These costs can be reduced by making the current care for hip fracture patients more 
efficient by prevention of osteoporosis-related fractures and by implementing evidence 
based care pathways. These care pathways take important aspects of fragile hip fracture 
patients into account and standardize screening, prevention and treatment, both pre- 
and postoperatively. 
Collaboration with geriatricians, preferably in so-called geriatric fracture units 
is essential to improve quality of care. These units are a combination of the skills and 
knowledge of orthopaedic and trauma surgeons on one hand and geriatricians, specialized 
nurses and physiotherapists on the other.
Admission of hip fracture patients to geriatric fracture units makes registration of 
base line parameters and measuring outcome easier as well. 
Prevention of osteoporosis-related fractures can be realized in many ways and is a field 
of research itself. Early screening for osteoporosis and starting medication is only one part 
of the solution. But equally important is the identification of risk factors for falling. (51) 
Core stability training with physiotherapy or tai chi or virtual training programs might play 
an important role, as are screening on and improvement of impaired sight and hearing. 
With regards to delirium prevention, multicomponent or multimodal intervention 
programs might contribute at least as much as chemical prophylaxis. (52)
Concluding, future research in hip fracture patients should address on all these 
different aspects of prevention of fractures. If a fracture does occur, the main goal should 
be minimizing the morbidity thus reducing the impact of this life event on the quality of 








































In dit proefschrift worden enkele van de vele klinische en functionele uitkomsten 
en risicofactoren voor een slechte resultaten van patiënten met een heupfractuur 
gepresenteerd. Verder zijn er twee risicomodellen (voor delirium en ontslag naar een 
alternatieve locatie) geëvalueerd en gevalideerd. Dit hoofdstuk bevat een samenvatting 
van de verschillende hoofdstukken van dit proefschrift. 
Afsluitend volgen enkele woorden over toekomstperspectieven. 
In de onderstaande tabel staan per hoofdstuk de aantallen en de herkomst van de 
patiënten en de periode waarin ze zijn behandeld.
Hoofdstuk Aantal patiënten Herkomst Periode
2 1262 Delft en Den Haag 2005-2009
3 230 vs. 1014 Delft en Den Haag 2005-2009
4 1229 Delft en Den Haag 2005-2009
5 444 Delft 2008-2009
6 390 Delft 2008-2009
7 445 Delft 2008-2009
8 378 Delft 2008-2009
9 310 Delft 2008-2009
10 125 vs. 310 Delft en Groningen 2008-2009
KLINISCHE rESULtatEN 
Om specifieke risicofactoren voor een slechte uitkomst bij patiënten met een heupfractuur 
te identificeren is van groot belang om (grote) databases te hebben, met betrouwbare 
patiënten kenmerken en klinische uitkomsten De betrouwbaarheid wordt onder andere 
bepaald door het aantal patiënten dat in de database is geïncludeerd. Daarom werd er een 
grote database gemaakt van 1269 patiënten van 50 jaar en ouder met een heupfractuur, 
allen opgenomen in het Reinier de Graaf Gasthuis in Delft en het Bronovo Ziekenhuis in 





































anemie bij opname en allogene bloedtransfusie (aBt)
Hoofdstuk twee beschrijft een retrospectieve analyse van 1262 patiënten van 65 jaar en 
ouder met een operatief behandelde heupfractuur. Uit de multivariabele regressieanalyse 
bleek dat anemie bij opname een belangrijke risicofactor was voor ontslag naar een 
verpleeghuis en een heropname binnen 90 dagen, maar niet voor sterfte. Indicatie voor 
een ABT, leeftijd en ASA classificatie waren onafhankelijke risicofactoren voor sterfte 
op alle momenten in de tijd, alleen het sterftecijfer gedurende drie tot 12 maanden na 
de operatie werd niet beïnvloed door ABT. Een indicatie voor een ABT was de grootste 
risicofactor voor een langer verblijfsduur in het ziekenhuis en de op één na grootste voor 
het ontwikkelen van een delirium.
Het is aangetoond dat anemie bij opname en postoperatieve anemie waarvoor 
een ABT nodig was (PANT) onafhankelijke risicofactoren waren voor slechtere uitkomst 
bij patiënten met een heupfractuur. Echter, anemie als zodanig had geen effect op de 
mortaliteit door een “rescue effect” van PANT. De mortaliteit tijdens opname in het 
ziekenhuis en na drie en 12 maanden werd negatief beïnvloed door PANT, met het 
grootste effect in de eerste drie maanden na de operatie. 
Deze studie toont eens te meer de complexe interactie aan van anemie en ABT en hun 
effect op klinische resultaten. Anemische patiënten moeten derhalve zorgvuldig worden 
gecontroleerd. Het effect van verschillende transfusie regimes is recent onderzocht in de 
FOCUS studie. (47) Deze studie toonde geen verschil in morbiditeit in de eerste 60 dagen 
na de ingreep tussen een restrictief en een liberaal transfusie regime voor patiënten met 
een hoog cardiovasculair risico. (47)
Negentigplussers versus jongere patiënten met een heupfractuur
In hoofdstuk drie wordt de studie gepresenteerd waarin 230 negentigplussers met een 
heupfractuur worden vergeleken met 1014 patiënten in de leeftijd van 65-89 jaar. Hierbij is 
gekeken naar klinische kenmerken, complicaties, mobiliteit en mortaliteit. Negentigplussers 
waren vaker vrouw en hadden vaker bloedarmoede en een pertrochantere femurfractuur. 
Het aantal patiënten met een ASA classificatie III / VI verschilde niet tussen de twee 
groepen. Tijdens het verblijf in het ziekenhuis, werden meer complicaties gezien bij 
negentigplussers in vergelijking met de jongere patiënten. De negentigplussers hadden 
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echter vergelijkbaar. De absolute sterfte van negentigplussers was hoger, de oversterfte 
(het sterftecijfer toegevoegd als gevolg van de ziekenhuisopname voor de heupfractuur) 
was vergelijkbaar. Veertig procent van de negentigplussers leefde in hun eigen huis voor 
de val en 41 procent van hen was binnen drie maanden na opname teruggekeerd naar 
de oude woonomgeving. Dit terugkeerpercentage was lager dan bij jongere patiënten. 
Het mobiliteitsniveau van de negentigplussers vóór de val was slechter dan dat van de 
jongere groep, maar het aantal patiënten dat de preoperatieve mobiliteit had herwonnen 
na drie maanden was vergelijkbaar.
Negentigplussers met een heupfractuur verschilden significant van jongere patiënten 
in de leeftijd 65-89 jaar qua klinische kenmerken en het uitkomsten op langere termijn. 
Echter, bijna de helft van de negentigplussers keert terug naar hun eigen huis en meer 
dan de helft van hen herwon hun preoperatieve mobiliteit. 
Aangezien het aantal, vaak relatief gezonde, negentigplussers in onze samenleving 
groeit, zijn betrouwbare uitkomsten van belang.
Negentigplussers moeten op dezelfde manier worden behandeld als alle patiënten 
met een heupfractuur, mede gezien het feit dat de oversterfte vergelijkbaar is met hun 
jongere lotgenoten. Aan hen moet speciale aandacht worden besteed, om vermijdbare 
complicaties te voorkomen die een terugval in mobiliteit en verlies van onafhankelijkheid 
veroorzaken.
Contralaterale heupfracturen en andere fracturen 
In een cohort van 1229 patiënten van 50 jaar en ouder, die een heupfractuur tussen 
januari 2005 en juni 2009 hadden opgelopen, werd het risico op bijkomende andere 
fracturen geëvalueerd. Het absolute risico op een contralaterale heupfractuur na de 
eerste heupfractuur was 13,8%, en 2% in het eerste jaar, met een kort interval (mediaan 
18,5 maanden) tussen de twee heupfracturen. Leeftijd was een risicofactor voor een 
contralaterale heupfractuur, een eerder opgelopen fractuur niet. 
Het tweede deel van deze studie was het aantonen van mogelijke risicofactoren voor 
een contralaterale heupfractuur. Alle fracturen werden retrospectief gescoord in de 
periode 2005-2008 en prospectief in 2008-2009. De percentages van een contralaterale 
heup en andere osteoporose-gerelateerde fracturen werden vergeleken tussen patiënten 





































Het absolute risico op een contralaterale heupfractuur was 13,8% en op één of meer 
andere osteoporose gerelateerde fracturen 28,6%. Het eerste-, tweede-en derdejaars 
risico voor een contralaterale heupfractuur was 2, 1 en 0%. De 1-jaars incidentie van 
andere fracturen was 6%. Alleen leeftijd was een risicofactor voor een contralaterale 
heupfractuur. Patiënten met een fractuur in de voorgeschiedenis (33,1%) hadden geen 
hogere fractuur incidentie tijdens follow-up (16,7%) dan patiënten zonder (14%).
FUNCtIONELE EN SOCIaLE rESULtatEN
Hoofdstukken vijf en zes behandelen studies met resultaten van een prospectieve follow-
up van 1 jaar van 498 patiënten met een heupfractuur, behandeld in het Reinier de Graaf 
Gasthuis, Delft in 2008-2009.
terugkeer naar de woonomgeving van vóór de fractuur 
In dit hoofdstuk worden de resultaten getoond van een prospectieve cohort follow-up 
studie van 444 patiënten van 65 jaar en ouder met een heupfractuur, gestratificeerd in 
categorieën op basis van de “pre-fractuur”-woonplaats. Tweeëndertig procent van de 
patiënten die zelfstandig in hun eigen huis woonden vóór de heupfractuur keerde terug 
naar huis bij ontslag, na drie en 12 maanden was 73% naar huis teruggekeerd. Leeftijd, 
het ontbreken van een partner, dementie, een lagere pre-fractuur ADL niveau (activiteiten 
van het dagelijks leven) en een beperkte mobiliteit waren onafhankelijke risicofactoren 
voor het niet-terugkeren naar huis bij ontslag en na drie en 12 maanden.
Van de patiënten die in een verzorgingshuis woonden voor de opname, keerde 
bij ontslag 33% terug, 68% na drie maanden en 64% na 12 maanden. Leeftijd was de 
enige onafhankelijke risicofactor voor het niet-terugkeren naar het verzorgingshuis bij 
ontslag. Leeftijd, dementie en een lager pre-fractuur ADL niveau waren de belangrijkste 
risicofactoren voor het niet-terug te keren naar de pre-fractuur woonomgeving in deze 
studie.
Vele andere factoren kunnen keuze van woonplaats na ontslag uit het ziekenhuis 
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Herwinnen van het pre-fractuur mobiliteitsniveau 
In dit hoofdstuk worden de resultaten gepresenteerd van een prospectieve cohort follow-
up studie van 390 patiënten van 65 jaar en ouder met een heupfractuur, gestratificeerd 
in categorieën op basis van de pre-fractuur mobiliteit. Eén van de belangrijkste conclusies 
van deze studie was dat bijna de helft van alle patiënten hun pre-fractuur niveau van 
mobiliteit na een jaar had herwonnen. Verder bleek dat patiënten die mobiel waren 
zonder een hulpmiddel vóór de heupfractuur een lagere kans hadden om hun mobiliteit 
te herwinnen, vergeleken met patiënten die mobiel waren met een hulpmiddel of alleen 
binnenshuis liepen. Bijna 19% van alle patiënten is na één jaar niet meer mobiel, d.w.z. 
ze zitten in een rolstoel of zijn bedlegerig. Het risico hierop was hoger in de groep met al 
een meer beperkte mobiliteit vóór de fractuur. Het pre-fractuur ADL niveau (activiteiten 
van het dagelijks leven), de mate van afhankelijkheid van anderen en het oplopen van een 
delier tijdens opname waren de belangrijkste risicofactoren voor het niet-herwinnen van 
de oude mobiliteit.
Een cognitieve stoornis is één van de belangrijkste niet-geëvalueerde risicofactoren 
voor het niet-herwinnen van mobiliteit in deze studie.
VOOrSPELMODELLEN
Het Risico Model voor Delirium werd geëvalueerd (hoofdstuk zeven) en gevalideerd 
(hoofdstuk acht).
Een tweede voorspelmodel, dat de ontslaglocatie voorspelt voor patiënten met een 
heupfractuur die vóór de val thuis woonden, de “Discharge of Hip fracture Patients score” 
(DHP), werd ontwikkeld (hoofdstuk negen) en extern gevalideerd (hoofdstuk tien).
Screenen op het risico op een delirium en het haloperidol profylaxe programma
In 2008 werd in het Reinier de Graaf Ziekenhuis een zorgpad geïntroduceerd voor 
patiënten met een heupfractuur, waarvan het Risico Model voor Delirium (RD-score) 
onderdeel is.
De RD-score is een 10-punts vragenlijst die het risico op een delirium inschat. Patiënten 





































Dit model werd geëvalueerd bij 445 patiënten van 65 jaar en ouder met een heupfractuur, 
opgenomen in 2008 en 2009.
De RD-score werd bij 378 patiënten ingevuld; 173 (45,8%) hoog-risico patiënten 
werden behandeld met profylactische medicatie. De sensitiviteit van de RD score voor 
een delirium was 71.6%, de specificiteit 63.8% en de negatief voorspellende waarde 
(NPV) van een score <5 was 85.9%.
De delirium incidentie (27 %) was niet significant verschillend ten opzichte van die 
in 2007 (28%) 2006 (24%) en 2005 (29%), de jaren voorafgaand aan de introductie van 
de RD-score. Logistische regressie-analyse toonde aan dat hoog-risico patiënten een 
significant hogere delirium incidentie hadden dan laag-risico patiënten (42,2% versus 
14,1%). Verder waren ze significant vaker niet teruggekeerd naar hun oude woonlocatie 
na drie maanden (62,3% versus 17,0%) en hadden ze minder kans om binnen tien dagen 
te worden ontslagen uit het ziekenhuis (34,9% versus 55,9%). Belangrijke onafhankelijke 
risicofactoren voor een delirium waren een RD-score ≥ 5, het mannelijk geslacht en 
leeftijd.
De belangrijkste conclusie van hoofdstuk zeven was dat de RD-score een nuttig 
hulpmiddel is om patiënten te identificeren met een hoog risico op een delirium en op 
andere slechtere uitkomsten. Echter, de invoering van het delirium preventie-protocol 
heeft de delirium incidentie niet verminderd. De belangrijkste beperkingen van deze 
studie waren het ontbreken van gedetailleerde informatie over de cognitieve status en 
duur en diepte van het delirium. 
Validatie van het risico Model voor Delirium
Hoofdstuk acht bevat de studie die de klinische betrouwbaarheid, validiteit en 
haalbaarheid van de RD Score heeft geëvalueerd met behulp van demografische 
gegevens, de RD scores en delirium incidentie van 378 patiënten van 65 jaar en ouder 
met een heupfractuur.
Honderd-en-twee patiënten (27%) werden gediagnosticeerd met een delirium. De 
intra-class correlatie coëfficiënt van het RD score was 0,77 (CI 0,68-0,84), de sensitiviteit 
80,4% (CI 71,4-87,6), en de specificiteit 56,2% (CI 50,1-62,1). De oppervlakte onder de 
“receiver operating characteristic” curve was 0,73 (CI 0,68-0,77). Een multivariabele 
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femurfractuur en het mannelijk geslacht onafhankelijke risicofactoren waren voor een 
delirium. De RD score blijkt een betrouwbaar, praktisch en een valide instrument voor het 
voorspellen van delirium bij patiënten met een heupfractuur. Het zou van toegevoegde 
waarde zijn om het model aan te passen door het toevoegen van score items “mannelijk 
geslacht” en “pertrochantere femurfractuur” en het verwijderen van de score items 
“dagelijkse consumptie van meer dan vier alcoholische dranken “en “het gebruik van 
heroïne, methadon of morfine“.
De ontslagscore (DHP)
Het doel van de studie beschreven in hoofdstuk negen was om een  betrouwbaar 
instrument te ontwikkelen dat al bij opname de ontslaglocatie voorspelt van patiënten 
met een heupfractuur die vóór de fractuur zelfstandig woonden; de “Discharge of Hip 
fracture Patients score” (DHP). Voor dit doel werden 310 patiënten van 50 jaar en ouder 
met een heupfractuur geanalyseerd, allen behandeld in Delft. De score loopt van 0-100. 
Risicofactoren voor ontslag naar een alternatieve locatie (OAL) waren een hogere leeftijd, 
het vrouwelijk geslacht, dementie, afwezigheid van een partner en een beperkte mate 
van mobiliteit. Het afkappunt werd gesteld op 30 punten, met een sensitiviteit van 83,8%, 
een specificiteit van 64,7% en een positief voorspellende waarde van 79,2%.
De DHP is een betrouwbare, korte en eenvoudige score die al bij opname kan worden 
gebruikt om de ontslaglocatie van patiënten met een heupfractuur te voorspellen. Er zijn 
eerder vergelijkbare scores ontwikkeld, maar deze hebben hun praktische beperkingen. 
Beperkingen van onze studie waren het gebrek aan gedetailleerde informatie over de 
cognitieve functie en het feit dat de mobiliteitsscategorie “immobiel” en de categorie 
“alleen mobiel binnenshuis” niet afzonderlijk konden worden beoordeeld. Tot slot, dit 
is een model voor de Nederlandse sociale situatie en mogelijk niet van toepassing op 
andere landen. Echter, de score items die wij hebben gebruikt waren vergelijkbaar met 
die van de eerdere modellen die zijn ontwikkeld in andere landen (Verenigd Koninkrijk, 
Zweden, Verenigde Staten). (48-50)
Externe validatie van de ontslagscore (DHP)
De externe validatie van de DHP werd uitgevoerd in een cohort van 125 patiënten van 






































Het Groningse cohort was jonger vergeleken met het Delftse cohort, (gemiddelde 
leeftijd 75,4 versus 78,5 jaar), maar had vaker ASA classificatie III / IV (46,4% versus 
25,2%). De sensitiviteit van de DHP voor ontslag naar een alternatieve locatie (OAL) in 
het Groningse cohort was 75% (versus 83,8%), de specificiteit 66,7% (versus 64,7%) en 
de positief voorspellende waarde (PPV) was 86,3% (versus 79,2%) vergeleken met het 
Delftse cohort.
De externe validatie van de DHP toonde dat deze score goed en betrouwbaar is, de 
score was een betrouwbare voorspeller van de ontslaglocatie van patiënten uit een andere 
Nederlandse cohort. Wel was de sensitiviteit voor OAL iets lager, de PPV daarentegen was 
hoger. Derhalve is de DHP score een nuttig, betrouwbaar en eenvoudig toe te passen 
instrument voor de algemene heupfractuur populatie in Nederland. 
tOEKOMSt
Onderzoek doen creëert bijna altijd nieuwe vragen en inzichten. Algemene en specifieke 
verbeteringen van de zorg voor patiënten met een heupfractuur moeten worden 
nagestreefd om betere en efficiëntere zorg te leveren voor deze kwetsbare populatie. 
De overheid en zorgverzekeraars stellen kwaliteitsindicatoren op voor ziekenhuizen 
(en artsen) om de patiëntenzorg te verbeteren. Echter, deze indicatoren moeten wel 
terecht zijn gekozen, bij voorkeur op basis van betrouwbare parameters en uitkomsten 
van Nederlandse patiënten. Dit kan alleen worden gedaan als er voldoende “baseline” 
parameters en kenmerken van patiënten met een heupfractuur zijn geregistreerd. Het 
succes van het landelijke Nederlandse implantaten register LROI (nu nog met alleen 
data van totale heup en knieprotheses, www.lroi.nl) is een uitstekend voorbeeld om te 
volgen. Sommige Europese landen zijn in het afgelopen decennium al begonnen met een 
landelijke heupfractuur database. Met deze databases kunnen geschikte indicatoren van 
goede zorg voor patiënten met een heupfractuur worden geïdentificeerd. In het NHS-
systeem in Schotland bijvoorbeeld worden diverse uitkomsten jaarlijks geanalyseerd 
en ziekenhuizen met een sterftecijfer dat hoger is dan verwacht worden nader 
onderzocht en waar mogelijk worden er verbetertrajecten ingesteld. Het herwinnen 
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patiënt-gerapporteerde kwaliteit van leven zouden belangrijke indicatoren van goede 
heupfractuur zorg kunnen zijn. De resultaten van de Nederlandse ziekenhuizen kunnen 
worden vergeleken en ziekenhuizen die beduidend lager presteren vergeleken met het 
nationale gemiddelde moeten verbeteringen van zorg doorvoeren.
Stijgende kosten zijn een reëel probleem voor alle landen met een vergrijzende 
bevolking. Zoals in de inleiding van dit proefschrift vermeld, bedragen volgens het rapport 
van de Nationale Hip Fracture Database uit 2011 deze kosten in het Verenigd Koninkrijk 
bijna twee en een half miljard euro per jaar. (7)
Deze kosten kunnen worden verminderd door de huidige zorg voor patiënten met 
een heupfractuur efficiënter te maken, door preventie van osteoporose-gerelateerde 
fracturen en door invoeren van “evidence-based” zorgpaden. Deze zorgpaden houden 
rekening met de meest belangrijke aspecten van deze fragiele patiëntenpopulatie en 
standaardiseren screening en preventie van diverse risico factoren en behandeling, zowel 
pre-, peri als postoperatief.
Samenwerking met geriaters, bij voorkeur op een zogenaamde “geriatrische 
fractuur afdeling” is een essentieel onderdeel om de kwaliteit van zorg te verbeteren. 
Op een dergelijke afdeling worden de vaardigheden en kennis van orthopedisch en 
traumachirurgen aan de ene kant en geriaters, gespecialiseerde verpleegkundigen en 
fysiotherapeuten anderzijds gecombineerd.
Ten slotte is het door opname van patiënten met een heupfractuur op een dergelijke 
geriatrische fractuur afdeling, de registratie van basislijn parameters en het meten van 
resultaten veel eenvoudiger. Preventie van osteoporose-gerelateerde fracturen kan op 
vele manieren worden gerealiseerd en is een onderzoeksgebied op zichzelf. Vroegtijdige 
opsporing van osteoporose en het starten van medicatie is slechts een deel van de 
oplossing. Even belangrijk is de identificatie van risicofactoren voor vallen. (51) Core 
stabiliteit training met fysiotherapie, tai chi of virtuele training kan een belangrijke rol 
spelen, net als screening op en verbetering van een verminderd gezichtsvermogen en 
gehoor.
Multi-component of multimodale interventieprogramma’s dragen minstens evenveel 
bij aan de preventie van een delirium als chemische profylaxe. (52)
Concluderend, toekomstig onderzoek bij patiënten met een heupfractuur zou gericht 





































met een fractuur, moet het minimaliseren van de morbiditeit de belangrijkste doelstelling 
zijn; hiermee wordt de impact van deze ingrijpende gebeurtenis op de kwaliteit van leven 









































Yn dit proefskrift wurde inkele fan de folle klinyske en funksjonele útkomsten en risiko 
faktoaren foar minne resultaten fan pasjinten mei in heupfraktuer presintearre. Fierder 
binne der twa risiko modellen (foar delirium en ûntslach nei in alternative lokaasje) 
evaluearre en fallidearre. Dit haadstik befettet in gearfetting fan de ferskillende 
haadstikken fan dit proefskrift.
Ôfslutend folgje inkele wurden oangeande takomst perspektiven.
Yn ûndersteande tabel stean per haadstik de oantallen en werkomst fan de pasjinten 
en de perioade wêryn sij behannele waarden.
Haadstik Oantal pasjinten Werkomst Perioade
2 1262 Delft en Den Haag 2005-2009
3 230 vs. 1014 Delft en Den Haag 2005-2009
4 1229 Delft en Den Haag 2005-2009
5 444 Delft 2008-2009
6 390 Delft 2008-2009
7 445 Delft 2008-2009
8 378 Delft 2008-2009
9 310 Delft 2008-2009
10 125 vs. 310 Delft en Groningen 2008-2009
KLINYSKE rESULtatEN 
Om spesifike risiko faktoaren foar in minne útkomst bij pasjinten mei in heupfraktuer 
te identifisearjen is fan grut belang om (grutte) databases te hawwen, mei betroubere 
pasjinten skaaimerken en klinyske útkomsten. De betrouberens wurdt ûnder oaren 
bepaald troch it tal pasjinten dat yn de database ynkludeard is.
Om dy reden waard der in grutte database makke fan 1269 pasjinten fan 50 jier en 
âlder mei in heup fraktuer, dy’t opnommen west binnen yn it Reinier de Graaf Gasthuis yn 





































anemy by opname en allogene bloedtransfúzje (aBt)
Haadstik twa beskriuwt in retrospektive analyze fan 1262 pasjinten fan 65 jier en âlder 
mei in operatyf behannele heupfraktuer. Út de multi fariabele regressy analyze die bliken 
dat anemy bij opname in wichtige risikofaktor wie foar ûntslach nei in ferpleechhûs en in 
weropname binnen 90 dagen, mar net om te stjerren. Yndikaasje foar in ABT, leeftyd en 
ASA klassifikaasje wienen ûnôfhinklike risiko faktoaren foar deagean op alle mominten yn 
de tiid, allinnich it tal stjergefallen tusken de 3 en 12 moannen nei de operaasje waarden 
net beynfloede troch ABT. In yndikaasje foar in ABT wie de grutste riskofaktor foar in 
langer ferbliuwen yn it sikehûs en de op ien nei grutste foar it ûntjouwen fan in delirium. 
It hat bliken dien dat anemy by opname en postoperative anemy wêrfoar in ABT nedich 
wie (PANT) ûnôfhinklike risikofaktoaren wienen foar in mindere útkomst by pasjinten 
mei in heupfraktuer. Lykwols anemy as sadanich gjin effekt hat op de mortaliteit troch 
in “rescue effect” fan PANT. De mortaliteit tidens opname yn it sikehûs en nei trije en 12 
moannen waard negatyf beynfloede troch PANT, mei it grutste effekt yn de earste trije 
moannen nei de operaasje.
Dizze stúdzje toant nochris de komplekse ynteraksje oan fan anemy en ABT en har 
effekt op klinyske útkomsten. Anemyske pasjinten moatte om dy reden wiidweidich 
kontroleard wurde. It effekt fan ferskillende transfúzje rezjyms is okkerdeis ûndersocht 
yn de FOCUS stúdzje (47) Dizze stúdzje toande gjin ferskil yn morbiditeit yn de earste 60 
dagen nei de yngreep tusken restriktyf en in liberale transfúzje rezjym foar pasjinten mei 
in heech kardiofaskulair risiko (47)
Njoggentichplussers fersus jongere pasjinten mei in heupfraktuer
Yn haadstik trije wurdt de stúdzje presintearre wêr yn 230 njoggentichplussers mei in 
heup fraktuer fergelike wurde mei 1014 pasjinten yn de leeftyd fan 65 – 89 jier.
Hjirby is sjoen nei klinyske skaaimerken, komplikaasjes, mobiliteit en mortaliteit. 
Njoggentichplussers wienen faker frou en hienen faker bloedearmoede en in 
pertrosjanteare femurfraktuer. It tal pasjinten mei in ASA klassifikaasje III / VI ferskilde net 
tusken de twa groepen. By it ferbliuw yn it sikehûs, waarden mear komplikaasjes sjoen 
bij njoggentichplussers yn fergelyk mei jongere pasjinten. De njoggentichplussers hienen 






































lykwols fergelykber. De absolute stjerte fan njoggentichplussers wie heger, de oerstjerte 
(it stjertesifer taheakke as gefolch fan de sikehûsopname foar de heupfraktuer) wie 
fergelykber. Fjirtich prosint fan de njoggentichplussers libben yn harren eigen hûs foar de 
fal en 41 prosint fan harren wienen binnen trije moannen nei de opname werom nei de 
âlde wenomjouwing. Dit persintaazje wie leger as bij jonge pasjinten. It mobiltieitsnifo 
fan de njoggentichplussers foar de fal wie minder dan fan de jongere groep, mar it tal 
pasjinten dat de preoperative mobiliteit herwûn nei trije moanne hie wie fergelykber.
Njoggentichplussers mei in heupfraktuer ferskille signifikant fan jongere pasjinten yn 
de leeftyd 65 -89 jier kwa klinyske merktekens en de útkomsten op langere termyn.
Lykwols, hast de helte fan de njoggentichplussers giet werom nei hûs en mear as de 
helte fan harren herwûn harren preoperative mobiliteit.
Omdat it tal, faak relatyf sûne, njoggentichplussers yn ús mienskip ta nimt binne 
betroubere útkomsten fan belang.
Njoggentichplussers moatte op deselde wize behannele wurde as alle pasjinten mei 
in heupfraktuer, mei omdat de oerstjerte fergelykber is mei harren jongere lotgenoaten. 
Oan harren moat spesjaal omtinken jûn wurde, om te mijen komplikaasjes yn it foar te 
wêzen dy’t in werom fal yn mobiliteit en ferlies fan ûnôfhinklikens feroarsaakje.
Kontralaterale heupfraktueren en oare fraktueren 
Yn in kohort fan 1229 pasjinten fan 50 jier en âlder, dy’t in heupfraktuer tusken jannewaris 
2005 en juny 2009 oprûn hienen, waard it risiko op bykommende oare fraktueren 
evaluearre. It absolute risiko op in kontralaterale heupfraktuer nei de earste heupfraktuer 
wie 13,8% en 2% yn it earste jier, mei in koarte ynterfal (mediaan 18,5 moannen) tusken 
de twa heupfraktueren. Leeftyd wie in risikofaktor foar in kontralaterale heupfraktuer, 
in fraktuer dy’t earder oprûn wie net. It twadde part fan dizze stúdzje wie it oantoanen 
fan mooglike risikofaktoaren foar in kontralaterale heupfraktuer. Alle heupen waarden 
retrospektyf skoart yn it tiidrak 2005-2008 en prospektyf yn 2008-2009.
De persintaazjes fan in kontralaterale heup en oare osteoporose-relatearre fraktueren 
wurde fergelike tusken pasjinten mei en minsken sûnder fraktueren yn de foarskiednis.
It absolute risiko op in kontralaterale heupfraktuer wie 13,8% en op ien as mear 
oare osteoporose relayearre 28,6%. It earste-, twadde- en treddejiers risiko foar in 





































6%. Allinnich leeftyd wie in risiko faktor foar in kontralaterale heupfraktuer. Pasjinten mei 
in fraktuer yn de foarskiednis (33,1%) hienen gjin hegere fraktuer ynsidintsje yn it ferfolch 
(16,7%) as pasjinten sûnder (14%).
FUNKSJONIELE EN SOSJaLE UtKOMStEN
De haadstikken fiif en seis behannelje stúdzjes mei útkomsten fan in prospektive follow-
up fan 1 jier fan 498 pasjinten mei in heupfraktuer, behannele yn it Reinier de Graaf 
Gasthuis, Delft yn 2008-2009
Werom gean nei de wenomjouwing fan foar de fraktuer
Yn dit haadstik wurde de útkomsten toant fan in prospektive kohort ferfolch stúdzje fan 
444 pasjinten fan 65 jier en âlder mei in heupfraktuer, stratifisearre yn kategoryen op grûn 
fan it “pre-fraktuer”- wenplak. Twaentritich prosint fan de pasjinten dy’t selsstannich yn 
harren eigen wenning wennen foar de heupfraktuer, gong nei it ûntslach werom nei hûs, 
nei trije en 12 moannen wie dat 73%.
Leeftyd, it ûntbrekken fan in partner, demintens, in legere pre-faktuer ADL nivo 
(warberens fan it deistich libben) en in beheinde mobiliteit wienen ûnôfhinklike risiko 
faktoaren foar it net werom gean nei hûs nei it ûntslach en nei trije en 12 moannen.
Fan de pasjinten dy’t yn in fersoargingshûs wennen foar de opname, gong bij ûntslach 
33% werom, 68% nei 3 moannen en 64% nei 12 moannen. Leeftyd wie de ienichste 
ûnôfhinklike risikofaktor foar it net werom gean nei it fersoargingshûs by ûntslach. Leeftyd, 
demintens en in leger pre-fraktuer ADL nivo wienen de wichtichste risikofaktoaren foar it 
net werom gean de pre-fraktuer wenomjouwing yn dizze stúdzje.
In protte oare faktoaren kinne de kar fan wenplak nei it ûntslach út it sikehûs 
beynfloedzje. Hjirfan soe it sosjaal netwurk wol ris ien fan de wichtichste wêze kinne.
Herwinnen fan it pre-fraktuer mobiliteitnivo
Yn dit haadstik wurde de útkomsten presintearre fan in prospektife kohort follow-
up stúdzje fan 390 pasjinten fan 65 jier en âlder mei in heupfraktuer, stratifisearre yn 






































dizze stúdzje wie dat hast de helte fan alle pasjinten syn pre-fraktuer nivo fan mobiliteit 
nei in jier werom hie. Fierder die bliken dat pasjinten dy’t sûnder helpmiddels mobyl 
wienen minder kâns hienen om harren mobiliteit te herwinnen, yn fergelyk mei pasjinten 
dy’t mobyl wienen mei in helpmiddels of allinnich binnen hûs rûnen. Hast 19% fan alle 
pasjinten is nei ien jier net mear mobyl, dat wol sizze se sitte yn in rolstoel of binne bûn 
oan bêd. It risiko hjir op wie heger yn de groep mei al mear as in beheinde mobiliteit 
foar de fraktuer. It pre-fraktuer ADL nivo (warberens fan it deistich libben), de omfang 
fan ôfhinklikens fan oaren en it oprinnen fan in delier bij opname wienen de wichtichste 
risiko faktoaren foar it net herwinnen fan de âlde mobiliteit.
In kognitive fersteuring is ien fan de wichtigste net-evalueare risikofaktoaren foar it 
net werwinnen mobiliteit yn dizze stúdzje.
FOarSPULMODELLEN
It Risiko Model foar Delrium waard evaluearre (haadstik sân) en falidearre (haadstik acht)
In twadde foarspulmodel, dat de ûntslachlokaasje foarseit foar pasjinten mei in 
heupfraktuer dy foar de fal thús wennen, de “Discharge of Hip fracture Patients score” 
(DHP), dy’t ûntwikkele waard (haadstik njoggen) en ekstern falidearre (haadstik tsien).
Neisjen op it risiko op in delirium en it haloperidol profylakse programma
Yn 2008 waard yn it Reinier de Graaf Gasthuis in soarchpaad yntrodusearre foar pasjinten 
mei in heupfraktuer, wêrfan it Risiko Model foar Delirium (RD-skoare) ûnderdiel fan is.
De RD- skoare is in út 10 punten besteande fragelist dy’t in beoardieling makket fan it 
risiko op delirium. Pasjinten mei in heech risiko (skoare ≥ 5 punten) krigen haloperidol as 
profylakse foarskreaun. Dit model waard evaluearre bij 445 pasjinten fan 65 jier en âlder 
mei in heupfraktuer, opnommen yn 2008 en 2009.
De RD skoare waard bij 378 pasjinten ynfuld; 173 (45,8%) heech-risiko pasjinten 
waarden behannele mei profylaktyske medikaasje. De sensitivens fan de RD skoare foar 
in delirium wie 71.6%, de spesifisiteit 63.8% en de negatyf foarseine wearde (NPV) fan in 





































De delirium ynsidintsje (27%) wie amper ferskillend fan dy yn 2007 (28%) 2006 (24%) 
en 2005 (29%), de jierren foarôfgeande oan de yntroduksje fan de RD-skoare. 
Logistike regresje analyze toande oan dat heech risiko pasjinten in belangryk hegere 
delirium ynsidintsje hienen dan leech risiko pasjinten (42,2 tsjinoer 14,1%). Fierder wienen 
se behoarlik faker net werom gongen nei harren âlde wenlokaasje nei trije moannen 
(62,3% tsjinoer 17,0%) en hienen se minder kâns om binnen tsien dagen ûntslein te 
wurden út it sikehûs (34,9% tsjinoer 55,9%). Wichtige ûnôfhinklike risikofaktoaren foar in 
delirium wienen in RD-skoare ≥ 5, fan it manlik geslacht en leeftyd. 
De wichtichste konklúzje fan haadstik sân wie dat de RD-skoare in nuttich helpmiddels 
is om pasjinten te identifisearjen mei in heech risiko op in delirium en op oare mindere 
útkomsten. Lykwols, de ynfiering fan it delirium previnsje foarskriften hat de delirium 
ynsidintsje net minder makke. De wichtichste beheinings fan dizze stúdzje wienen it 
ûntbrekken fan ynformaasje op fine puntsjes oer de kognitive status en doer en djipte 
fan it delirium.
Falidaasje fan it risiko Model foar Delirium
Yn haadstik acht fynt men de stúdzje dy’t de klinyske betrouberens, faliditeit en helberens 
fan de RD skoare evaluearre hat mei help fan demografyske gegevens, de RD skoares en 
delirium ynsidintsje fan 378 pasjinten fan 65 jier en âlder mei in heupfraktuer.
Hûndert en twa pasjinten (27%) waarden diagnostisearre mei in delirium. De ‘intra-
class correlatie coëfficiënt’ fan de RD skoare wie 0,77 (CI 0,68-0,84), de sensitivens 80,4% 
(CI 71,4-87,6), en de spesifisiteit 56,2% (CI 50,1-62,1). De oerflakte ûnder de “receiver 
operating characteristic” kurve wie 0,73 (CI 0,68-0,77). In multifariabele logistyske 
regressy analyze toande oan dat njonken de RD skoare, in pertrosjanteare femurfraktuer 
en it manlik slach ôfhinklike risikofaktoaren wienen foar in delirium. It die bliken dat de 
RD skoare betrouber, praktysk en in falide ynstrumint wie foar it foarsizzen fan delirium 
bij pasjinten mei in heupfraktuer. It soe fan tafoege wearde wêze om it model oan te 
passen troch it tafoegen fan skoare manlik geslacht en “ pertrochantere femurfractuur” 
en it fuortheljen fan de skoares “deistige konsumpsjes fan mear as fjouwer alkohoalyske 







































It doel fan de stúdzje beskreaun yn haadstik njoggen wie om in betrouber ynstrumint 
te ûntwikkeljen dat al bij de opname de ûntslachlokaasje foarseit foar pasjinten mei in 
heupfraktuer dy foar de fraktuer selsstannich wennen: de “Discharge of Hip fracture 
Patients score”. Foar dit doel waarden 310 pasjinten fan 50 jier en âlder mei in heupfraktuer 
analysearre, allegear behannele yn Delft. De skoare rûn fan 0-100. Risikofaktoaren foar 
ûntslach nei in alternative lokaasje (OAL) wienen in hegere leeftyd, it froulik geslacht, 
demintens, ôfwêzigens fan in partner en in beheinde mobiliteit. It ôfknappunt waard 
steld op 30 punten, mei in sensitivens fan 83,8%, in spesifisiteit fan 64,7% en in posityf 
foarsizzende wearde fan 79,2%.
De DHP is in betroubere, koarte en ienfâldige skoare dy’t al bij opname brûkt wurde 
kin om de ûntslachlokaasje fan pasjinten mei in heupfraktuer te foarsizzen. Der binne 
earder fergelykbere skoares ûntwikkele, mar dizze ha harren praktyske beheinings.
Beheinings fan ús stúdzje wie de krapte oan ynformaasje op detail nivo oer de 
kognative funksje en it feit dat de mobiliteit kategory “ymmobyl” en de kategory “allinnich 
mobyl yn hûs” net apart beoardielt wurde koenen. 
Ta beslút, dit is in model foar de Nederlânske sosjale situaasje en mooglik net fan 
tapassing op oare lannen. Lykwols, de skoare ûnderdielen dy’t wy brûkt ha wienen te 
fergelykjen mei dy fan eardere modellen dy’t ûntwikkele waarden yn oare lannen ((it 
Feriene Keninkryk, Sweden, Feriene Steaten). (48-50).
Eksterne falidaasje fan de ûntslachskoare (DHP)
De eksterne falidaasje fan de DHP waard útfierd yn in kohort fan 125 pasjinten fan 50 jier 
en âlder mei in heupfraktuer opnommen yn it Universitair Medisch Centrum in Grins.
It Grinzer kohort wie jonger as men fergeliket mei it Delfts kohort, (gemiddelde 
leeftyd 75,4 tsjinoer 78,5 jier) mar hie faker ASA klassifikaasje III / IV (46,4% fersis 
25,2%). De sensitiviteit fan de DHP foar ûntslach nei in alternative lokaasje (OAL) yn it 
Grinzer kohort wie 75% (tsjin 83,8%), de spesifisiteit 66,7% (tsjin 64,7%) en de posityf 
foarsizzende wearde (PPV) wie 86,3% (tsjin 79,2%) as men dat fergeliket mei it Delfts 
kohort. De eksterne falidaasje fan de DHP toande oan dat dizze skoare goed en betrouber 
wie, de skoare wie in betroubere foarsizzer fan de ûntslachlokaasje fan pasjinten út in 






































Om dy reden is de DHP skoare in nuttich, betrouber en ienfâldich ta te passen 
ynstrumint foar de algemiene heupfraktuer populaasje yn Nederlân.
taKOMSt
As men ûndersyk docht sil dit altyd nije fragen en ynsjoggen opsmite. Algemiene en 
spesjale ferbetteringen fan de soarch foar pasjinten mei in heup fraktuer moatte neistribbe 
wurde om bettere en doelmjittiger soarch te leverjen foar dizze kwetsbere populaasje. 
De oerheid en soarchfersekerders stelle kwaliteit yndikatoaren op foar sikehuzen (en 
dokters) om de pasjintensoarch te ferbetterjen. Lykwols, dizze yndikatoaren moatte wol 
terjochte koazen wêze, bij foarkar op grûn fan betroubere parameters en útkomsten 
fan Nederlânske pasjinten. Dit kin allinnich dien wurde as der foldwaande “baseline” 
parameters en bysûnderheden fan pasjinten mei in heupfraktuer registrearre binne. It 
sukses fan it lanlik Nederlânske ymplantaten register LROI (no noch allinnich mei data fan 
totale heup en knibbel protezen, www.lroi.nl) is in prima foarbyld om te folgjen.
Guon Europeeske lannen binne yn it ôfrûne desennium al begongen mei in lanlike 
heupfraktuer database. Mei dizze databases kinne geskikte yndikatoaren fan goeie soarch 
foar pasjinten mei in heupfraktuer werkend wurde. Yn it NHS-systeem yn Skotlân bygelyks 
wurde de útkomsten jierliks analysearre en sikehuzen mei in stjertesifer dat heger is as 
ferwacht wurde neier ûndersocht en wêr mooglik wurde der ferbetter projekten yn 
gong set. It herwinnen fan it pre-fraktuer nivo fan mobiliteit, werom gean nei de âlde 
wenomjouwing en pasjint rapportearre kwaliteit fan libben soenen wichtige yndikatoaren 
fan goede heupfraktuer soarch wêze kinne. De útkomsten fan de Nederlânske sikehuzen 
kin men fergelykje en sikehuzen die behoarlik leger prestearje yn fergelyk mei it nasjonaal 
trochstrings, moatte ferbetteringen fan soarch trochfiere.
Stigende kosten binne in wier probleem foar alle lannen mei in hieltyd grizer wurdende 
befolking. Sa as yn de ynlieding fan dit proefskrift al neamt is, binne neffens it rapport fan 
de Nationale Hip Fracture Database út 2011 dizze kosten yn it Feriene Keninkryk hast twa 
en in heal miljard euro per jier (7)
Dizze kosten kinne fermindere wurde troch de hjoeddeiske soarch foar pasjinten mei 






































fraktueren en troch ynfieren fan “evidence-based” soarchpaden. Dizze soarchpaden 
hâlde rekkening mei de meast belangrike aspekten fan dizze fragile pasjinten populaasje 
en standerdisearje de wize fan neisjen en previnsje fan ferskate risiko faktoaren en 
behanneling, sawol pre-, peri as postoperatyf.
Gearwurking mei geriaters, by foarkar op in saneamde “geriatrische fractuur 
afdeling” is in wêzenlik ûnderdiel om de kwaliteit te ferbetterjen. Op sa’n ôfdieling wurde 
it kinnen en kunde fan ortopedysk en trauma sjirurchen oan de iene kant en geriaters, 
spesjalisearre ferpleechkundigen en fysioterapeuten oan de oare kant, kombinearre.
Ta beslút is it troch opname fan pasjinten mei in heupfraktuer op sa’n geriatryske 
fraktuer ôfdieling, de registraasje fan basislijn parameters en it mjitten fan útkomsten 
folle ienfâldiger. Previnsje fan osteoporose-relatearre fraktueren kin op ferskate wizen 
realisearre wurde en is in ûndersykmêd op himsels. Betide opspoaring fan osteoporose 
en it begjinnen fan medikaasje is mar in part fan de oplossing. Like wichtich is de 
identifikaasje fan risikofaktoaren foar fallen (51). Core stabiliteit training mei fysioterapy, 
tai chi as firtuele training kin in wichtige rol spylje, krekt as neisjen op en ferbettering 
fan in minder wurdend sicht en gehoar. Multi-komponint of multimodale yntervinsje 
programma’s drage op syn minst likefolle bij oan de previsje fan in delirium as gemyske 
profylaxe. (52)
De konklúzje is dat takomstich ûndersyk by pasjinten mei in heupfraktuer rjochte wêze 
moat op al dizze ferskate aspekten fan previnsje fan fraktueren. By pasjinten mei in 
fraktuer, moat it minimalisearjen fan de morbiditeit de wichtichste doelstelling wêze; 
hjirmei wurdt de ympakt fan dit yngripend barren op de kwaliteit fan libben en de 
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‘Collum Care’, een zorgpad voor patiënten met een gebroken heup
Voor elke heup een rode map
In het Reinier De Graaf Ziekenhuis verloopt de 
behandeling van patiënten met een heupfractuur volgens 
een vast model. Voor elke patiënt is er een rode map met 
formulieren en protocollen waarin allerlei facetten van 
de zorg zijn vastgelegd.
Omdat naar verwachting het aantal heupfracturen 
de komende jaren fors zal toenemen en omdat de 
behandeling ervan ingewikkeld is, moet deze zorg met 
innovatieve concepten verder worden gestroomlijnd. 
Parker en Johansen karakteriseren de heupfractuur 
in dat verband ‘als een echte test en bruikbare marker 
voor de integratie en effectiviteit van de moderne zorg’.1 
Het succes van zorgpaden voor electieve orthopedische 
ingrepen zoals totale heup- of knieprothesen was de 
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Osteoporosescreening is onderdeel van het proces geworden. Links aios orthope die Anne Vochteloo en 
rechts nurse practitioner osteoporose Peter van den Berg.
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De kwetsbaarheid van de patiënten met een heupfractuur blijkt wel uit de hoge 
mortaliteit.
De éénjaarsmortaliteit ligt rond 25 procent, terwijl dit bij leeftijdgenoten zonder 
fractuur ongeveer 10 procent is.1 3
Zo’n 10 procent van de patiënten met een heupfractuur kan niet terugkeren naar 
de oude woonsituatie. Dit heeft ingrijpende gevolgen voor de patiënten en veroorzaakt 
daarnaast grote doorstroomproblemen in ziekenhuizen.1
Naast het niet-electieve karakter van heup- fracturen zijn deze punten de meest in het 
oog springende verschillen met de patiëntenpopulaties van de zorgpaden voor electieve 
heup- en knieprothesiologie. Bij het vertalen van de basisprincipes zal daarom de nadruk 
op deze verschillen moeten liggen.
Standaardiseren en integreren
In het Reinier de Graaf Ziekenhuis (RdGG) wordt de traumatologie van het bewegings- 
apparaat – net als in veel (opleidings)ziekenhuizen – verzorgd door de afdelingen 
Orthopedie en Heelkunde. Het ontwikkelen van een zorgpad begon met het inventariseren 
van de bestaande opvattingen en protocollen voor de preoperatieve screening door 
internist en/of cardioloog, voor postoperatieve belastbaarheid van osteosynthesen, 
voor tromboseprofylaxe, voor perioperatieve pijnstilling en voor het screenen van 
osteoporose. Om dit nauwkeurig te doen, hebben we de patiëntenpopulatie van 
2005-2007 retrospectief zo gedetailleerd mogelijk in kaart gebracht. Naast cijfers uit 
verschillende informatiesystemen en statussen zijn ook de gegevens van het verpleeghuis 
waar de meeste patiënten naartoe gaan, aan het geheel toegevoegd. Doordat in de status 
Met behulp van de ‘rode mappen’ kunnen 
anamnese, diagnostiek, communicatie en (peri)
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expliciete vermeldingen van screening op onderwerpen als deliriumrisico, ondervoeding 
en osteoporose meestal ontbraken, was de kwaliteit 
van het beleid op deze gebieden niet te toetsen. In 
2007 is de werkgroep ‘heupfracturen’ begonnen 
met het standaardiseren van de diverse protocollen 
en het integreren van deze protocollen tot een 
standaardpatiëntendossier dat leidend werd voor het (para) medische team. Onderdelen 
van dit dossier zijn het inschatten van het risico op een delirium en het inventariseren 
van de voedingstoestand, het mobilisatieniveau, de woonsituatie en de geestelijke en 
lichamelijke gezondheidsbeleving van de ‘Collum Care’-patiënten. Dit dossier kreeg de 
werknaam de ‘rode map’.
In de nieuwbouwplannen van het RdGG staat een verpleeghuisafdeling van de Pieter van 
Foreest Stichting (PvF) gepland. Doordat er vanaf oktober 2007 een ruimte in het huidige 
ziekenhuis beschikbaar kwam, de ‘Herstelunit’, kon er ervaring worden opgedaan. Er 
werd een begin gemaakt met de doorstroom van stabiele patiënten die alleen nog in het 
ziekenhuis verbleven om te revalideren.
Delirium
Hoewel er een screeningsprotocol bestond, werd vóór de invoering van het zorgpad 
‘Collum Care’ noch op de Spoedeisende Hulp (SEH) noch op de verpleegafdelingen 
standaard de voedingstoestand en het risico op een delirium bepaald.
Nu vult de verpleegkundige of de dienstdoende a(n)ios op de SEH het Risicomodel 
Delirium in.4 Als deze score boven de 5 is, wordt er preoperatief gestart met profylaxe, 
te weten haloperidol (Haldol) en lorazepam (Lorazepam, Temesta). Bij contra-indicaties 
voor haloperidolgebruik wordt in overleg met de psychiater een alternatief gezocht.
Voor de voedingstoestand wordt de SNAQ-score ingevuld.5 Deze score bestaat uit 
drie vragen die elk 1 punt kunnen opleveren. Een totaalscore van 1 of 2 punten geeft 
recht op extra tussengerechten; bij een score van 3 punten wordt de ziekenhuisdiëtiste 
geconsulteerd.5
De afdelingen Heelkunde en Orthopedie hanteerden een verschillend tromboseprofylaxe-
protocol (vitamine-K-antagonisten versus laagmoleculaire heparine). Het nieuwe 
uniforme protocol bestond uit zes weken laagmoleculaire heparine of hervatten van 
Een totaalscore van






































vitamine-K-antagonisten bij patiënten die deze al preoperatief gebruiken. De nierfunctie 
werd voorheen niet standaard berekend, terwijl van enkele patiënten die NSAID’s kregen 
de nierfunctie onnodig achteruitging. Sinds 2008 wordt standaard met paracetamol als 
pijnstilling gestart en een NSAID bij een acceptabele nierfunctie (de creatinineklaring 
wordt nu standaard berekend), zo nodig aangevuld met een opiaat.
Preoperatief consult
In veel ziekenhuizen worden acuut opgenomen oudere patiënten met een operatie-
indicatie preoperatief gezien door een internist en vaak nog apart door een cardioloog. 
Anesthesiologen willen echter vaak andere informatie over de medische conditie van een 
patiënt dan hetgeen de geconsulteerde internist aanbiedt. Bovendien waren de consulten 
in het RdGG erg wisselend van inhoud en sterk afhankelijk van het aandachtsgebied 
van de superviserende internist. Om de meerwaarde van het preoperatieve consult te 
vergroten en dubbelwerk te voorkomen is er, in samenspraak tussen Anesthesiologie 
en Interne Geneeskunde een consult opgesteld met standaardaandachtpunten die 
specifiek zijn gericht op de perioperatieve zorg. Zo is er een kant-en-klaardocument met 
perioperatieve adviezen over vochtbeleid en medicatie voor anesthesioloog en a(n)ios op 
de verpleegafdeling ontstaan.







































Per 1 januari 2008 zijn we begonnen met een prospectieve registratie van de gegevens 
uit de ‘rode map’. Hierin zitten vragenlijsten die de patiënt invult, eventueel met hulp van 
familie, begeleiders of een SEH-verpleegkundige.
Deze vragenlijsten zijn de SF-12 (een score voor 
emotionele en lichamelijke gezondheidsbeleving), de 
Groningen Activity Restriction Score (GARS, een score 
voor functionele algemene dagelijkse levensverrichtingen), de eerder genoemde SNAQ-
score en het Risicomodel Delirium.4-6
Verder worden de mobiliteit, de woonsituatie en de geleverde mantelzorg van de 
patiënt vastgelegd. Daarnaast bevat de rode map het gestandaardiseerde preoperatieve 
consult interne geneeskunde en een opnamestatus met een invulvel voor anamnese, 
lichamelijk onderzoek, ASA-classificatie en doktersorders. Ook zitten er formulieren in 
voor de postoperatieve statusvoering.
Daardoor kan op uniforme wijze de anamnese, diagnostiek, communicatie en (peri)
operatieve zorg worden uitgevoerd. Bovendien worden er gegevens verzameld om de 
kwaliteit te toetsen.
Osteoporose
Vóór de invoering van het zorgpad besteedde de afdeling Heelkunde meer aandacht 
aan het screenen op osteoporose dan Orthopedie. Op beide afdelingen was de 
osteoporosescreening echter beneden de maat. Momenteel wordt op de tweede dag na 
de operatie het routinebloedonderzoek (onder andere hemoglobinebepaling) uitgebreid 
met aanvragen die specifiek bij osteoporosescreening horen.
Bij ontslag uit het ziekenhuis wordt de post-operatieve afspraak bij de behandelend 
(orthopedisch) chirurg gecombineerd met een bezoek aan een nurse practitioner op het 
osteoporose- spreekuur. Afhankelijk van een vragenlijst en de laboratoriumuitslagen 
van het klinisch bloedonderzoek wordt een botdensiometrie uitgevoerd. 
Osteoporosescreening is hiermee een onderdeel van het proces geworden. Behalve dat 
er enkele wetenschappelijke studies zijn gestart, is er ook een follow-up van alle patiënten 
bijgehouden over 2008. Deze bestaat uit de klinische registratie van alle patiënten, een 
beoordeling van de mortaliteit 3 en 12 maanden na de operatie en een beschrijving van 
De osteoporosescreening






































de woonsituatie, de mobiliteit en de gezondheidsbeleving, vaak ingevuld met hulp van 
mantelzorgers.
Herstelunit
Aan de hand van de vragenlijsten krijgt men een goed beeld van pre- en postoperatieve 
woonsituatie van patiënten. Van degenen die naar de Herstelunit werden ontslagen, ging 
na gemiddeld 30 dagen, 90 procent terug naar de oude woonsituatie. Uiteindelijk is na 
drie maanden twee derde van de mensen die uit een zelfstandige woonsituatie of uit een 
verzorgingshuis kwamen, weer terug in de oude situatie.
Bij het evalueren van de pre- en postoperatieve mobiliteit vielen twee zaken op. 
Preoperatief liep 36 procent van de patiënten zonder hulpmiddel, drie maanden na de 
operatie kon slechts 11 procent dit. Verder was 4 procent preoperatief bedlegerig, na drie 
maanden is dit toegenomen tot 13 procent. Bij 106 (86%) patiënten was er sprake van 
homogene dataverzameling.
Verbetering
Vooral het feit dat de Spoedeisende Hulp veel door jonge, vaak onervaren artsen wordt 
bemand, maakt het gebruik van een zorgpad met een standaardpatiëntendossier (waarin 
alle benodigde stappen staan aangeven en de beno- digde papieren zitten) een nuttig 
hulpmiddel. Inventariseren van het risico op een delier en van de voedingstoestand, 
goede perioperatieve adviezen over (pijn)medicatie, vochtmanage- ment en poliklinische 
screening op osteoporose zijn standaard geworden. Daarnaast zijn door het invoeren van 
het zorgpad alle protocollen doorgelicht en uniform gemaakt. Daarom kunnen wij zeggen 
dat een zorgpad als ‘Collum Care’ een kwaliteitsverbetering is voor ons ziekenhuis, hoewel 
deze nieuwe opzet nog minder dan een jaar operationeel is. De behaalde verbeteringen 
zijn weergegeven in het overzicht.
Het geïntegreerde programma is verder een goede basis om de zorg verder te 
optimaliseren door middel van de diverse opgezette wetenschappelijke projecten en 
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Verbeteringen door ‘Collum Care’
onderwerp uitgangssituatie huidige situatie
osteoporose willekeurige screening standaardscreening
trombose 
profylaxe
twee verschillende protocol len één uniform protocol
voedingstoestand geen standaardinventarisatie op 
SEH, aandacht protocol verschilt per 
verpleegafdeling
altijd SNAQ score bij opname
delierrisico geen standaardrisico inschatting op 
SEH, aan dacht protocol verschilt 
per verpleegafdeling
standaarddelierscore bij opname




pijnstilling arts afhankelijk terug 
houdendheid met NSAID’s
NSAID’s afhankelijk van 
nierfunctie
Samenvatting 
De verschillende proto collen van de afdelingen Orthopedie en Heel kunde voor patiënten 
met een gebroken heup zijn tot één uniform multidisciplinair zorgpad samengevoegd.
Het zorgpad levert complete zorg door middel van integratie van eenvoudige 
interventies.
Dataverzameling levert in de nabije toekomst zeer relevante informatie over onder 
andere het postoperatieve beloop van woonsituatie en mobilisatiegraad van patiënten 
met een gebroken heup.
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Experiences with a fracture clinic. 
“De Delftse Fractuur- en Osteoporosepolikliniek. 
Via casefinding naar lifestyle interventie: 
meer aandacht voor medicatietrouw.” 











































































Screening en tijdige behandeling voorkomen fracturen
Osteoporose vroeger signaleren
Met de juiste behandeling zijn veel osteoporotische 
fracturen te voorkomen. Maar dan moeten de 
risicofactoren voor osteoporose wél in een vroeg stadium 
worden gesignaleerd. En de patiënt moet trouw zijn 
medicijnen slikken.
Osteoporotische fracturen komen de laatste decennia 
steeds vaker voor. Ze zijn echter voor een groot deel 
te voorkomen door risicofactoren vroegtijdig te 
onderkennen en een passende behandeling te starten. 
Peter van den Berg,
nurse practitioner fracturen en 
osteoporose
dr. Dave Schweitzer, 
internistendocrinoloog; drs. Anne 
Vochteloo, aios orthopedie; dr. 
Peter Pilot, senior onderzoeker 
orthopedie; drs. Dieu Donné 
Niesten, orthopedisch chirurg; 
dr. Mark de Vries, chirurg-
traumatoloog; dr. Maarten van der 
Elst, chirurg-traumatoloog, allen 











































Zo’n behandeling zou volgens de CBO-consensus geschikt zijn voor patiënten van 
50 jaar en ouder met een laagenergetische fractuur.1 In 2005 werd, in navolging van 
McLellan en Hegeman, in het Delftse Reinier de Graaf 
Gasthuis een werkgroep opgericht die een fractuur- en 
osteoporosepolikliniek moest opzetten.2 3 De werkgroep 
bestond uit een chirurg/traumatoloog, een orthopedisch 
chirurg, een endocrinoloog/internist, een nucleair geneeskundige, een fysiotherapeut 
en een gipsverbandmeester/nurse practitioner. De oprichting van de polikliniek werd 
mogelijk gemaakt door een eenmalige financiële injectie van de lokale zorgverzekeraar 
DSW.
De Delftse Fractuur en Osteoporose Polikliniek screent fractuurpatiënten van 50 jaar 
en ouder op risicofactoren voor osteoporose, verstrekt leefstijladviezen, schrijft medicatie 
voor (indien geïndiceerd), communiceert met de huisarts en ondersteunt de patiënt 
bij de medicatietrouw. Dit laatste is een belangrijk aspect; uit de literatuur is namelijk 
bekend dat de medicatietrouw een jaar na het voorschrijven van de medicatie sterk is 
afgenomen.4 Sommige rapportages melden al in het eerste jaar een medicatieontrouw 
van 50 procent; de groep die met medicatie was gestopt had een significant hogere 
fractuurkans.5
risicopatiënt
In de periode van 1 juli 2007 tot 1 juli 2008 is in het Reinier de Graaf Gasthuis een 
groep mannen en vrouwen van 50 jaar en ouder gescreend, die met een fractuur op de 
Spoedeisende Hulp (SEH) waren terechtgekomen. Na de initiële fractuurbehandeling zijn 
de patiënten doorverwezen naar de Fractuur en Osteoporose Polikliniek. Daar werd aan 
de hand van de botdichtheid (gemeten met de DEXA-scan) het fractuurrisico vastgesteld 
op basis van de standaardindeling van de Wereldgezondheidsorganisatie WHO (T-score 
<-2,5 SD bij osteoporose, -2,5 tot -1,0 SD bij osteopenie). Bij een T-score van <-2,0 werd 
laboratoriumonderzoek verricht en werden röntgenfoto’s van de wervelkolom gemaakt.
In de optiek van de werkgroep is de volgende werkwijze efficiënt: het identificeren van 
de risicopatiënt, een zorgvuldige diagnostiek, de start van een effectieve behandeling en
ondersteuning door goede communicatie met de patiënt en huisarts.6 Met alle betrokken 
partijen is afgesproken om gedurende het eerste jaar van de behandeling vier maal 
De casefinding vindt 
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telefonisch contact op te nemen met de patiënt. Dit contact is vooral gericht op de vraag 
naar medicatie- trouw en op ondersteuning van de patiënt om met de medicatie door te 
gaan.
De casefinding vindt bewust niet plaats op de SEH vanwege de hectiek, maar in de 
gipskamer en de traumapoliklinieken. Daar wordt het belang van screeningsonderzoek 
naar osteoporose uitgelegd en een combinatieafspraak gemaakt voor een DEXA-
onderzoek en een gesprek over de uitslag met de nurse practitioner. Deze controleert met 
behulp van de SEH-gegevens de volledigheid van de inclusie en benadert de patiënt zo 
nodig schriftelijk voor een onderzoek op osteoporose. Fractuurbehandeling én onderzoek 
op osteoporose worden op dezelfde dag gedaan (one-stop visiting). Voor patiënten met 
een heupfractuur is de screening op osteoporose al geïntegreerd in een vast zorgpad.7
Om het polikliniekbezoek te stroomlijnen en de patiënt in staat te stellen alle 
informatie te overdenken, krijgt elke patiënt schriftelijke informatie en een vragenlijst 
mee naar huis. Met behulp van dit anamneseformulier volgt een soepel en vlot verlopend 
anamnesegesprek en krijgt de patiënt een leefstijladvies op maat.







normale BMD T-score ≥ –1,0 121 (23%) 39 (30%) 160 (25%)
osteopenie T-score –1,0  ≥ –2,4 206 (41%) 49 (38%) 255 (40%)
osteoporose T-score ≤ –2,5 180 (36%) 41 (32%) 221 (35%)
Het fractuurrisico van 636 patiënten gemeten aan de hand van de botmineraal- dichtheid (BMD). 
De T-score vergelijkt de gemeten BMD met de gemiddelde waarde bij een groep jonge, gezonde 
personen van hetzelfde geslacht.







internist 52 (28%) 32 (78%) 84 (38%)
andere specialist 15 (10%) 3  (8%) 18  (8%)
huisarts 113 (62%) 6 (14%) 119 (54%)
Na screening in de osteoporosepolikliniek wordt ruim de helft van de patiënten doorverwezen naar 







































In totaal werden 636 patiënten doorverwezen; zij kregen een eerste voorlichtingsgesprek 
met de nurse practitioner en werden geëvalueerd met behulp van een DEXA-analyse. 
Het betrof 129 mannen en 507 vrouwen met een gemiddelde leeftijd van 63 jaar (zie 
tabel 1). Patiënten met vormen van secundaire osteoporose werden doorverwezen naar 
de internist; sommige patiënten werden naar een andere specialist (terug)verwezen 
(zie tabel 2). Patiënten met een normale botdichtheid en patiënten met een verlaagde 
botmassa kregen een leefstijladvies met betrekking tot bewegen, het reduceren van 
het valrisico en de inname van calcium met de voeding. De overblijvende groep (221 
patiënten) werd nader onderzocht.
Van deze patiënten werd de vitamine-D-spiegel onderzocht; van hen hadden 100 
patiënten (45%) vitamine-D-insufficiëntie (<50 nmol/l) en 10 patiënten (0,5%) vitamine-
D-deficiëntie (<20 nmol/l). Patiënten met een vitamine-D- spiegel lager dan 50 nmol/l 
adviseerden wij een vitamine-D-houdend preparaat. De huisartsen van deze patiënten 
ontvingen een schriftelijke rapportage van uitgevoerd onderzoek en de door ons 
ingestelde behandeling.




































Een bot van een  89jarige 
vrouw met osteoporose. 
 
beeld:  Corbis 
normale botdichth id en patiënten met een 
verlaagde botmassa kregen een leefstijladvies 
met betrekking tot bewegen, het reduceren van 
het valrisico en de inname van calcium met de 
voeding. De overblijvende groep (221 patiënten) 
werd nader onderzocht. 
Van deze patiënten werd de vitamineDspiegel 
onderzocht; van hen hadden 100 patiënten 
(45%) vitamineDinsufficiëntie (<50 nmol/l) 
en 10 patiënten (0,5%) vitamineDdeficiëntie 
(<20 nmol/l). Patiënten met een vitamineD 
spiegel lager dan 50 nmol/l adviseerden wij een 
vitamineDhoudend preparaat. De huisartsen 
va  deze patiënten ontvingen een schriftelijke 
rapportage van uitgevoerd onderzoek en de 
door ons ingestelde behandeling. 
 
 
Uiteindelijk ontdekten we met behulp van 
onze casefindingstrategie dat 119 patiënten 
(19%) m t een fractuur een vorm van osteopo 
rose hadden die door de huisarts verder kon 
worden behandeld. Deze patiënten kregen een 
bisfosfonaat als medicatie voorgeschreven en 
zo nodig calciumsuppletie. Voor deze groep 
werd de huisarts gevraagd de behandeling 
over te nemen. De medicatietrouw werd echter 
gedurende het eerste jaar vanuit het ziekenhuis 
ondersteund door de nurse practitioner. Deze 
nam in het eerste jaar vier keer telefonisch con 
tact op met alle patiënten die werden behan 
deld met bisfosfonaten. Alle gegevens werden 
systematisch toegevoegd aan een bewerkbaar 
databestand met eerder verkregen uitkomsten. 
De telefooncontacten, aan de hand van een 
vaste vragenlijst, vonden plaats na één, drie, 
zeven en twaalf maanden. De nurse practitio 
ner vroeg in deze gesprekken naar eventueel 
opgetreden nieuwe fracturen, de valfrequentie, 
voeding en medicatietrouw. 
Bij het vierde telefonische contact, een jaar na 
de fractuur, bleek dat 93 patiënten (80%) 
medicatietrouw waren gebleven. Er waren 3 
patiënten overleden gedurende de followup, 
9 patiënten hadden de bisfosfonaten gestaakt 
in overleg met de huisarts zonder terugkop 
peling aan ons, 9 patiënten waren uit eigen 
beweging gestopt en 5 patiënten namen de 
bisfosfonaten niet meer volgens voorschrift in. 
 
 
Voornaamste beweegredenen die osteoporose 
patiënten aanvoeren voor het stoppen met de 
onderhoudsmedicatie zijn enerzijds gebrek 
aan geloof in het effect, anderzijds de vrees 
voor bijwerkingen van de medicatie op korte en 
langere termijn. 
De medicatie wordt ook gestopt in overleg met 
de huisarts en meestal vindt geen vervolgbe 
handeling plaats.8 9 Onderzoek onderstreept 
echter het belang van de mening van de behan 
delaar ten aanzien van onderhoudsmedicatie 
én de positieve communicatie hierover met de 
patiënt.10 Daar komt bij dat frequenter contact 
de therapietrouw bevordert.11 Onze ervaring 
is dat de fractuur een centrale rol speelt in de 
beleving van patiënten. Velen vinden in deze 
traumatische ervaring een motivering om 
trouw de medicatie te blijven nemen. Om die 
reden propageren wij de medicatie zo spoedig 
mogelijk na een fractuur te starten. Een tweede 
argument voor een vlotte start van de behan 
deling is het gegeven dat de eerste recidief 
fractuur veelal zal optreden binnen één jaar na 
de eerste fractuur.12 
Het eerste telefonische contact via de nurse 
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Uiteindelijk ontdekten we met behulp van onze casefindingstrategie dat 119 patiënten 
(19%) met een fractuur een vorm van osteoporose hadden die door de huisarts verder kon 
worden behandeld. Deze patiënten kregen een bisfosfonaat als medicatie voorgeschreven 
en zo nodig calciumsuppletie. Voor deze groep werd de huisarts gevraagd de behandeling 
over te nemen. De medicatietrouw werd echter gedurende het eerste jaar vanuit het 
ziekenhuis ondersteund door de nurse practitioner. Deze nam in het eerste jaar vier keer 
telefonisch contact op met alle patiënten die werden behandeld met bisfosfonaten. Alle 
gegevens werden systematisch toegevoegd aan een bewerkbaar databestand met eerder 
verkregen uitkomsten. De telefooncontacten, aan de hand van een vaste vragenlijst, 
vonden plaats na één, drie, zeven en twaalf maanden. De nurse practitioner vroeg in 
deze gesprekken naar eventueel opgetreden nieuwe fracturen, de valfrequentie, voeding 
en medicatietrouw.
Bij het vierde telefonische contact, een jaar na de fractuur, bleek dat 93 patiënten 
(80%) medicatietrouw waren gebleven. Er waren 3 patiënten overleden gedurende de 
follow-up, 9 patiënten hadden de bisfosfonaten gestaakt in overleg met de huisarts 
zonder terugkoppeling aan ons, 9 patiënten waren uit eigen beweging gestopt en 5 
patiënten namen de bisfosfonaten niet meer volgens voorschrift in.
Bijwerkingen
Voornaamste beweegredenen die osteoporosepatiënten aanvoeren voor het stoppen 
met de onderhoudsmedicatie zijn enerzijds gebrek aan geloof in het effect, anderzijds de 
vrees voor bijwerkingen van de medicatie op korte en langere termijn.
De medicatie wordt ook gestopt in overleg met de huisarts en meestal vindt geen 
vervolgbehandeling plaats.8 9 Onderzoek onderstreept echter het belang van de mening 
van de behandelaar ten aanzien van onderhoudsmedicatie én de positieve communicatie 
hierover met de patiënt.10 Daar komt bij dat frequenter contact de therapietrouw 
bevordert.11 Onze ervaring is dat de fractuur een centrale rol speelt in de beleving van 
patiënten. Velen vinden in deze traumatische ervaring een motivering om trouw de 
medicatie te blijven nemen. Om die reden propageren wij de medicatie zo spoedig 
mogelijk na een fractuur te starten. Een tweede argument voor een vlotte start van de 
behandeling is het gegeven dat de eerste recidieffractuur veelal zal optreden binnen één 





































Het eerste telefonische contact via de nurse practitioner concentreert zich op de eerste 
ervaringen van de patiënt met het gebruik van bisfosfonaten; in verband met de mogelijke 
bijwerkingen vindt dit contact al na vier weken plaats. Na de eerste doses ontstaan vaak 
griepachtige verschijnselen die vanzelf weer overgaan, maar die de medicatietrouw 
negatief kunnen beïnvloeden. Wij veronderstellen dat extra uitleg en aandacht dit effect 
zullen tegengaan.
De overige telefonische contacten zijn voornamelijk gericht op het bevorderen van 
medicatietrouw en het benadrukken van het belang van de leefstijl; ook wordt nagegaan 
of de huisarts herhalingsrecepten heeft voorgeschreven. Uit de gesprekken kwam naar 
voren dat algemene gezondheidsadviezen zonder uitgebreide toelichting tegenstrijdig 
kunnen overkomen.13
Motiverend
De telefonische contacten namen in ons onderzoek doorgaans 10 minuten per gesprek 
en verslaglegging in beslag. Dat resulteerde in 119 x 10 minuten x 4 gesprekken = 4760 
minuten (79,3 uur) op jaarbasis. Ons inziens een waardevolle tijdsinvestering indien men 
zich realiseert dat hieraan voorafgaand 636 patiënten werden gescreend. Per fractuur 
betekent dit 40 minuten, oftewel 8 minuten per gescreende patiënt.
Financieel gezien is hiervoor echter vaak geen 
ruimte in de krappe intramurale budgettering van 
een ziekenhuis. Om kosten te besparen hebben wij 
daarom besloten de telefonische contacten voort te 
zetten met een lagere frequentie van drie keer in het eerste jaar. De ervaringen hiermee 
gaan we in de toekomst vergelijken met de hier gepresenteerde gegevens.
Casefinding door screening in de setting van een Fractuur en Osteoporose Polikliniek 
blijkt een goede strategie om patiënten met verhoogd osteoporoserisico op te sporen. 
Naast de 13 procent die naar de internist werd verwezen, kon bij 19 procent van de 
patiënten van 50 jaar en ouder (gemiddelde leeftijd 61 jaar) de diagnose osteoporose 
worden gesteld. De vier telefonische contacten in het eerste jaar werden door deze 
patiënten als motiverend ervaren en resulteerden in een medicatietrouw van 80 procent 
na één jaar. Deze doelmatigheidsslag vereist een goede organisatie maar betaalt zichzelf 
terug.
Vier telefoontjes resulteerden in 
een medicatietrouw







































De Delftse Fractuur en Osteoporose Polikliniek screent fractuurpatiënten van 50 jaar 
en ouder op risicofactoren, biedt leefstijladviezen, start medicatie en communiceert de 
interventies met de huisarts.
De patiënt krijgt telefonisch ondersteuning bij leefstijl(verandering) en medicatietrouw.
Deze contacten met een verpleegkundige ervaart de patiënt als motiverend, wat zich 
uit in een hoge medicatietrouw.




Cemented versus non-cemented hemiarthroplasty 
of the hip as a treatment for a displaced 
femoral neck fracture: design of a randomised 
controlled trial
Anne JH Vochteloo, DieuDonné Niesten, Roeland Riedijk, Willard J Rijnberg, Stefan BT Bolder, 
Sander Koëter, Keetie Kremers-van de Hei, Taco Gosens and Peter Pilot






































Background: A discussion is ongoing whether displaced femoral neck fractures in elderly 
patients should be treated with a non-cemented or a cemented hemiarthroplasty. A 
recent Cochrane analysis stresses the importance of further research into the relative 
merits of these techniques. We hypothesise that non-cemented hemiarthroplasty will 
result in at least the same technical-functional outcome and complication rate, with a 
shorter operation time.
Methods and design: A randomised controlled multicentre trial will be performed.
The study population consists of 200 patients of 70 years and older. Patients with 
a displaced femoral neck fracture will be allocated randomly to have a cemented or a 
non-cemented hemiarthroplasty. Data will be collected preoperatively, immediately 
postoperatively, and 6 weeks, 3 months and 1 year postoperatively.
The main outcome measures of this study are technical-functional results of the 
hemiarthroplasty, duration of surgery, complications, and mid-thigh pain. Secondary 
outcome measures are living conditions at final follow up, self-reported health-related 
quality of life, and radiological evaluation of the hemiarthroplasty.
Conclusion: A recent Cochrane analysis did not find arguments in favour of either non-
cemented or cemented hemiarthroplasty. The forthcoming trial will compare treatment 
for a displaced femoral neck fracture by cemented versus non-cemented hemiarthroplasty. 
Our results will be published as soon as they become available.







































Patients with a hip fracture form a heterogeneous group with a high mortality rate, 
frequently troubled with multiple and severe co-morbidities. They are usually frail and 
elderly, with more than 30% aged ≥ 85 years. In European series, hip fracture patients 
have a 30-day mortality of >10%, and a 1-year mortality of 25–30%.[1] Despite the 
advances in surgical and anaesthetic techniques during the last 20 years there has been 
no decrease in mortality after surgical repair of hip fractures. [1]
The discussion about cemented or non-cemented hemiarthroplasty is similar to 
the discussion about cemented or cementless prostheses in primary hip arthroplasty. 
With respect to the latter, conflicting data are presented by the Swedish and Norwegian 
arthroplasty registers. [2,3] The general opinion is that cementless hip arthroplasties 
are more suitable for younger patients owing to the quality of their bone stock. In 
hemiarthroplasty for hip fracture surgery there are insufficient data from randomised 
trials to conclude on the superiority of either type of arthroplasty. Some authors found 
patients with cemented stems to have less pain and better mobility postoperatively 
than those with an non-cemented press fit.[4] Mid-thigh pain is frequently reported 
in primary cementless total hip arthroplasties. However, the reported incidence varies 
tremendously; D’Lima et al.[5] in a control-matched study reported 34% vs. 3%, while 
Grübl et al.[6] in a non-controlled series reported only 3% for cementless primary total 
hip arthroplasties.
In cemented hemiarthroplasties polymethylmethacrylate bone cement is applied at 
the time of surgery, forming a solid bond between the prosthesis and the femoral bone; 
on the contrary, in cementless prosthesis the bonding between prosthesis and femur 
is dependent upon bony in-growth. Potential advantages of cementing are a less post-
operative mid thigh pain, as the prosthesis is firmly fixed within the femur, and a reduced 
long-term revision rate from loosening of the prosthesis. Major side effects of cement 
are cardiac arrhythmias and cardiorespiratory collapse, which occasionally occur on 
application. These potentially fatal complications are caused either by embolism from 
marrow contents forced into the circulation or by a direct toxic effect of the cement. [7] 






































The non-cemented hemiarthroplasty used in our study is the DB-10 (Biomet, Warsaw, 
USA), a straight collared stem designed to provide primary stability and to prevent 
migration. The primary stability of the stem, which has a narrow tip to guide the implant, 
is optimised by metaphyseal anchoring: intimate trabecular bone contact and optimised 
load transfer to the dynamic bone through to the posterolateral angle situated in the axis 
of the neck. Secondary stability (prevention of migration) is facilitated by optimizing bone 
in-growth surface through full hydroxyapatite coating on macro-structured titanium and 
grooves on A/P sides.
The cemented hemiarthroplasty used in our study is the Müller Straight Stem 
prosthesis (Zimmer, Warsaw, USA), developed with the advice of Professor M.E. Müller. 
It has now been in use reliably for many years; Ried et al. found a 15-year survival of 
94%. [8] The fluted structure of the stem, with the two particularly marked longitudinal 
grooves AP in the stem axis, enables good cement adhesion. The small proximal collar 
serves to compress the cement, prevents the stem from sinking into the cement, and, 
together with the fine-blasted surface of the straight stem, achieves a stable anchorage 
of the implant.
Both prostheses have a unipolar head.
Methods and design
Study design
A single blinded randomised clinical multicentre trial will be conducted. Patients will be 
randomised to 2 groups of 100 in the operation theatre by a randomisation computer 
(IRIS®, SDS Medical, The Netherlands). The treatment will be either a cemented 
hemiarthroplasty or a non-cemented hemiarthroplasty. If complications occur during the 
procedure, the surgeon can change the procedure to ensure best medical practice.
We acknowledge the possibility that the patients might be able to tell which prosthesis 
they have received due to seeing their X ray during the outpatient clinic visits.
All patients with a displaced femoral neck fracture who are admitted to one of the 
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of (mental) incompetence of the patient his/her legal representative is consulted to 
obtain informed consent.
The study design, procedures and informed consent are approved by the Medical 
Ethical Committee of South West Netherlands.
Trial number Netherlands Trial Registry NTR 1508, http:/ /www.trialregister.nl
Study population
The study will be conducted at the Orthopaedic Departments of the Reinier de Graaf 
Gasthuis Delft, Ziekenhuis Rijnstate Alysis Zorggroep Arnhem, Canisius Wilhelmina 
Ziekenhuis Nijmegen and Elisabeth Ziekenhuis Tilburg.
Authors PP and AV will be responsible for the data and safety monitoring.
Inclusion criteria: patients aged = 70 years, with a displaced femoral neck fracture 
(Garden type III or IV) not older than 7 days are included.
Exclusion criteria: patients with a pathological fracture, a fracture older than 7 days or 
ASA-V classification are excluded.
Accrual is planned in the period from August 2008 to August 2009.
Intervention
Patients will be receive either a cemented hemiarthro-plasty, type Müller Straight Stem 
(Zimmer, Warsaw USA), or a non-cemented hemiarthroplasty, type DB-10 (Biomet, 
Warsaw USA). Every surgeon will use the same surgical approach for all implants – 
either straight lateral or posterolateral. The approach of choice is up to the surgeon’s 
preference, as Parker’s Cochrane analysis has shown that insufficient evidence is available 
for superiority of either approach. [9]
Anaesthesia, analgesia and postoperative physical therapy will be standardized in 
both groups.
Study variables
Preoperatively, social demographic data, the ASA classification, Groningen Activity 
Restriction Scale (GARS, from which the Parker mobility score can be derived) and the 





































The main outcome measures of this study are the functional results, complication 
rate and duration of surgery of the hemiarthroplasty.
Primary outcome measures
• Duration of surgery is defined as skin-to-skin surgical time, measured in minutes. 
• Complications, divided in major and minor complications, are recorded during the 
follow up period of 1 year. The complications are ranked in the modified Elixhauser mode, 
as described by Parvizi.[11] 
• Functional outcome is measured by the Timed-Up-and-Go (TUG) score and the 
Groningen Activity Restriction Scale (GARS). [10,14] 
• Postoperative mid-thigh pain is defined as pain explicit in the front and mid part of 
the femur, and scored on a 4-point ordinal scale (non/mild/moderate/severe). 
Secondary outcome measures
Living conditions at final follow up are measured in percentage of pre-fracture situation.
• Self reported health-related quality of life is measured by the SF 12. [13] 
• Standard radiological evaluation of hemiarthroplasty and cement positioning 
and adequate size of the hemiarthroplasty measured on plain AP and axial X-rays of the 
operated hip. Adequate AP positioning is defined as less than 10 degrees varus or valgus. 
Adequate axial positioning is defined as 0–15 degrees anteversion. 
Follow up
The primary follow up for each patient will be 1 year. The first postoperative assessment 
will be in a clinical setting as the patient is still in the hospital. Assessments at 6, 12 and 
52 weeks postoperatively will be made in the outpatient clinic, unless the patient is not 
able to visit the out-patient clinic; in that case questionnaires are mailed to the patient 
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Determination of sample size
(a) Duration of surgery
It is expected that a cemented hemiarthroplasty on average will take 12 min longer than a 
non-cemented hemiarthroplasty. Taking into account an estimated standard deviation of 
12 min, a 1-year mortality of 25% and 10% of patients being lost to follow up or providing 
insufficient data we need a minimum of 46 patients per group.
(b) Functional outcome
Only for patients who are admitted from their own homes or assisted living facilities, 
functional outcome is measured by the Timed-Up-and-Go (TUG) score and the Groningen 
Activity Restriction Scale, and mid-thigh pain a non-inferiority design is used. [10,14]
• TUG performed; Giving the fact that at discharge with a cut-off point of over 30 
seconds is significantly associated with falls. Less than 24 seconds is considered good 
functioning and has hardly any chance to fall. 42 seconds is considered poor functioning 
with a considerable chance to fall. [14] About 30% of the patients have a poor score at 
discharge. About 70% of all patients are admitted from their own homes or assisted living 
facilities. If non-inferiority is considered for TUG, a worsening of score from 30 to 42 is 
considered clinically relevant, with a SD of 10 sec., giving 16 patients a group. Corrected 
for the percentage admitted from home or assisted living facility (70%) and the drop out 
of 35% gives 34 patients a group 
• GARS: The GARS data for this group of patients are insufficient to make valid 
calculations of statistical power. While data for multiple sclerosis patients and healthy 
older patients are available, there are none for patients with a hip fracture. An estimate 
is made based on preliminary data from a prospective survey in progress. As soon as 
sufficient data from this survey are available a final power calculation for GARS will be 
done.
• Mid thigh pain
Rather varying figures about mid-tight pain are reported in literature. D’Lima [5] reported 
40 vs. 3% whereas v/d Wal et al. [15] reported 20 vs. 12% in non-tight proximal fit 
prosthesis. Therefore the average values of these two studies are taken.
π1 = 30%, π 2 = 7.5%, π = (30%+7.5%)/2 = 18.75%
n






































If the 25% 1-year mortality combined with expected 10% lost-to follow-up (or missing 
values) is taken into account this number is raised by 35%, then a total of 86 patients a 
group is needed. [16]
(c) Complications
The complication rate in this patient category is rather high, but heterogeneous. The rate 
of thromboembolic complications may depend on the type of intervention (cemented vs. 
non-cemented).
However, the incidence of deep vein thrombosis (DVT) and pulmonary embolism 
(PE) is such that an unachievable high number of patients is needed to acquire adequate 
power.
In conclusion, the total number of patients per group is set on 100, making a total of 
200 patients is needed for this study.
Statistical analysis
Primary outcome measures
The differences in operation time, mid-thigh pain, complications and TUG test will be 
analyzed using a Student’s t-test, setting the level of significance at p < 0.05.
Secondary outcome measures
We will use the chi-squared test or Fisher’s exact test for the binary variables. In cases of 
paired binary data (out-come variables) we will use the McNemar test and a paired t-test 
for mean differences. In the case of a statistically significant association (p < 0.05), we will 
use a logistic regression to model the probability/odds of an outcome.
The variables obtained from the clinical evaluation will be tabulated and analysed as 
mean, standard deviation, minimum and maximum values. All analyses will be performed 
using SPSS software (SPSS Inc., Chicago, IL, USA).
Kaplan Meijer survival analysis will be done after final follow up, using failure 







































In the treatment of displaced femoral neck fractures with hemiarthroplasty in elderly 
patients the use of bone cement is a controversial topic. A cemented hemiarthroplasty 
has been used in the majority of cases in most countries, but the non-cemented prosthesis 
is gaining popularity. Parker et al. [1] concluded that there is only limited evidence from 
randomised studies that cementing prosthesis in place may reduce the amount of post-
operative pain and may lead to improved mobility. Furthermore no study has adequately 
addressed long-term outcome measures concerning this topic.
Cementing has potential physiologically adverse side effects. The major side effects 
are cardiac arrhythmias and cardio-respiratory collapse, which occasionally occur upon 
application; these potentially fatal complications are caused either by embolism from 
marrow contents forced into the circulation or by a direct toxic effect of the cement. 
[7] Transesophageal echocardiography could be used to monitor emboli during surgery, 
but logistics prevent this in our centres, as most patients are operated outside regular 
working hours. Nevertheless, Pitto et al. [17] have already shown severe embolic events 
and intraoperative pulmonary impairment during fixation of the cemented femoral 
component in total hip arthroplasty, while fixation without cement clearly demonstrated 
a low risk of embolism. Clark et al. [18] found a transient but significant reduction in 
cardiac output and stroke volume for those receiving cement.
In non-cemented prostheses, bone quality is of importance; this is generally poor 
in elderly patients. LaPorte et al. [19] stated two relative contraindications for non-
cemented total hip prosthesis: interference with bone in-growth and inability to achieve 
a congruent fit; both of these preclude establishment of rigid initial stability.
The purpose of this study is to compare treatment for displaced femoral neck fracture 
by cemented versus non-cemented hemiarthroplasty. We hypothesise that, relative to 
cemented hemiarthroplasty, non-cemented hemiarthroplasty will result in at least the 
same technical-functional outcome and complication rate, with a shorter operation time. 
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